Home Cart Sign in  
Chemical Structure| 69-93-2 Chemical Structure| 69-93-2

Structure of Uric acid
CAS No.: 69-93-2

Chemical Structure| 69-93-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Uric acid activates NFκB in a variety of cell culture models including proximal tubular cells. Uric acid suppresses 1-α hydroxylase mRNA and protein expression in dose dependent and time dependent manner.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Brandt, Tiffany J ; Skaggs, Hayden ; Hundley, Thomas ; Yoder-Himes, Deborah R ;

Abstract: Staphylococcus aureus asymptomatically colonizes the nasal cavity and pharynx of up to 60% of the human population and, as an opportunistic pathogen, can breach its normal habitat, resulting in life-threatening infections. S. aureus infections are of additional concern for populations with impaired immune function such as those with cystic fibrosis (CF) or chronic granulomatous disease. Multi-drug resistance is increasingly common in S. aureus infections, creating an urgent need for new antimicrobials or compounds that improve efficacy of currently available antibiotics. S. aureus biofilms, such as those found in the lungs of people with CF and in soft tissue infections, are notoriously recalcitrant to antimicrobial treatment due to the characteristic metabolic differences associated with a sessile mode of growth. In this work, we show that another CF pathogen, Burkholderia cenocepacia, produces one or more secreted compounds that can prevent S. aureus biofilm formation and inhibit existing S. aureus biofilms. The B. cenocepacia-mediated antagonistic activity is restricted to S. aureus species and perhaps some other staphylococci; however, this inhibition does not necessarily extend to other Gram-positive species. This inhibitory activity is due to death of S. aureus through a contact-independent mechanism, potentially mediated through the siderophore pyochelin and perhaps additional compounds. This works paves the way to better understanding of interactions between these two bacterial pathogens.

Keywords: Burkholderia cenocepacia ; Staphylococcus aureus ; biofilm ; inhibition

Purchased from AmBeed: ; ; ; ;

Alternative Products

Product Details of Uric acid

CAS No. :69-93-2
Formula : C5H4N4O3
M.W : 168.11
SMILES Code : O=C(NC(N1)=C2NC1=O)NC2=O
MDL No. :MFCD00005712
InChI Key :LEHOTFFKMJEONL-UHFFFAOYSA-N
Pubchem ID :1175

Safety of Uric acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Isoform Comparison

Biological Activity

Description
Uric acid acts as a scavenger of oxygen radicals and is a crucial antioxidant that helps maintain blood pressure stability and manage oxidative stress. It effectively removes reactive oxygen species (ROS) such as singlet oxygen and peroxynitrite, thus preventing lipid peroxidation[1].[2].

In Vitro:

Cell Line
Concentration Treated Time Description References
HL-60 cells (differentiated into neutrophil-like cells, dHL-60) 0.2, 0.5, 2 mM 1, 2, 3 hours To evaluate the effect of uric acid on the bactericidal activity of dHL-60 cells. Results showed that uric acid significantly inhibited the bactericidal activity of dHL-60 cells against PA14 and reduced the release of inflammatory cytokines IL-1β and TNF-α. Redox Biol. 2018 Jun;16:179-188

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
PLSJL mice and IFN-γ receptor knockout mice Experimental allergic encephalomyelitis (EAE) Intraperitoneal injection 500 mg/kg Four times daily for 7 days or longer To evaluate the therapeutic effects of uric acid on EAE. Uric acid treatment significantly improved clinical symptoms of EAE and increased survival rates in mice. Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):675-80

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00664144 Hyperuricemia Phase 2 Terminated(due to poor enrollm... More >>ent) Less << - Belgium ... More >> Sanofi-Aventis Administrative Office Diegem, Belgium France Sanofi- Aventis Administrative Office Paris, France Germany Sanofi-Aventis Administrative Office Berlin, Germany Italy Sanofi-Aventis Administrative Office Milan, Italy Less <<
NCT00477789 Chronic Heart Failure Phase 4 Completed - Italy ... More >> Division of Cardiology, University Hospital of Verona Verona, Italy, 37129 Less <<
NCT00290992 Nutritional and Metabolic Dise... More >>ases Less << Phase 2 Completed - Japan ... More >> Sanofi-Aventis Tokyo, Japan Less <<
NCT00174915 Gout Phase 3 Completed - -
NCT00325195 Gout Phase 3 Completed - -
NCT02187029 Gout Phase 1 Terminated(B7911002 was premat... More >>urely discontinued due to a safety concern that led to decision to terminate the study on 10 Nov 2014) Less << - United States, Florida ... More >> MRA Clinical Research, LLC Miami, Florida, United States, 33143 Miami Research Associates, Inc. South Miami, Florida, United States, 33143 United States, Kansas Vince and Associates Clinical Research Inc. Overland Park, Kansas, United States, 66211 Vince and Associates Clinical Research, Inc. Overland Park, Kansas, United States, 66212 Less <<
NCT00325195 - Completed - -
NCT00174915 - Completed - -
NCT01472692 Prehypertension ... More >> Gout Pulse Wave Velocity Hypertension 24 Hour Blood Pressure Less << Phase 4 Completed - United States, California ... More >> Univerisity Of California San Diego San Diego, California, United States, 92037 Less <<
NCT03511248 Heart Failure ... More >> Heart Failure, Systolic Less << Phase 2 Recruiting December 2020 United Kingdom ... More >> Queen Mary University of London Recruiting London, United Kingdom Contact: Prof Amrita Ahluwalia, BSc PhD       a.ahluwalia@qmul.ac.uk    Contact: Dr Christopher P Primus, MBBS BSc MRCP       c.primus@qmul.ac.uk    Principal Investigator: Amrita Ahulwalia, BSc PhD          Sub-Investigator: Christopher P Primus, MBBS BSc MRCP          Principal Investigator: Simon Woldman, MD FESC FRCP          Principal Investigator: Ceri Davies, MD FRCP FESC          Sub-Investigator: Charlotte Manisty, MBBS PhD MRCP          Sub-Investigator: Shanti Velmurugan, MBBS PhD MRCP          Sub-Investigator: Clement Lau, MBChB BMedSci MRCP          Sub-Investigator: Krishnaraj Rathod, MBBS BMedSci MRCP Less <<
NCT03506919 Treatment of Arthritis Phase 1 Phase 2 Recruiting June 30, 2018 Pakistan ... More >> clinical trial was conducted in Bahawalpur, and Rawalpindi Recruiting Bahawalpur, Punjab, Pakistan, 062 Contact: Muhammad Asif, Ph.D    923346911256    doctor.asif101@gmail.com    Principal Investigator: Muhamamd Bilal, M. PHil Less <<
NCT02129764 Heart Failure, Hyperuricemia Phase 2 Phase 3 Completed - China, Hebei ... More >> Shijiazhuang, Hebei, China, 050031 Less <<
NCT02187029 - Terminated(B7911002 was premat... More >>urely discontinued due to a safety concern that led to decision to terminate the study on 10 Nov 2014) Less << - -
NCT01973088 - Unknown - -
NCT00174967 Gout Phase 2 Completed - -
NCT00174967 - Completed - -
NCT01077284 Hyperuricosuria ... More >> Kidney Stones Less << Phase 2 Completed - -
NCT02837198 Hyperuricemia Phase 2 Completed - Japan ... More >> Tokyo, Japan Less <<
NCT01077284 - Completed - -
NCT00111657 Gout Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01510769 Tophaceous Gout Phase 3 Completed - -
NCT00111657 - Completed - -
NCT02038179 Pre-hypertension ... More >> JNC 7 Stage I Hypertension Less << Phase 2 Phase 3 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT02371421 Hyperuricemia, Gout Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01510769 - Completed - -
NCT01568879 Recurrent or Tophaceous Gout Not Applicable Completed - United States, California ... More >> Kaiser Permanente Northern California Medical Facilities All KPNC Facilities, California, United States Less <<
NCT03495999 - Terminated(The study interest ... More >>was reached) Less << - Taiwan ... More >> Tri-service General Hospital, songshan branch Taipei, Songshan Dist., Taiwan, 105 Less <<
NCT02614469 Healthy Phase 1 Completed - United States, Indiana ... More >> Covance Clinical Research Unit Inc. Evansville, Indiana, United States, 47710 Less <<
NCT02500641 Gout Phase 4 Completed - Germany ... More >> Dresden, Germany Italy Avezzano, Italy Bologna, Italy Brescia, Italy Chieti, Italy Coppito, Italy Netherlands Reade Amsterdam, Netherlands Poland Gdansk, Poland Grudziadz, Poland Katowice, Poland Krakow, Poland Lodz, Poland Warsaw, Poland Zgierz, Poland Romania Bucharest, Romania Craiova, Romania Timisoara, Romania Serbia Belgrade, Serbia Less <<
NCT03157960 Chronic Kidney Diseases ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Recruiting November 30, 2019 Sweden ... More >> Karolinska University Hospital Recruiting Stockholm, Sweden, 17176 Contact: Neda R Ekberg, M.D./Ph.D.    +46-51770000    neda.ekberg@ki.se Less <<
NCT00921375 Hyperuricemia Phase 3 Completed - India ... More >> Dr. Raghunathrao Hyd, Andhra Pradesh, India Less <<
NCT03375632 Hyperuricemia With or Without ... More >>Gout Less << Phase 1 Completed - Japan ... More >> Mochida Investigational sites Tokyo, Japan Less <<
NCT03353298 Renal Transplant Donor of Left... More >> Kidney Renal Transplant Donor of Right Kidney Less << Phase 2 Recruiting December 31, 2021 Norway ... More >> Oslo University Hospital Recruiting Oslo, Norway Contact: NE Langberg       nlangb@ous-hf.no    Contact: DO Dahle       dagdah@ous-hf.no    Principal Investigator: DO Dahle Less <<
NCT02614469 - Completed - -
NCT01407874 Gout Hyperuri... More >>cemia Arthritis Joint Disease Renal Insufficiency Less << Phase 2 Completed - United States, Alabama ... More >> Mobile, Alabama, United States, 36608 United States, Arizona Peoria, Arizona, United States, 85381 United States, California Irvine, California, United States, 92618 United States, Florida Oldsmar, Florida, United States, 34677 United States, Hawaii Honolulu, Hawaii, United States, 96814 United States, Kansas Newton, Kansas, United States, 67114 United States, Tennessee Knoxville, Tennessee, United States, 37923 United States, Texas Dallas, Texas, United States, 75235 San Antonio, Texas, United States, 78215 United States, Virginia Alexandria, Virginia, United States, 22304 Less <<
NCT02797028 Cardiovascular Disease Phase 4 Unknown December 2017 China, Guangdong ... More >> General Hospital of Guangzhou Military Command of People's Liberation Army Recruiting Guangzhou, Guangdong, China, 020 Contact: Hui Dai    020-36653321    daihui66@sina.com    Contact: Yuan Zhang    020-61653566    1035834805@qq.com Less <<
NCT01320722 Renal Function ... More >> Endothelial Function Blood Pressure Overweight Obesity Less << Phase 3 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT03162341 Gout Not Applicable Recruiting November 2020 France ... More >> Hospital Group of the Catholic Institute Recruiting Lomme, France, 59462 Contact: Amélie Lansaux, MD PhD          Principal Investigator: Tristan Pascart, MD          Bichat Hospital Recruiting Paris, France, 75018 Contact: Sébastien Ottaviani, MD       sebastien.ottaviani@aphp.fr    Lariboisière Hospital Recruiting Paris, France, 75475 Contact: Pascal Richette, MD PhD       pascal.richette@aphp.fr Less <<
NCT00985127 Gout Phase 2 Completed - -
NCT01564277 Adult Acute Myeloid Leukemia W... More >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Blastic Phase Chronic Myelogenous Leukemia Contiguous Stage II Adult Burkitt Lymphoma de Novo Myelodysplastic Syndromes Noncontiguous Stage II Adult Burkitt Lymphoma Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Stage I Adult Burkitt Lymphoma Stage III Adult Burkitt Lymphoma Stage IV Adult Burkitt Lymphoma Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Terminated(low accrual) - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT01320722 - Completed - -
NCT00738842 Gout Coronary... More >> Artery Disease Less << Phase 1 Completed - -
NCT02984358 Healthy Not Applicable Completed - -
NCT02903446 Gout Phase 2 Recruiting December 2019 United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Jeff Foster, MPH    205-996-6086    pjfoster@uabmc.edu    Principal Investigator: Angelo L Gaffo, MD, MPH Less <<
NCT01564277 - Terminated(low accrual) - -
NCT00987415 Heart Failure ... More >> Elevated Serum Uric Acid Less << Phase 2 Completed - United States, Georgia ... More >> Morehouse School of Medicine Atlanta, Georgia, United States United States, Massachusetts Harvard University Boston, Massachusetts, United States United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States Mayo Clinic Rochester, Minnesota, United States United States, North Carolina Duke University Medical Center Durham, North Carolina, United States United States, Ohio University Hospitals-Case Medical Center Cleveland, Ohio, United States, 44106 United States, Texas Baylor College of Medicine Houston, Texas, United States United States, Utah Univ. of Utah Health Sciences Center Salt Lake City, Utah, United States United States, Vermont University of Vermont Burlington, Vermont, United States Canada University of Montreal Montreal PQ, Canada Less <<
NCT02642393 Parkinson's Disease Phase 3 Active, not recruiting October 2019 -
NCT03211403 Gout Hyperuri... More >>cemia Less << Phase 1 Completed - Australia, New South Wales ... More >> Atridia Pty Limited Sydney, New South Wales, Australia, 2000 Less <<
NCT01425125 Cerebral Hyponatremia ... More >> SIADH Cerebral Salt-wasting Syndrome Reset Hypothalamic Osmostat Less << Not Applicable Withdrawn - United States, New York ... More >> Winthrop-University Hospital Mineola, New York, United States, 11501 Less <<
NCT03648996 Diabetes Mellitus, Type 2 ... More >> Hyperuricemia Less << Phase 2 Not yet recruiting September 30, 2021 -
NCT00230178 - Completed - -
NCT03336203 Gout CKD Stag... More >>e 1-4 SUA Level (>8 mg/dL; 480 μmol/L) Less << Phase 4 Recruiting March 1, 2021 Ukraine ... More >> Medical Practice Prof D.Ivanov Recruiting Kiev, Ukraine, 01014 Contact: Dmytro Ivanov, MD, Prof    504448788    ivanovdd@i.kiev.ua    Sub-Investigator: Tatyana B Bevzenko, MD, PhD          Sub-Investigator: Oleg B Synyachenko, MD, PhD, Prof          Sub-Investigator: Iryna Yu Golovach, MD, PhD, Prof Less <<
NCT03218709 Hyperuricemia Phase 4 Recruiting April 2018 China, Guangdong ... More >> Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Min Xia, Ph.D       xiamin@mail.sysu.edu.cn    Contact: Yi Guo, Ph.D       guoyi_019@126.com Less <<
NCT00230178 Tumor Lysis Syndrome ... More >> Cancer Hyperuricemia Less << Phase 3 Completed - United States, California ... More >> Alta Bates Comprehensive Cancer Center Berkeley, California, United States, 94704 UCLA Medical Center Los Angeles, California, United States, 90095 United States, Colorado Rocky Mountain Cancer Center Denver, Colorado, United States, 80218 United States, Florida University of Florida Health Science Center at Jacksonville Jacksonville, Florida, United States, 32209 United States, Louisiana Ochsner Clinic Foundation New Orleans, Louisiana, United States, 70121 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York New York Methodist Hospital Brooklyn, New York, United States, 11215 Roswell Park Cancer Institute Buffalo, New York, United States, 14263 University of Rochester Medical Center Rochester, New York, United States, 14642 New York Medical College Valhalla, New York, United States, 10595 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Oregon Oregon Health and Sciences University Portland, Oregon, United States, 97201 United States, Pennsylvania University of Pennsylvania Health Systems Philadelphia, Pennsylvania, United States, 19194 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, West Virginia Mary Babb Randolph Cancer Center Morgantown, West Virginia, United States, 26506-9162 Less <<
NCT00756964 Hyperuricemia Phase 2 Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT00756964 - Completed - -
NCT00987415 - Completed - -
NCT03361618 Infertility Unexplained Not Applicable Completed - Iraq ... More >> Mahmoud Hussein Hadwan Hilla, Babylon, Iraq, 51002 Less <<
NCT03569020 Gout Hyperuri... More >>cemia Less << Not Applicable Recruiting June 30, 2019 United States, Maryland ... More >> Johns Hopkins ProHealth Research Clinic Recruiting Woodlawn, Maryland, United States, 21207 Contact: Jeanne Charleston, RN    410-281-1600    digo@jhu.edu    Contact: Beiwen Wu, MSPH    410-281-1600    digo@jhu.edu    Principal Investigator: Edgar R Miller, MD, PhD          Sub-Investigator: Stephen P Juraschek, MD, PhD          United States, Massachusetts Massachusetts General Hospital Active, not recruiting Boston, Massachusetts, United States, 02114 Less <<
NCT02063997 Gout Phase 2 Completed - -
NCT02671656 - Unknown April 2016 France ... More >> Service de Rhumatologie, Hôpital Lariboisière Not yet recruiting Paris, France, 75010 Contact: Thomas BARDIN, MD, PhD    33 1 49 95 62 90    thomas.bardin@lrb.aphp.fr Less <<
NCT03580226 - Completed - -
NCT03274063 Gout Not Applicable Not yet recruiting March 2021 -
NCT01881919 Hyperuricemia ... More >> Gout Kidney Calculi Diabetes Cardiovascular Disease Less << Early Phase 1 Completed - United Kingdom ... More >> School of Food Science and Nutrition Leeds, West Yorkshire, United Kingdom, LS2 9JT Less <<
NCT02344602 Type 1 Diabetes Mellitus Phase 4 Completed - Canada, Ontario ... More >> Renal Physiology Laboratory, University Health Network Toronto, Ontario, Canada, M5G 2N2 Less <<
NCT03168711 Amyotrophic Lateral Sclerosis Phase 2 Recruiting January 2020 United States, Florida ... More >> Holy Cross Hospital Recruiting Fort Lauderdale, Florida, United States, 33308 Contact: Lindita Burba    954-489-4314    Lindita.burba@holy-cross.com    Contact: Franco Salas    954-229-7965    franco.salas@holy-cross.com    Principal Investigator: Eduardo Locatelli, MD, MPH          United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Jianing (Ning) Liu    617-726-1880    jliu45@mgh.harvard.edu    Principal Investigator: Katharine Nicholson, MD          United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Valerie Ferment    612-301-1535    ferm0016@umn.edu    Principal Investigator: David Walk, MD Less <<
NCT00793585 - Completed - -
NCT02598596 Gout Phase 2 Recruiting April 2020 United States, Alabama ... More >> University of Alabama at Birminingham Recruiting Birmingham, Alabama, United States, 35294 Rheumatology Associates of North Alabama Recruiting Huntsville, Alabama, United States, 35801 United States, California Pacific Arthritis Center Medical Group Withdrawn Santa Maria, California, United States, 93454 United States, Maryland The Center for Rheumatology and Bone Research Recruiting Wheaton, Maryland, United States, 20902 United States, Massachusetts Clinical Pharmacology Study Group Recruiting Worcester, Massachusetts, United States, 01609 United States, Michigan Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 United States, Minnesota Saint Paul Rheumatology Recruiting Eagan, Minnesota, United States, 55121 United States, New York Montefiore Medical Center Recruiting Bronx, New York, United States, 10467 Buffalo Rheumatology and Medicine Recruiting Orchard Park, New York, United States, 14127 United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 United States, Pennsylvania Altoona Center for Clinical Research Recruiting Duncansville, Pennsylvania, United States, 16635 United States, South Carolina ACME Research, LLC Recruiting Orangeburg, South Carolina, United States, 29118 Less <<
NCT00241839 Cardiovascular Diseases ... More >> Heart Diseases Hypertension Less << Phase 3 Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT01158911 - Completed - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 Less <<
NCT00833690 Parkinson Disease Phase 2 Completed - United States, California ... More >> University of Southern California Los Angeles, California, United States, 90083 United States, Connecticut Eastern Connecticut Neurology Specialists, LLC Manchester, Connecticut, United States, 06040 Institute for Neurodegenerative Disorders New Haven, Connecticut, United States, 06510 United States, Florida Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton, Florida, United States, 33486 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Louisiana Ochsner Clinic Foundation New Orleans, Louisiana, United States, 70121 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Boston University Medical Center Boston, Massachusetts, United States, 02118 United States, Michigan Michigan State University East Lansing, Michigan, United States, 48824 United States, Minnesota Struthers Parkinson's Center Golden Valley, Minnesota, United States, 55427 United States, North Carolina Duke University School of Medicine Durham, North Carolina, United States, 27705 United States, Ohio University of Cincinnati Cincinnati, Ohio, United States, 45219 Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Rhode Island Butler Hospital Movement Disorder Program Providence, Rhode Island, United States, 02906 United States, Texas Scott & White Hospital Temple, Texas, United States, 76508 Less <<
NCT01112982 Gout Phase 4 Completed - United States, Florida ... More >> University of South Florida Medical Clinics Tampa, Florida, United States, 33612-4742 Less <<
NCT00868673 Overweight and Obesity ... More >> Metabolic Syndrome Hyperuricemia Less << Not Applicable Completed - Mexico ... More >> Instituto Nacional de Cardiología Igancio Chávez Mexico, Mexico city, Mexico, 14080 Less <<
NCT03316131 Asymptomatic Hyperuricemia Phase 2 Completed - United States, California ... More >> Research Site Glendale, California, United States, 91206 United States, Maryland Research Site Baltimore, Maryland, United States, 21225 Less <<
NCT03395977 Oxidative Stress ... More >> Endothelial Function Cardiovascular System Hypertension Less << Not Applicable Recruiting December 31, 2020 Belgium ... More >> Erasme Hospital Recruiting Brussels, Belgique, Belgium, 1070 Contact: Benjamin De Becker    +32474328542    Benjamin.De.Becker@erasme.ulb.ac.be    Principal Investigator: Benjamin De Becker Less <<
NCT00833690 - Completed - -
NCT00978653 Hyperuricemia ... More >> Chronic Kidney Disease Less << Not Applicable Completed - Turkey ... More >> Istanbul Faculty of Medicine Istanbul, Turkey, 34390 Less <<
NCT00793585 IgA Nephropathy Not Applicable Completed - China, Guangdong ... More >> The 1st Affiliated Hospital, Sun Yet-sen University GuangZhou, Guangdong, China, 510080 Less <<
NCT01589705 - Terminated(Patients recruitmen... More >>t and analysis were terminated) Less << - Turkey ... More >> Erciyes University Medical School Kayseri, Turkey, 38039 Less <<
NCT02959918 Gout Chronic ... More >>Hyperuricemia Less << Phase 2 Active, not recruiting January 2019 United States, California ... More >> Anaheim Clinical Trials Anaheim, California, United States, 92801 Tri West Research Associates LLC El Cajon, California, United States, 92020 Irvine Center for Clinical Research Inc. Irvine, California, United States, 92614 United States, Florida Clinical Research of West Florida Clearwater, Florida, United States, 33765 Omega Research Consultants LLC DeBary, Florida, United States, 32713 Compass Research LLC Orlando, Florida, United States, 32806 United States, Hawaii East-West Medical Research Institute Honolulu, Hawaii, United States, 96814 United States, Idaho Advanced Clinical Research Boise, Idaho, United States, 83642 United States, Kentucky L-MARC Louisville, Kentucky, United States, 40213 United States, North Carolina Triad Clinical Trials LLC Greensboro, North Carolina, United States, 27410 United States, Ohio New Horizons Clinical Research Cincinnati, Ohio, United States, 45242 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 United States, Utah Advanced Clinical Research West Jordan, Utah, United States, 84088 Less <<
NCT00241839 - Completed - -
NCT03473951 - Recruiting December 2018 Taiwan ... More >> Tri-service General Hospital, songshan branch Recruiting Taipei, Songshan Dist., Taiwan, 105 Contact: Liu, MD    +886-910682383    issac700319@gmail.com    Principal Investigator: Cheng-Wei Liu, MD          Sub-Investigator: Wei-Cheng Chang, MD Less <<
NCT02502565 - Active, not recruiting March 2019 United States, District of Col... More >>umbia Howard University Hospital Washington, District of Columbia, United States, 20060 WashingtonVAMC Washington, District of Columbia, United States, 20422 Less <<
NCT02502071 Type 1 Diabetes ... More >> Diabetic Nephropathy Diabetic Kidney Disease Less << Phase 4 Completed - United States, Colorado ... More >> Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT02648269 Gout Phase 1 Completed - United States, Arkansas ... More >> Baptist Health Center for Clinical Research Little Rock, Arkansas, United States, 72205 United States, Florida Miami Research Associates Miami, Florida, United States, 33143 Orlando Clinical Research Center, Inc. Orlando, Florida, United States, 32809 United States, Maryland SNBL Clinical Pharmacology Center Inc. Baltimore, Maryland, United States, 21201 United States, Minnesota Davita Clinical Research Minneapolis, Minnesota, United States, 55404 United States, Pennsylvania Altoona Center for Clincal Research Duncansville, Pennsylvania, United States, 16635 Less <<
NCT02502071 - Completed - -
NCT03118739 Hyperuricemia ... More >> Albuminuria Type 2 Diabetes Less << Phase 2 Completed - United States, California ... More >> Research Site Canyon Country, California, United States, 91351 Research Site Chula Vista, California, United States, 91911 Research Site Corona, California, United States, 92882 Research Site Escondido, California, United States, 92025 Research Site Lakewood, California, United States, 90805 Research Site Lincoln, California, United States, 95648 Research Site Los Angeles, California, United States, 90017 Research Site Los Angeles, California, United States, 90022 Research Site Los Angeles, California, United States, 90036 Research Site North Hollywood, California, United States, 91606 Research Site Oceanside, California, United States, 92056-4510 Research Site Orange, California, United States, 92868 Research Site Sacramento, California, United States, 95821 United States, Texas Research Site Houston, Texas, United States, 77058 Research Site Houston, Texas, United States, 77070 Research Site Pearland, Texas, United States, 77584 Research Site Sugar Land, Texas, United States, 77478 Research Site Webster, Texas, United States, 77598 Less <<
NCT02862522 - Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03616418 - Enrolling by invitation August 1, 2020 -
NCT03076684 Hyperuricemia Early Phase 1 Recruiting December 2019 United States, Missouri ... More >> University of Missouri Recruiting Columbia, Missouri, United States, 65212 Less <<
NCT02464605 Gout Phase 1 Completed - United States, Pennsylvania ... More >> Altoona Center for Clincal Research Duncansville, Pennsylvania, United States, 16635 United States, Texas Metroplex Clinical Research Center Dallas, Texas, United States, 75231 Less <<
NCT01532622 Hyperuricemia Not Applicable Completed - United States, Mississippi ... More >> University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 Less <<
NCT01363869 Hyperuricemia ... More >> Gout Less << Not Applicable Completed - Thailand ... More >> Department of Internal Medicine, Faculty of Medicine, Chiang Mai University Chiang Mai, Thailand, 50200 Less <<
NCT03568864 Healthy Not Applicable Completed - United Kingdom ... More >> St Luke's Campus - University of Exeter Exeter, Devon, United Kingdom, EX1 2LU Less <<
NCT00474396 Healthy Not Applicable Completed - -
NCT01830725 - Completed - United States, Mississippi ... More >> Keesler Medical Center Keesler AFB, Mississippi, United States, 39564 Less <<
NCT03425305 - Active, not recruiting February 2019 -
NCT03691688 - Recruiting March 1, 2022 China, Shanghai ... More >> Shanghai Zhongshan Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Shalaimaiti Shali, MD    86+13761553110    shali@zs-hospital.sh.cn    Contact: Yuxiang Dai, MD,PhD    +86-13818988550    dai.yuxiang@zs-hospital.sh.cn    Principal Investigator: Junbo Ge, Professor Less <<
NCT01368185 - Completed - -
NCT00904046 Uric Acid Kidney Stone Disease Not Applicable Recruiting December 2019 United States, Texas ... More >> UT Southwestern Medical Center - Center for Mineral Metabolism Recruiting Dallas, Texas, United States, 75390-8885 Less <<
NCT02891031 Hyperuricemia Not Applicable Recruiting November 2017 Iran, Islamic Republic of ... More >> Shahid Motahhari Clinic, Shiraz University of Medical Sciences Recruiting Shiraz, Fars, Iran, Islamic Republic of Contact: Mesbah Shams, M.D.    +989171115134    shams@sums.ac.ir Less <<
NCT01931527 Obesity Metab... More >>olic Syndrome Hyperuricemia Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT01368185 - Completed - -
NCT01931527 - Completed - -
NCT01825070 Inflammation Not Applicable Completed - United Kingdom ... More >> Northumbria University Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST Less <<
NCT01228903 Kidney Disease Not Applicable Completed - United States, Colorado ... More >> University of Colorado at Denver Aurora, Colorado, United States, 80045 Less <<
NCT00860366 Acute Ischemic Stroke Phase 2 Phase 3 Completed - Spain ... More >> Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital Universitari de Bellvitge Bellvitge, Barcelona, Spain Corporació Sanitària del Parc Taulí Sabadell, Barcelona, Spain, 08208 Hospital Universitari Mútua de Terrassa Terrassa, Barcelona, Spain, 08221 Hospital de Navarra Pamplona, Navarra, Spain, 31008 Hospital General Universitario de Albacete Albacete, Spain, 02006 Hospital de la Santa Creu y Sant Pau Barcelona, Spain, 08025 Hospital Clínic de Barcelona Barcelona, Spain, 08036 Hospital Dr Josep Trueta Girona, Spain, 17007 Hospital Clínico Universitario de Valladolid Valladolid, Spain, 47005 Less <<
NCT01228903 - Completed - -
NCT03512600 Lithiasis, Urinary Not Applicable Completed - Spain ... More >> Universitat de les Illes Balears, IUNICS Palma De Mallorca, Islas Baleares, Spain, 07122 Less <<
NCT03403309 Multiple System Atrophy Phase 2 Not yet recruiting December 31, 2018 -
NCT01323335 Healthy Volunteers Phase 1 Completed - United States, Maryland ... More >> National Institute of Aging, Clinical Research Unit Baltimore, Maryland, United States, 21224 Less <<
NCT02561858 Uric Acid Stones Not Applicable Completed - France ... More >> CHU de Nice Nice, France, 06000 Less <<
NCT02563405 Hypertension Phase 2 Phase 3 Unknown October 2018 China, Heilongjiang ... More >> uric acid test and 24-hour ambulatory BP monitoring Recruiting Harbin, Heilongjiang, China, 150001 Contact: Yujiao Pan, MM    86-451-85555671    panyujiao@163.com Less <<
NCT03306758 Asymptomatic Hyperuricemia ... More >> Gout Less << Not Applicable Not yet recruiting September 30, 2018 -
NCT01523327 - Unknown October 2012 Egypt ... More >> Ain shams maternity hospital Recruiting Cairo, Egypt, 11117 Principal Investigator: nermin marzouk touma, M.B.,B.Ch Less <<
NCT02975986 Uric Acid Nephrolithiasis Not Applicable Recruiting December 2021 United States, Texas ... More >> UT Southwestern Medical Center - Center for Mineral Metabolism Recruiting Dallas, Texas, United States, 75390-8885 UT Southwestern Medical Center Active, not recruiting Dallas, Texas, United States, 75390 Less <<
NCT03531203 Blood Pressure ... More >> Prehypertension Uric Acid Less << Not Applicable Completed - Indonesia ... More >> Mlati 2 Health Center working area (Sumberadi, Tlogoadi,Tirtoadi) Sleman, Yogyakarta, Indonesia, 55284 Less <<
NCT03483532 - Recruiting September 2018 Spain ... More >> Hospital de Manacor Recruiting Manacor, Islas Baleares, Spain, 07500 Contact: Yumaira Elena Hernández Martínez    658666975    yumairah@yahoo.com Less <<
NCT03616769 - Completed - -
NCT03622632 - Recruiting September 2019 Canada, Quebec ... More >> Hôpital du Sacré-Cœur de Montréal Recruiting Montreal, Quebec, Canada, H4J1C5 Contact: Emmanuel Charbonney, MD PhD Less <<
NCT03752567 - Recruiting October 31, 2019 Italy ... More >> Farmacia La Regina dott. Rocco Vito Recruiting San Rufo, Salerno, Italy, 84030 Contact: Raffaele La Regina    0975395336    raffaele.laregina@gmail.com Less <<
NCT03006445 Hyperuricemia With or Without ... More >>Gout Less << Phase 3 Completed - Japan ... More >> Tokyo, Japan Less <<
NCT01025076 Morbid Obesity Phase 2 Completed - Canada, Alberta ... More >> CAMIS, Royal Alexandra Hospital Edmonton, Alberta, Canada, T5H 3V9 Less <<
NCT00302653 Hyperuricemia Phase 4 Completed - Brazil ... More >> Sanofi-aventis administrative office São Paulo, Brazil Less <<
NCT01953497 Healthy Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00610532 Epilepsy Phase 4 Terminated(Investigators decid... More >>ed not to continue) Less << - United States, Ohio ... More >> The Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT03314727 Hypertension ... More >>Sodium Excess Oxidative Stress Inflammation Less << Not Applicable Completed - Turkey ... More >> Koc University Hospital Istanbul, Turkey, 34010 Less <<
NCT00002297 Lymphatic Disease ... More >> HIV Infections Less << Not Applicable Completed - United States, California ... More >> Newport Pharmaceuticals International Inc Laguna Hills, California, United States, 92656 Less <<
NCT00976365 Metastatic Breast Cancer Phase 2 Completed - Taiwan ... More >> National Taiwan University Hospital Taipei city, Taiwan, 110 Less <<
NCT02905448 Hyperlipidemia ... More >> Metabolic Syndrome X Less << Not Applicable Unknown March 2017 -
NCT02094768 Obesity Dysli... More >>pidemia Less << Not Applicable Completed - United States, California ... More >> Cholesterol Research Center Berkeley, California, United States, 94705 Less <<
NCT01547650 - Active, not recruiting February 2023 Japan ... More >> Nagaoka Red Cross Hospital Nagaoka, Niigata, Japan, 940-2085 Less <<
NCT02160496 Weight Loss O... More >>besity Overweight Diet, Reducing Lipids Less << Not Applicable Completed - -
NCT01025076 - Completed - -
NCT02377076 Type 2 Diabetes Mellitus ... More >> Overweight Less << Not Applicable Completed - Brazil ... More >> Metabolism and body composition laboratory, Federal University of Vicosa Viçosa, Minas Gerais, Brazil, 36570-000 Less <<
NCT00567905 Type 2 Diabetes Phase 2 Phase 3 Completed - Taiwan ... More >> Branch of Chinese Medicine, Taipei City Hospital Taipei, Taiwan, 886 Branch of Chinese Medicine Taipei, Taiwan, 886 Less <<
NCT00610532 - Terminated(Investigators decid... More >>ed not to continue) Less << - -
NCT00141310 Pre-Eclampsia Phase 2 Terminated(Study prematurely d... More >>iscont’d 20-Apr-2006 after interim analysis suggested sample size could be reduced without losing power. No safety concerns led to decision.) Less << - United Kingdom ... More >> Pfizer Investigational Site Pembury, Kent, United Kingdom, TN2 4QJ Pfizer Investigational Site Royal Tunbridge Wells, Kent, United Kingdom, TN1 1JU Pfizer Investigational Site Ashton under Lyne, Lancs, United Kingdom, 0L6 9RW Pfizer Investigational Site Bolton, United Kingdom, BL4 0JR Pfizer Investigational Site Dundee, United Kingdom, DD1 9SY Pfizer Investigational Site Fife, United Kingdom, KY2 5RA Pfizer Investigational Site London, United Kingdom, SE1 7EH Pfizer Investigational Site London, United Kingdom, SW10 9NH Pfizer Investigational Site Manchester, United Kingdom, M14 0JH Pfizer Investigational Site Manchester, United Kingdom, M6 8HD Less <<
NCT00509470 Essential Hypertension Phase 4 Completed - Japan ... More >> Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine Tokyo, Japan, 113-8655 Less <<
NCT01500265 - Completed - France ... More >> CHU d'Amiens Amiens, France, 80054 CHU d'Angers Angers, France, 49933 CHU de Besancon Besancon, France, 25000 CHU de Bordeaux - Hôpital Saint André Bordeaux, France, 33000 CHU de Brest Brest, France, 29609 CHU de CAEN Caen, France, 14033 CHU de Clermont Ferrand Clermont Ferrand, France, 63003 AP-HP - Hôpital Beaujon Clichy, France, 92110 Centre Hospitalier Laennec de Creil Creil, France, 60109 Centre Hospitalier d'Hyères Hyères, France, 83407 Centre Hospitalier de La Roche sur Yon La Roche sur Yon, France, 85925 AP-HP - Hôpital Kremlin Bicêtre Le Kremlin Bicêtre, France, 94275 CHU de Lille - Hôpital Huriet Lille, France, 59037 CHU de Limoges - Fédération Hépatologie Limoges, France, 87042 Hospices Civils de Lyon - Hôpital Croix Rousse Lyon, France, 69317 CHU de Montpellier - Hôpital Saint Eloi Montpellier, France, 34295 CHU de Nice Nice, France, 06202 AP-HP - Hôpital La Pitié Salpétrière Paris, France, 75651 AP-HP - Hôpital Bichat Paris, France, 75877 CHU de Bordeaux - Hôpital Haut Levêque Pessac, France, 33604 CHU de Point à Pitre Point à Pitre, France, 97159 CHU de Poitiers Poitiers, France, 86021 CHU de Strasbourg - Hôpital Civil Strasbourg, France, 67091 CHU de Tours - Hôpital Trousseau Tours, France, 37044 CHU de Nancy - Hôpital Brabois Vandoeuvre les Nancy, France, 54511 Less <<
NCT02290613 Systemic Sclerosis ... More >> Pulmonary Hypertension Less << Phase 2 Active, not recruiting July 2018 Germany ... More >> Thoraxclinic at the University of Heidelberg Heidelberg, Germany, 69126 Less <<
NCT03602573 - Recruiting July 31, 2019 Taiwan ... More >> Chang Gung Memorial Hospital Recruiting Taoyuan, Taiwan, 333 Contact: Yi-Cheng Chen, MD    886-3-3281200 ext 8107    yichengliver@gmail.com    Sub-Investigator: Rong-Nan Chien Less <<
NCT01696448 Metabolic Syndrome Not Applicable Completed - United States, Georgia ... More >> Atlanta Vascular Research Foundation Atlanta, Georgia, United States, 30342 Less <<
NCT02295852 Hypertension ... More >>Body Weight Less << Not Applicable Unknown July 2016 Italy ... More >> Hypertention Outpatient Clinic Dept. of Clinica Medica; Federico 2nd University of Naples Recruiting Naples, Italy, 80131 Contact: Aldo L Ferrara, MD    +390817462302    ferrara@unina.it    Contact: Delia Pacioni, Dietician    +390817463688    pacioni@unina.it    Sub-Investigator: Valentina Di Fronzo, MD          Sub-Investigator: Barbara Russo, MD          Sub-Investigator: Viviana Carlino, MD          Sub-Investigator: Francesco Gargiulo, MD          Sub-Investigator: Enza Speranza, Nutritionist Less <<
NCT02559479 Weight Loss O... More >>besity Diabetes Diet, Reducing Carbohydrates Protein Less << Not Applicable Unknown June 2017 Spain ... More >> Fernando Civeira Recruiting Zaragoza, Spain, 50009 Contact: Rocio Mateo-Gallego, RD, PhD    +34 976765500 ext 2895    rmateo.iacs@aragon.es    Contact: Victoria Marco-Benedí, RD    +34 976765500 ext 2895    vito2911@hotmail.com Less <<
NCT00461448 Rheumatoid Arthritis Phase 1 Completed - Iran, Islamic Republic of ... More >> Division of Rheumatoloy, Sina Teaching Hospital, Tabriz Medical Sciences University Tabriz, East Azerbaidjan, Iran, Islamic Republic of Sheikh-ol-Raees Ultra Specialized Clinic Tabriz, East Azerbaidjan, Iran, Islamic Republic of Less <<
NCT01735188 - Completed - -
NCT00360438 Leukemia Lymp... More >>homa Tumor Lysis Syndrome Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02361255 - Recruiting April 2019 United States, Pennsylvania ... More >> PVAMC Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: James Morley    215-823-5800 ext 5934    james.morley@va.gov Less <<
NCT02259153 Lipid Metabolism Disorders ... More >> Sterols Diet, High-Fat Cholesterol Fatty Acids Hyperlipidemias Less << Not Applicable Completed - -
NCT01424917 - Withdrawn(Investigator Left un... More >>iversity) Less << - United States, Minnesota ... More >> Cardiology Division, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00207974 Hyperuricemia, Anserine, Pharm... More >>acokinetic Less << Phase 1 Unknown - Taiwan ... More >> China Medical University Hospital Taichung, Taiwan Less <<
NCT00963118 Metabolic Syndrome Not Applicable Completed - United States, Massachusetts ... More >> Jean Mayer USDA-Human Nutrition Research Center on Aging at Tufts University Boston, Massachusetts, United States, 02111 Less <<
NCT00572403 - Completed - Canada, Ontario ... More >> Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N3M5 Less <<
NCT01907373 Drug Interaction of Olmesartan... More >> in Healthy Chinese Volunteers Less << Phase 4 Completed - China, Hunan ... More >> Center of New Drug Clinical Trial, Hunan Provincial Tumor Hospital (The Affiliated Tumor Hospital of Xiangya Medical School of Central South University) Changsha, Hunan, China, 410006 Less <<
NCT00795847 Hypertension Phase 4 Completed - Japan ... More >> Cardio-vascular Medicine, Kurume University Kurume, Fukuoka, Japan, 830-0011 Less <<
NCT00208000 "Hyperuricemia,Anserine" Phase 2 Unknown April 2006 Taiwan ... More >> China Medical University Hospita Recruiting Taichung, Taiwan, 404 Contact: Chiu-Shong Liu, PhD    886-4-22052121 ext 5068    huang@lsc.net.tw    Contact: Kuo-Chin Huang, PhD    886-4-22052121 ext 5068    huang@lsc.net.tw Less <<
NCT02974478 Healthy Not Applicable Completed - Germany ... More >> Institute of Nutritional Medicine, University of Hohenheim Stuttgart, Germany, 70599 Less <<
NCT03053986 Endothelial Dysfunction Not Applicable Recruiting April 1, 2017 Italy ... More >> S. Orsola-Malpighi University Hospital Recruiting Bologna, Italy, 40038 Contact: Arrigo FG Cicero, MD, PhD    ++39 512142224    arrigo.cicero@unibo.it    Contact: Arrigo FG Cicero, MD, PhD    ++39 3498558017    afgcicero@gmail.com Less <<
NCT00443092 Osteoarthritis Phase 4 Completed - United States, Pennsylvania ... More >> VA Medical Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02081261 - Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT03440164 - Completed - -
NCT01249209 Morbid Obesity Not Applicable Completed - Norway ... More >> Sykehuset Innlandet Kongsvinger Kongsvinger, Norway, 2214 Less <<
NCT02569268 - Completed - -
NCT02190786 Hyperuricemia Phase 2 Completed - Japan ... More >> Tokyo and Other Japanese City, Japan Less <<
NCT01965990 - Completed - Italy ... More >> Clinical Nutrition Unit - A.O.R.N. "San Giuseppe Moscati" Avellino, Italy, 83100 Less <<
NCT00356252 Oxidative DNA Damage Not Applicable Completed - United States, Massachusetts ... More >> Jean Mayer USDA-Human Nutrition Research Center on Aging, Tufts University Boston, Massachusetts, United States, 02111 Less <<
NCT03459703 Obesity Not Applicable Recruiting May 2019 United States, Alabama ... More >> UAB Weight Loss Medicine Clinic Recruiting Birmingham, Alabama, United States, 35205 Contact: David Bryan, M.A.    205-975-0269    dbryan@uab.edu Less <<
NCT00149305 - Terminated(Non significative p... More >>reliminary data) Less << - Italy ... More >> Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 Less <<
NCT01479855 - Unknown December 2013 Norway ... More >> OsloUH, Ullevål Recruiting Oslo, Norway, 0424 Principal Investigator: Ingun D Ulstein, MD PhD Less <<
NCT02224092 Heart Health Markers ... More >> General Nutritional Status Less << Not Applicable Completed - Russian Federation ... More >> Russian Institute of Nutrition Moscow, Russian Federation Less <<
NCT02716870 - Active, not recruiting January 2019 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT00374595 - Active, not recruiting April 2019 United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-1230 Less <<
NCT00980187 Hypertension ... More >>Type 2 Diabetes Mellitus Less << Phase 4 Completed - Romania ... More >> Cardiology, University and Emergency Hospital Bucharest, Romania, 050098 Less <<
NCT00560079 Mania Phase 4 Completed - Brazil ... More >> Hospital Espirita de Porto Alegre Porto Alegre, RS, Brazil, 91720-440 Less <<
NCT01172886 - Unknown - Italy ... More >> Dept. of Senology - National Cancer Institute of Naples Recruiting Naples, Italy, 80131 Contact: immacolata capasso, MD    00393381829067    icapasso@tiscali.it    Principal Investigator: immacolata capasso, MD Less <<
NCT02815839 Gout; Hyperuricemia Phase 1 Completed - China, Sichuan ... More >> Southwest Hospital Chongqing, Sichuan, China, 400038 Less <<
NCT01894659 Neonatal Procedural Pain Not Applicable Active, not recruiting June 2019 United States, California ... More >> Loma Linda University Medical Center Loma Linda, California, United States, 92354 Less <<
NCT03305562 - Enrolling by invitation October 20, 2027 United States, North Carolina ... More >> Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00651001 - Completed - Spain ... More >> Renal Unit of Mateo Orfila Hospital, Balearic Islands - Spain Menorca, Balearic Islands, Spain, 07703 Less <<
NCT02829177 Type 1 Diabetes ... More >> Diabetic Nephropathy Less << Phase 4 Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Less <<
NCT02974491 Oxidative Stress Not Applicable Completed - -
NCT02237339 Hypertension ... More >>Hypertrophy, Left Ventricular Less << Phase 4 Completed - United Kingdom ... More >> University of Dundee, Ninewells Hospital Dundee, Tayside, United Kingdom, DD1 9SY Less <<
NCT02513927 Hypertension Phase 2 Phase 3 Unknown October 2018 Hungary ... More >> Twenty-four-hour ambulatory BP monitoring Recruiting Budapest, Hungary Contact: Jingyan Piao, MM    86-451-85555333    411483521@qq.com    Contact: Yujiao Pan, MM    86-451-85555671    panyujiao@163.com Less <<
NCT02956278 Chronic Gout ... More >>Hyperuricemia Less << Phase 4 Active, not recruiting December 30, 2019 United States, California ... More >> Open Medicine Institute Mountain View, California, United States, 94040 Less <<
NCT00631579 Hyperuricemia ... More >> Leukemia Lymphoma Less << Phase 2 Completed - Japan ... More >> Sanofi-Aventis Tokyo, Japan Less <<
NCT03169257 Obesity, Childhood ... More >> Cardiovascular Diseases Less << Not Applicable Active, not recruiting December 2019 -
NCT03592511 Food Selection ... More >> Metabolic Syndrome Less << Not Applicable Completed - -
NCT03341650 Diet Therapy Not Applicable Completed - Italy ... More >> Department of Food and Drug, University of Parma Parma, Italy, 43125 Less <<
NCT00679679 Polycystic Ovary Syndrome Phase 4 Completed - Argentina ... More >> Hospital Privado de Córdoba Cordoba, Argentina, X5016KEH Less <<
NCT01510158 Gout Phase 3 Completed - -
NCT02017171 Diabetic Nephropathies ... More >> Coronary Artery Disease Less << Phase 3 Active, not recruiting June 2019 -
NCT01508702 Gout Phase 3 Completed - -
NCT01350388 - Completed - -
NCT01510158 - Completed - -
NCT01508702 - Completed - -
NCT01350388 Chronic Kidney Disease ... More >> Diabetes Less << Not Applicable Completed - United States, Utah ... More >> University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT00199043 Adult Acute Lymphocytic Leukem... More >>ia High-Grade Lymphoma Less << Phase 3 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00559624 Leukemia, B-Cell, Chronic Phase 1 Phase 2 Completed - Belgium ... More >> Hematology Department, ZNA Stuivenberg Antwerpen, Belgium Cliniques universitaires Saint-Luc Haematology Dept Brussels, Belgium Hematology Department UZ Gasthuisberg Leuven, Belgium France Hôpital Avicenne Bobigny, France Service des maladies du sang Hôpital HURIEZ, CHRU Lille, France Spain Hematologia Clinica, Institut Catala d'Oncologia Barcelona, Spain, 08907 Hospital Madrid Nortesanchinarro Madrid, Spain, 28050 Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 Less <<
NCT02176499 Hypertension Phase 3 Completed - -
NCT01988402 - Completed - -
NCT00749801 Hyperlipidemia Not Applicable Completed - Taiwan ... More >> Chi Mei Medical Hospital Tainan, Taiwan, 710 Less <<
NCT01808131 Gout Phase 3 Completed - -
NCT01988402 Gout Phase 4 Completed - United States, Texas ... More >> Wilford Hall Ambulatory Surgical Center Lackland Air Force Base, Texas, United States, 78236 Less <<
NCT00563771 Hyperuricemia Phase 4 Completed - Korea, Republic of ... More >> Sanofi-Aventis Seoul, Korea, Republic of Less <<
NCT01808144 Gout Phase 3 Completed - -
NCT02509780 Healthy Not Applicable Completed - Belgium ... More >> CHU Brugmann Brussels, Belgium, 1020 Less <<
NCT00760162 - Completed - United States, New York ... More >> Downstate Medical Center,HSCB, State University of New York Brooklyn, New York, United States, 11203 SUNY DownState Medical Center-Renakl Division Brooklyn, New York, United States, 11203 Less <<
NCT01713023 Type 1 Diabetes Not Applicable Completed - Brazil ... More >> University Hospital of Rio de Janeiro, Federal University of Rio de Janeiro Rio de Janeiro, Brazil, 21941-590 Less <<
NCT02176460 Knee Osteoarthritis Phase 2 Phase 3 Completed - Singapore ... More >> Singapore General Hospital Singapore, Singapore, 169608 Less <<
NCT00230217 Tumors Hyperu... More >>ricemia Tumor Lysis Syndrome Less << Phase 4 Completed - United States, California ... More >> Alta Bates Comprehensive Cancer Center Berkley, California, United States, 94704 United States, Colorado Rocky Mountain Cancer Center Denver, Colorado, United States, 80218 United States, Florida University of Florida Health Science Center at Jacksonville Jacksonville, Florida, United States, 32209 United States, New York New York Medical College Valhalla, New York, United States, 10595 United States, Oklahoma University of Oklahoma HSC Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania University of Pennsylvania Health Systems Philadelphia, Pennsylvania, United States, 19104 United States, West Virginia Mary Babb Randolph Cancer Center Morgantown, West Virginia, United States, 26506-9162 Less <<
NCT01808144 - Completed - -
NCT01109121 Moderate to Severe Gout ... More >> Hyperuricemia Less << Phase 2 Completed - -
NCT01007656 - Completed - -
NCT02338323 Chronic Kidney Disease ... More >> Hyperuricemia Abnormal Renal Function Less << Not Applicable Unknown December 2018 China, Shanghai ... More >> Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital Recruiting Shanghai, Shanghai, China, 200072 Contact: Ai Peng, MD, PhD       pengai@tongji.edu.cn    Contact: Ling Wang, MD, PhD       nowax@126.com    Sub-Investigator: Ling Wang, MD, PhD Less <<
NCT02979106 Hereditary Fructose Intoleranc... More >>e Fructose Metabolism, Inborn Errors Glucose Metabolism Disorders Less << Not Applicable Completed - -
NCT00288158 Obesity Pre-H... More >>ypertension Hyperuricemia Less << Phase 2 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT01007656 Healthy Not Applicable Completed - Taiwan ... More >> PingTung Christian Hospital Pingtung, Taiwan Less <<
NCT02037321 - Unknown December 2017 Canada, Ontario ... More >> Toronto 3-D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT00607152 Hyperuricemia Phase 3 Terminated(the patient enrollm... More >>ent is too difficult) Less << - China ... More >> Sanofi-Aventis Administrative Office Shanghai, China Less <<
NCT01477346 Gout Not Applicable Completed - United Kingdom ... More >> Academic Rheumatology, University of Nottingham Nottingham, United Kingdom, NG5 1PB Less <<
NCT03545581 Hereditary Fructose Intoleranc... More >>e Less << Not Applicable Recruiting April 1, 2019 Belgium ... More >> Guillaume Debray Recruiting Liège, Belgium Contact: Guillaume F Debray, MD    +3242249057    fg.debray@chu.ulg.ac.be Less <<
NCT02564679 Morbid Obesity ... More >> NAFLD Less << Not Applicable Completed - -
NCT01129648 Gout Phase 2 Completed - -
NCT01500343 Heart Failure Phase 2 Completed - Brazil ... More >> Hospital Universitário Antonio Pedro Niteroi, Rio de Janeiro, Brazil, 24033-900 Less <<
NCT00675103 - Completed - -
NCT00675103 Chronic Gout Refractory to Con... More >>ventional Therapy Less << Phase 3 Completed - United States, Illinois ... More >> University of Chicago- Dept. Biological Services Chicago, Illinois, United States, 60637 United States, Maryland The Center for Rheumatology and Bone Research Wheaton, Maryland, United States, 20902 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Oregon Portland Rheumatology Clinic, L.L.C. Lake Oswego, Oregon, United States, 97035 Less <<
NCT01294995 Cardiovascular Diseases Phase 1 Completed - China, Zhejiang ... More >> Department of food science and nutrition Hangzhou, Zhejiang, China, 310029 Less <<
NCT02649140 Urolithiasis Not Applicable Unknown March 2016 China, Guangdong ... More >> Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510230 Contact: Guohua Zeng, Ph.D and M.D    +86 13802916676    gzgyzgh@vip.tom.com    Principal Investigator: Guohua Zeng, Ph.D and M.D          Sub-Investigator: Zhou Yang Less <<
NCT01398748 Parkinson's Disease (PD) Phase 1 Completed - United States, Washington ... More >> Bastyr Clinical Research Center Kenmore, Washington, United States, 98023 Less <<
NCT02623894 - Unknown December 2017 Spain ... More >> Primary care Research unit. La Alamedilla health centre Recruiting Salamanca, Spain, 37003 Contact: Jose I Recio    0034 923124465    Lgarciao@usal.es    Principal Investigator: Manuel A Gomez Marcos, MD          Sub-Investigator: Luis Garcia Ortiz, MD          Sub-Investigator: José I Recio Rodríguez          Sub-Investigator: Yolanda Castaño Sánchez          Sub-Investigator: Emiliano Rodríguez Sanchez, MD          Sub-Investigator: Angel de Cabo Laso          Sub-Investigator: Benigna Sanchez Salgado          Manuel A Gómez Marcos Completed Salamanca, Spain, 37006 Less <<
NCT01893918 - Unknown July 2013 Italy ... More >> Azienda Ospedaliero-Universitaria di Modena Recruiting Modena, Italy, 41100 Contact: Bianca Beghé, MD PhD    +39 059 4225814    bianca.beghe@unimore.it    Contact: Alessia Verduri, MD PhD    +39 059 4225769    alessia.verduri@unimore.it Less <<
NCT02373579 Acute Lymphoblastic Leukemia Phase 2 Completed - -
NCT00600392 - Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02650336 - Completed - China, Guangdong ... More >> Xiaodong Zhaung Guangzhou, Guangdong, China, 510080 Less <<
NCT00694824 - Completed - Italy ... More >> Nhephrology Dialysis Transplantation Unit St.Orsola University Hospital Bologna, Italy, 40100 Less <<
NCT02122146 Neoplasms Phase 1 Terminated(The study was prema... More >>turely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.) Less << - United States, California ... More >> Keck Hospital of USC Los Angeles, California, United States, 90033 LAC&USC Medical Center Los Angeles, California, United States, 90033 USC/Norris Comprehensive Cancer Center / Investigational Drug Services Los Angeles, California, United States, 90033 USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Colorado Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver CTO (CTRC) Aurora, Colorado, United States, 80045 University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Washington Swedish Medical Center Seattle, Washington, United States, 98104 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 Less <<
NCT02029066 Actinic Keratosis Phase 1 Completed - Taiwan ... More >> National Cheng Kung University Hospital Tainan, Taiwan, 70403 Less <<
NCT02702479 - Unknown June 2016 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT01414179 - Unknown December 2011 France ... More >> Centre médecine Preventive Recruiting Vandoeuvre lès Nancy, France, 54500 Contact: Celine Hertz    +33 3 83 15 73 12    cel.hertz@chu-nancy.fr Less <<
NCT02122146 - Terminated(The study was prema... More >>turely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.) Less << - -
NCT03126981 PreDiabetes Not Applicable Active, not recruiting April 30, 2019 United States, Florida ... More >> MB Clinical Research Boca Raton, Florida, United States, 33487 United States, Illinois Illinois Institute for Food Safety and Health (IFSH) at Illinois Instiute of Technology (IIT) Chicago, Illinois, United States, 60616 Less <<
NCT00196755 Peritoneal Dialysis ... More >> Chronic Kidney Disease Less << Phase 3 Completed - Belgium ... More >> UZ Gasthuisberg Leuven, Belgium, B-3000 Denmark Fredericia Sygehus Fredericia, Denmark, DN-7000 Copenhagen University Hospital Herlev, Denmark, DN-2730 Aarhus University Hospital Århus N, Denmark, DN-8200 France CHRU Clémenceau Caen, France, FR-14033 Italy Ospedale civico e benfratelli Palermo, Italy, IT-90127 Ospedale San Bortolo Vicenza, Italy, IT-36100 Netherlands AMC Amsterdam, Netherlands, NL-1105 AZ Spain Fundacion Jimenez Diaz Madrid, Spain, ES-28040 Hospital Universitario La Paz Madrid, Spain, ES-28046 United Kingdom University Hospital ,Queen Elizabeth Hospital Birmingham, United Kingdom, B15 2TH High Wycombe Hospital Buckinghamshire, United Kingdom, HP11 2TT University of Wales College of Medicine Cardiff, United Kingdom, CF 14 4XN Glasgow Western Infirmary Glasgow, United Kingdom, G11 6NT Royal Hospital The Royal London London, United Kingdom, E1 1BB Milton Keynes General Hospital Milton Keynes, United Kingdom, MK6 5LD The Churchill Hospital, Oxford Radcliffe Hospitals NHS Trust Oxford, United Kingdom, OX3 7LJ Less <<
NCT02477163 - Unknown April 2018 India ... More >> P D Patel Ayurveda Hospital Recruiting Nadiad, Gujarat, India, 387001 Contact: Manishkumar V Patel, MD(Ayurveda)    9979589865    manishayu97@yahoo.com Less <<
NCT02213770 - Completed - Norway ... More >> OUS- Rikshospitalet Oslo, Norway, 0424 Less <<
NCT01444807 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Recruiting September 2019 Italy ... More >> Istituto Tumori Milano Recruiting Milan, Mi, Italy, 20156 Contact: Giuseppe Procopio, MD    +390223902557    Giuseppe.Procopio@istitutotumori.mi.it    Contact: Elena Verzoni, MD    +390223902557    elena.verzoni@istitutotumori.mi.it    Principal Investigator: Giuseppe Procopio, MD          Cinzia Ortega Recruiting Alba, Italy Alessandra Bearz Recruiting Aviano, Italy Alfredo Berruti Recruiting Brescia, Italy Saverio Cinieri Recruiting Brindisi, Italy Francesco Atzori Recruiting Cagliari, Italy Rodolfo Passalaqua Recruiting Cremona, Italy Francesco Di Costanzo Recruiting Firenze, Italy Vincenzo Emanuele Chiuri Recruiting Lecce, Italy Alessandra Mosca Recruiting Novara, Italy Vittorio Gebbia Recruiting Palermo, Italy Enrico Cortesi Recruiting Roma, Italy Francesco Cognetti Recruiting Roma, Italy Contact: Michele Milella          Franco Morelli Recruiting San Giovanni Rotondo, Italy Less <<
NCT00745303 - Completed - Taiwan ... More >> Taipei Veterans General Hospital Taipei, Taiwan, 112 Less <<
NCT03672591 - Not yet recruiting March 31, 2019 -
NCT00882336 - Completed - -
NCT01114386 - Completed - Italy ... More >> Azienda Ospedaliero-Universitaria di Modena Modena, Italy, 41124 Less <<
NCT02321553 Metabolic Syndrome Not Applicable Completed - United States, Massachusetts ... More >> Clinical and Translation Research Center, Tufts Medical Center Boston, Massachusetts, United States, 02111 Less <<
NCT02808013 Lower Urinary Tract Symptoms Phase 2 Unknown - -
NCT01814904 Chronic Kidney Disease ... More >> Dialysis Hyperphosphatemia Paediatric Less << Phase 3 Terminated(This study has been... More >> terminated because of insufficient patient recruitment.) Less << - United Kingdom ... More >> Investigational site London, United Kingdom Less <<
NCT01971476 Leukemia Neop... More >>lasms Less << Phase 1 Completed - Belgium ... More >> UNIV UZ Gent Gent, Belgium, 9000 Czechia University Hospital Motol Prague, Czechia, 150 06 France INS Curie Paris, France, 75248 Germany Universitätsklinikum Köln (AöR) Köln, Germany, 50937 Italy Osp. Pediatrico Bambin Gesù Roma, Italy, 00165 Less <<
NCT01838759 - Completed - Turkey ... More >> Bulent Ecevit University Hospital Zonguldak, Turkey, 67300 Less <<
NCT00940797 Diabetes Type 2 Phase 2 Completed - Mexico ... More >> Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, México Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT01977430 Chronic Kidney Insufficiency ... More >> Hemodialysis Treatment Diuresis Preserved Less << Phase 4 Unknown March 2015 Spain ... More >> Corporació Sanitària Parc Taulí Recruiting Sabadell, Barcelona, Spain, 08208 Contact: Mabel - Bolos-Contador, MD    0034937231010 ext 25010    mabeline17@hotmail.com Less <<
NCT01971476 - Completed - -
NCT01845870 - Completed - China, Tianjin ... More >> General Hospital of Tianjin Medical University Tianjin, Tianjin, China, 300052 Less <<
NCT01221714 - Terminated(Ameriscience went b... More >>ankrupt.) Less << - United States, Mississippi ... More >> Mississippi Family Doctors Pearl, Mississippi, United States, 39208 United States, North Carolina Carolina Medical Associates Charlotte, North Carolina, United States, 28226 United States, West Virginia Logan General Hospital Logan, West Virginia, United States, 25601 Less <<
NCT01637168 Memory Deficit Phase 3 Unknown September 2014 Brazil ... More >> Cliníca Dr. Felício Savioli Not yet recruiting Cotia, São Paulo, Brazil, 06710-670 Less <<
NCT02420418 Bipolar Disorder Not Applicable Unknown May 2017 Brazil ... More >> State University of Londrina Not yet recruiting Londrina, Paraná, Brazil, 86.057-970 Contact: Kamila Landucci Bonifácio, MS    +554333386447    kamilalondrina@hotmail.com    Principal Investigator: Kamila Landucci Bonifácio, MS          Principal Investigator: Ana Carolina Rossaneis, PhD Less <<
NCT02521038 - Recruiting January 2018 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Hyo-Soo Kim, MD,PhD    82-2-2072-2226 Less <<
NCT02471261 - Unknown March 2017 United States, Maryland ... More >> The Center for Rheumatology and Bone Research Recruiting Wheaton, Maryland, United States, 20902 Contact: Theresa Bass-Goldman    301-942-6610    tbgoldman@arapc.com    Principal Investigator: Paul J DeMarco, MD          Sub-Investigator: Alan K Matsumoto, MD          Sub-Investigator: Herbert S Baraf, MD          Sub-Investigator: Robert L Rosenberg, MD          Sub-Investigator: Evan L Siegel, MD          Sub-Investigator: Ashley D Beall, MD          Sub-Investigator: Nicole Sadddic-Thomas, MD Less <<
NCT00643123 - Completed - -
NCT02348372 Anaemia Phase 1 Completed - Australia, New South Wales ... More >> GSK Investigational Site Randwick, Sydney, New South Wales, Australia, 2031 Less <<
NCT00893724 Neovascular Age-related Macula... More >>r Degeneration Diabetic Macular Edema Less << Not Applicable Unknown September 2011 United States, West Virginia ... More >> Mid-Atlantic Retina Consultations, Inc. Morgantown, West Virginia, United States, 26505 Less <<
NCT00643123 Bipolar Disorder ... More >> Mixed Mania Treatment-Resistant Mania Less << Phase 4 Completed - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT01982201 Healthy Phase 1 Completed - United States, Michigan ... More >> Kalamazoo, Michigan, United States, 49007 Less <<
NCT03128229 - Recruiting June 2019 United States, Colorado ... More >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80238 Contact: Petter Bjornstad, M.D.          Principal Investigator: Petter Bjornstad, M.D.          Sub-Investigator: Kristen Nadeau, M.D. Less <<
NCT00005520 - Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States Less <<
NCT01855048 Healthy Volunteers ... More >> Anti-Bacterial Agents Methicillin-Resistant Staphylococcus Aureus Less << Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02116751 - Completed - Spain ... More >> Ramon y Cajal Hospital Madrid, Spain, 28034 Less <<
NCT01828528 - Completed - Israel ... More >> Liver Disease Center, Sheba Medical Center, Tel-Hashomer Ramat-Gan, Israel, 52621 Less <<
NCT01038947 Gout Hyperuri... More >>cemia Less << Phase 1 Unknown May 2010 United States, Florida ... More >> MRA Clinical Research Recruiting Miami, Florida, United States, 33143 Contact: Vivian Rosales    305-772-2857    vrosales@miamiresearch.com    Principal Investigator: Patricia Pardo, MD          United States, Pennsylvania Altoona Center for Clinical Research Recruiting Duncansville, Pennsylvania, United States, 16635 Contact: Ellen Kivitz    814-693-0300 ext 224       Principal Investigator: Alan J Kivitz, MD Less <<
NCT02195388 - Completed - Poland ... More >> Departament of Cardiology Lodz, Lodzkie, Poland, 91-347 Less <<
NCT01276288 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> 1245.42.1 Boehringer Ingelheim Investigational Site Neuss, Germany Less <<
NCT01276288 - Completed - -
NCT00095147 Rheumatoid Arthritis Phase 3 Completed - -
NCT01805258 HIV/TB Co-infection Phase 3 Completed - India ... More >> All India Institute of Medical Sciences New Delhi, India, 110029 Less <<
NCT00406575 Congestive Heart Failure (CHF) Phase 2 Terminated - Russian Federation ... More >> Russian Scientific Centre of Surgery n.a. B.V.Petrovsky of Russian Academy of Medical Sciences Moscow, Russian Federation, 119992 Educational Scientific Medical Center of the General Management Department of the President of Russian Federation. City Clinical Hospital №51 Moscow, Russian Federation, 121309 Less <<
NCT01619735 - Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale, Arizona, United States, 85259 United States, California UCSD San Diego, California, United States, 92103 United States, Maryland James Buchanan Brady Urological Institute Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York Bellevue Hospital New York, New York, United States, 10016 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 Ohio State University Columbus, Ohio, United States, 43210 United States, Tennessee Vanderbilt University School of Medicine Nashville, Tennessee, United States, 37232 Canada, British Columbia University of British Columbia Vancouver, British Columbia, Canada Less <<
NCT02189850 Colonoscopy Phase 2 Completed - United States, Arkansas ... More >> Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States United States, Georgia Children's Center for Digestive Health Care Atlanta, Georgia, United States United States, Louisiana Delta Research Partners Bastrop, Louisiana, United States United States, Mississippi Gastrointestinal Associates Jackson, Mississippi, United States United States, New York University of Buffalo Pediatric Associates Buffalo, New York, United States Less <<
NCT01475240 - Completed - United Kingdom ... More >> St Stephen's AIDS Trust London, United Kingdom, SW10 9NH Less <<
NCT00095147 - Completed - -
NCT02422992 - Completed - United States, California ... More >> University of California San Diego, California, United States, 92093 United States, Washington Bastyr University Research Institute Kenmore, Washington, United States, 98028 University of Washington Seattle, Washington, United States, 98195 Less <<
NCT00664001 Acute Mountain Sickness Phase 3 Completed - United Kingdom ... More >> University of Edinburgh Edinburgh, United Kingdom Less <<
NCT00584311 Gout Not Applicable Completed - United States, Florida ... More >> University of South Florida Tampa, Florida, United States, 33612 Less <<
NCT02175654 Colorectal Neoplasms ... More >> Metastatic Disease Less << Phase 2 Terminated(The trial was prema... More >>turely closed due to lack of accrual) Less << - Spain ... More >> Spanish Cooperative Group for Digestive Tumour Therapy (TTD) Madrid, Spain, 28046 Less <<
NCT03733262 - Not yet recruiting March 1, 2020 Canada, British Colombia ... More >> Providence Health Care Not yet recruiting Vancouver, British Colombia, Canada, V6Z 1Y6 Contact: Judith Marin, PharmD    604-806-8146    judith.marin@fraserhealth.ca    Contact: Monica Beaulieu, MD    604 681-7191    MBeaulieu@providencehealth.bc.ca    Canada, Manitoba Manitoba Renal Program Not yet recruiting Winnipeg, Manitoba, Canada, R2V 3M3 Contact: Cali Orsulak, PharmD    204 770-9312    COrsulak@hsc.mb.ca    Contact: Clara Bohm, MD    204-787-3583    CBOHM@hsc.mb.ca    Canada, Nova Scotia Nova Scotia Health Authority Not yet recruiting Halifax, Nova Scotia, Canada Contact: Jo-Anne Wilson, PharmD    902-473-5418    sjawilson@gmail.com    Canada, Ontario University Health Network Not yet recruiting Toronto, Ontario, Canada, M5G 2C4 Contact: Marisa Batistella, PharmD    416-340-4800 ext 3207    marisa.battistella@uhn.ca    Contact: Melissa Lefebvre, MBiotech    4168589786    melissa.lefebvre@uhnresearch.ca Less <<
NCT01902186 HIV Infection ... More >> Osteopenia Less << Phase 4 Terminated(Low enrollment) - Italy ... More >> University of Milano Milano, Italy University of Torino Torino, Italy Less <<
NCT02132728 Metabolic Syndrome Not Applicable Completed - Brazil ... More >> Clinical Hospital of Ribeirao Preto Ribeirão Preto, São Paulo, Brazil, 14049-900 Less <<
NCT03388411 - Recruiting October 12, 2018 Korea, Republic of ... More >> Hallym University Kangnam Sacred Heart Hospital Recruiting Seoul, Korea, Republic of, 07440 Contact: Saeam Shin, M.D.    82-2-829-5695    saeam0304@hallym.or.kr Less <<
NCT01496469 Hypertension Phase 2 Completed - -
NCT01314586 Hypercholesterolemia Not Applicable Completed - United States, Iowa ... More >> Nutrition & Wellness Research Center Ames, Iowa, United States, 50011 Less <<
NCT01496469 - Completed - -
NCT01883167 Healthy Phase 1 Completed - United States, Michigan ... More >> Kalamazoo, Michigan, United States, 49007 Less <<
NCT01466166 - Completed - -
NCT00885989 Healthy Phase 1 Completed - United Kingdom ... More >> Site 1 London, United Kingdom Less <<
NCT02710461 Subjects With Abdominal Obesit... More >>y Less << Not Applicable Completed - Spain ... More >> Institute of Food Science, Technology and Nutrition, National Research Council (ICTAN-CSIC) Madrid, Spain, 28040 Less <<
NCT01137474 Type 2 Diabetes Phase 3 Completed - -
NCT01137474 - Completed - -
NCT01715987 - Terminated - United States, California ... More >> Asian Pacific Liver Center at St. Vincent Medical Center Los Angeles, California, United States, 90057 United States, New York New Discovery LLC New York, New York, United States, 11355 Less <<
NCT01363791 - Unknown March 2016 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Micheal's Hospital Toronto, Ontario, Canada, M5C 2N8 Less <<
NCT01021241 Gout Hyperuri... More >>cemia Less << Phase 1 Unknown March 2010 United States, Florida ... More >> MRA Clinical Research Miami, Florida, United States, 33143 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 Less <<
NCT02741700 Gout Low Medi... More >>cation Adherence Health Related Quality of Life Less << Not Applicable Recruiting February 28, 2021 United States, Alabama ... More >> Birmingham VA Medical Center, Birmingham, AL Recruiting Birmingham, Alabama, United States, 35233 Contact: Jasvinder A Singh, MD MPH    205-933-8101 ext 2280    jasvinder.singh@va.gov    Contact: Holly M Deal, MBA    (205) 933-8101 ext 5301    holly.deal@va.gov    Principal Investigator: Jasvinder A Singh, MD MPH          United States, Missouri St. Louis VA Medical Center John Cochran Division, St. Louis, MO Recruiting Saint Louis, Missouri, United States, 63106 Contact: Amy M Joseph       Amy.Joseph@va.gov    Contact: Ziyad Al-Aly, MD    (314) 289-6485    Ziyad.Al-Aly@va.gov    Sub-Investigator: Amy M. Joseph          United States, Pennsylvania Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Joan M Von Feldt, MD MSEd    215-823-5800    Joan.VonFeldt@va.gov    Contact: Said A Ibrahim, MD MPH MBA    (215) 823-5847    said.ibrahim2@va.gov    Sub-Investigator: Joan M. Von Feldt, MD MSEd          Sub-Investigator: Sally Pullman-Mooar, MD Less <<
NCT01412658 Drug Safety Phase 1 Completed - United States, Texas ... More >> Baylor University Center for Exercise, Nutrition, and Preventive Health Research Waco, Texas, United States, 76706 Less <<
NCT03482284 Dietary Habits ... More >> Endotoxemia Less << Not Applicable Active, not recruiting September 15, 2018 -
NCT01200485 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03388515 Gout Phase 1 Recruiting January 31, 2020 China, Zhejiang ... More >> The First Affilicated Hospital Zhejiang University Recruiting Hangzhou, Zhejiang, China Contact: Jian zhong Shen tu, Doctor    0571-87236560    stjz@zju.edu.cn    Principal Investigator: Jian zhong Shen tu, Doctor Less <<
NCT01814917 Chronic Kidney Disease ... More >> Dialysis Hyperphosphatemia Paediatric Less << Phase 3 Terminated(This study has been... More >> terminated because of insufficient patient recruitment.) Less << - United Kingdom ... More >> Investigational site London, United Kingdom Less <<
NCT00811889 Chronic Kidney Disease ... More >> Type 2 Diabetes Diabetic Nephropathy Less << Phase 2 Completed - -
NCT03092908 Nephrolithiasis Not Applicable Recruiting December 31, 2022 China, Guangdong ... More >> The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Guohua Zeng, Ph.D.    +86 13802916676    gzgyzgh@vip.sina.com    Principal Investigator: Guohua Zeng, M.D.          Sub-Investigator: Wei Zhu, Ph.D. Less <<
NCT02336594 - Completed - -
NCT01138241 - Completed - Thailand ... More >> HIV-NAT, Thai Red Cross AIDS Research Centre Bangkok, Thailand, 10330 Less <<
NCT03207659 Urolithiasis Not Applicable Recruiting December 2018 China, Guangdong ... More >> Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510230 Contact: Guohua Zeng, Ph.D & MD.    +86 13802916676    gzgyzgh@vip.sina.com    Principal Investigator: Guohua Zeng, Ph.D & MD.          Sub-Investigator: Chao Cai, PH.D & MD Less <<
NCT01265264 Gout Hyperuri... More >>cemia Arthritis Joint Disease Less << Phase 2 Completed - -
NCT02336594 Gout Phase 1 Completed - United States, Texas ... More >> Austin, Texas, United States, 78744 Less <<
NCT03527277 Cardiovascular Risk Factor ... More >> Type2 Diabetes Mellitus Insulin Sensitivity Metabolic Syndrome Less << Not Applicable Recruiting March 31, 2023 United States, California ... More >> University of California, Davis Recruiting Davis, California, United States, 95616 Contact: Kimber Stanhope, Ph.D.    530-752-3720    klstanhope@ucdavis.edu    Contact: Vivien Lee, B.S.    530-752-2714    vilee@ucdavis.edu Less <<
NCT03599700 - Not yet recruiting December 31, 2021 Egypt ... More >> Clinical Hematology Unit Active, not recruiting Assiut, Egypt, 22413749 Less <<
NCT02891954 Diabetes Mellitus, Type 2 Phase 1 Enrolling by invitation June 30, 2023 -
NCT03405350 Osteoarthritis ... More >> Degenerative Disc Disease Less << Not Applicable Completed - -
NCT03543774 Hypercholesterolemia ... More >> Chronic Kidney Diseases Less << Phase 4 Recruiting September 15, 2019 Vietnam ... More >> Hue University of Medicine and Pharmacy Recruiting Hue, Thua Thien Hue, Vietnam, 0234 Contact: Nguyen Thanh Thao    84.234.3822873    hcmp@huemed-univ.edu.vn    Contact: Nguyen Thanh Thao    84.234.3822873    thaonrad@gmail.com    Principal Investigator: Duong Thi Ngoc Lan, Master          Sub-Investigator: Le Van An, A/Professor Less <<
NCT03235336 - Recruiting December 2018 China, Sichuan ... More >> Sichuan Hospital Recruiting Chengdu, Sichuan, China Contact: Shufa Dr       chns@unc.edu Less <<
NCT02219516 Gout Phase 1 Completed - United States, Colorado ... More >> Lakewood, Colorado, United States, 80228 United States, Florida Orlando, Florida, United States, 32809 United States, Minnesota Minneapolis, Minnesota, United States, 55404 United States, Tennessee Knoxville, Tennessee, United States, 37920 Less <<
NCT02147002 Chronic Kidney Disease ... More >> Cardiovascular Complications Less << Not Applicable Unknown December 2014 Poland ... More >> 1Katedra i Klinika Nefrologii, Nadciśnienia Tętniczego i Chorób Wewnętrznych, Bydgoszcz Recruiting Bydgoszcz, Kujawsko-pomorskie, Poland, 85-094 Contact: Agnieszka Pluta, dr    693716980 ext 0048    agnieszkapluta@poczta.onet.pl    Principal Investigator: Paweł Stróżecki, dr Less <<
NCT01310673 Gout Gout Acu... More >>te Less << Phase 4 Completed - United States, Vermont ... More >> White River Junction VA Medical Center White River Junction, Vermont, United States, 05009 Less <<
NCT01100580 Urinary Stones ... More >> Hypertension Overweight Obesity Less << Not Applicable Unknown May 2012 Italy ... More >> University of Parma Not yet recruiting Parma, Italy, 43100 Contact: Loris Borghi, Prof    +390521703375    loris.borghi@unipr.it    Principal Investigator: Loris Borghi, Prof Less <<
NCT02219516 - Completed - -
NCT02996539 - Completed - China, Yunnan ... More >> Internal medicine department, Kunming First People's Hospital Kunming, Yunnan, China, 650000 Less <<
NCT02018237 Nonalcoholic Fatty Liver Disea... More >>se Obesity Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT02524678 Healthy Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT02214589 Prevention of Procedural Pain ... More >> Reduction of Procedural Pain Biochemical Effects of Oral Sucrose Less << Not Applicable Recruiting July 2019 United States, California ... More >> Loma Linda University Children's Hospital Recruiting Loma Linda, California, United States, 92354 Contact: Danilyn M Angeles, PhD    909-558-7563    dangeles@llu.edu Less <<
NCT03206411 - Recruiting November 30, 2018 Egypt ... More >> Assiut University Recruiting Assiut, Egypt Less <<
NCT01157936 Systolic and Diastolic Blood P... More >>ressure Levels Uric Acid Levels Metabolic Syndrome Parameters Hepatic Enzymes Less << Phase 2 Completed - Mexico ... More >> Insituto Nacional de Cardiología Ignacio Chávez Mexico, Mexico, 14080 Less <<
NCT01775098 Gout Not Applicable Withdrawn(because of a lack of... More >> funding) Less << - -
NCT01698489 - Active, not recruiting April 2020 United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287 Less <<
NCT03105583 - Enrolling by invitation October 2017 -
NCT01788358 Hypertension Phase 3 Completed - -
NCT01788358 - Completed - -
NCT01409408 Hypertension ... More >>Diabetes Mellitus Less << Phase 4 Withdrawn(Due to preliminary r... More >>esults of Altitude Trial.) Less << December 2013 Brazil ... More >> Hospital Universitario Pedro Ernesto Rio de Janeiro, Brazil, 20551030 Less <<
NCT03766308 Type 2 Diabetes Mellitus Not Applicable Active, not recruiting May 31, 2019 China, Hubei ... More >> Tongji Hospital, Tongji Medical College, Huazhong University of Science and technology Wuhan, Hubei, China Less <<
NCT03386890 - Recruiting December 31, 2018 China, Beijing ... More >> Beijing Friendship Hospital Recruiting Beijing, Beijing, China, 100000 Contact: Qianyi Wang    86-13811629824    wangqy1001@hotmail.com Less <<
NCT00655824 Arthritis, Rheumatoid Phase 2 Terminated(The clinical develo... More >>pment of intravenously administered ofatumumab in RA will no longer be pursued, so this study was prematurely terminated by the Sponsor.) Less << - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90095 United States, Florida GSK Investigational Site Fort Lauderdale, Florida, United States, 33334 United States, New York GSK Investigational Site New York, New York, United States, 10003 United States, Pennsylvania GSK Investigational Site Duncansville, Pennsylvania, United States, 16635 Denmark GSK Investigational Site Glostrup, Denmark, 2600 GSK Investigational Site Hellerup, Denmark, 2900 GSK Investigational Site Koebenhavn, Denmark, 2100 Hungary GSK Investigational Site Szombathely, Hungary, 9700 Poland GSK Investigational Site Warszawa, Poland, 02-256 United Kingdom GSK Investigational Site Ipswich, United Kingdom, IP4 5PD Less <<
NCT01362244 Nasal Polyps Phase 2 Completed - Belgium ... More >> GSK Investigational Site Gent, Belgium, 9000 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1105 AZ United Kingdom GSK Investigational Site Cambridge, United Kingdom GSK Investigational Site London, United Kingdom, EC1M 6BQ GSK Investigational Site London, United Kingdom, SE1 1YR GSK Investigational Site London, United Kingdom, SW3 6NP GSK Investigational Site London, United Kingdom, WC1X 8DA Less <<
NCT00655824 - Terminated(The clinical develo... More >>pment of intravenously administered ofatumumab in RA will no longer be pursued, so this study was prematurely terminated by the Sponsor.) Less << - -
NCT01362244 - Completed - -
NCT02345161 - Completed - -
NCT02069197 Obesity Diabe... More >>tes Obstructive Sleep Apnea Less << Phase 2 Recruiting September 2020 United States, Maryland ... More >> Mid-Atlantic Epilepsy and Sleep Center, LLC Recruiting Bethesda, Maryland, United States, 20817 Contact: Ivana Tyrlikova, MD    301-530-9744    tyrlikovai@epilepsydc.com    Contact: Arcady Barber, MSCN    301-530-9744    barbera@epilepsydc.com Less <<
NCT00550459 - Completed - -
NCT02345161 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT00550459 Hyponatremia Phase 3 Completed - United States, California ... More >> Sarah. S. Olelewe, MD Hawthorne, California, United States, 90250 Progressive Clinical Research Vista, California, United States, 92083 United States, Colorado Pikes Peak Cardiology Colorado Springs, Colorado, United States, 80907 United States, Florida Innovative Research of West FL Largo, Florida, United States, 33770 Coastal Nephrology Assoc. Research Center Punta Gorda, Florida, United States, 33950 United States, Georgia Rockdale Medical Research Associates Conyers, Georgia, United States, 30094 United States, Louisiana Otis Barnum, DO Natchitoches, Louisiana, United States, 71457 United States, North Dakota Lillestol Research, LLC Fargo, North Dakota, United States, 58106 United States, South Carolina Carolina Research Associates Columbia, South Carolina, United States, 29201 United States, Tennessee Wayne O. Wells, MD Lebanon, Tennessee, United States, 37087 United States, Texas Memorial Clinical Associates Houston, Texas, United States, 77043 United States, Virginia Mitchell Rosner, MD Charlottesville, Virginia, United States, 22908 Less <<
NCT01808313 Vascular Disease Phase 3 Completed - China, Heilongjiang ... More >> GSK Investigational Site Harbin, Heilongjiang, China, 150001 China, Hubei GSK Investigational Site Wuhan, Hubei, China, 430022 China, Hunan GSK Investigational Site Hunan, Hunan, China, 410008 China, Jilin GSK Investigational Site Changchun, Jilin, China, 130021 China, Shaanxi GSK Investigational Site Xian, Shaanxi, China, 710032 China, Shandong GSK Investigational Site Jinan, Shandong, China, 250012 China GSK Investigational Site Beijing, China, 100032 GSK Investigational Site Beijing, China, 100034 GSK Investigational Site Beijing, China, 100037 GSK Investigational Site Beijing, China, 100038 GSK Investigational Site Shanghai, China, 200001 GSK Investigational Site Shanghai, China, 200433 Less <<
NCT01160224 Asthma Phase 2 Completed - Canada, Alberta ... More >> GSK Investigational Site Calgary, Alberta, Canada, T2N 4Z6 Canada, Ontario GSK Investigational Site Hamilton, Ontario, Canada, L8N 4A6 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2X 2P4 GSK Investigational Site Montreal, Quebec, Canada, H4J 1C5 Canada GSK Investigational Site Quebec, Canada, G1V 4G5 Less <<
NCT01808313 - Completed - -
NCT01205451 Spasticity, Post-Stroke Phase 3 Completed - China, Guangdong ... More >> GSK Investigational Site Guangzhou, Guangdong, China China, Heilongjiang GSK Investigational Site Haerbin, Heilongjiang, China, 150001 China, Hubei GSK Investigational Site Wuhan, Hubei, China, 430060 China, Jiangsu GSK Investigational Site Nanjing, Jiangsu, China, 210029 GSK Investigational Site Suzhou, Jiangsu, China, 215004 China, Liaoning GSK Investigational Site Shenyang, Liaoning, China, 110001 China, Sichuan GSK Investigational Site Chengdu, Sichuan, China, 610041 China GSK Investigational Site Beijing, China, 100050 GSK Investigational Site Beijing, China, 100068 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Hangzhou, China, 310016 GSK Investigational Site Shanghai, China, 200025 GSK Investigational Site Shanghai, China, 200040 Less <<
NCT00608491 - Completed - -
NCT01899768 Cough Phase 2 Completed - United Kingdom ... More >> GSK Investigational Site Manchester, Lancashire, United Kingdom, M23 9LT GSK Investigational Site Belfast, United Kingdom, BT9 7AB Less <<
NCT00608491 Heart Failure Phase 3 Completed - United States, Arizona ... More >> Mayo Clinic Arizona Phoenix, Arizona, United States, 85054 United States, Georgia Morehouse School of Medicine Atlanta, Georgia, United States, 30310 United States, Minnesota Minnesota Heart Failure Network Minneapolis, Minnesota, United States, 55415 Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Utah University of Utah Health Sciences Center Murray, Utah, United States, 84107 United States, Vermont University of Vermont - Fletcher Allen Health Care Burlington, Vermont, United States, 05401 Canada, Quebec Montreal Heart Institute Montreal, Quebec, Canada, H1T - 1C8 Less <<
NCT01494610 Asthma Phase 2 Completed - Australia, New South Wales ... More >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 New Zealand GSK Investigational Site Wellington, New Zealand, 6021 Less <<
NCT00577135 Heart Failure Phase 3 Completed - United States, Georgia ... More >> Morehouse School of Medicine Atlanta, Georgia, United States, 30310 United States, Massachusetts Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 United States, Minnesota Minnesota Heart Failure Network Minneapolis, Minnesota, United States, 55415 Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Utah University of Utah Health Sciences Center Murray, Utah, United States, 84107 United States, Vermont University of Vermont - Fletcher Allen Health Care Burlington, Vermont, United States, 05401 Canada, Quebec Montreal Heart Institute Montreal, Quebec, Canada, H1T - 1C8 Less <<
NCT01899768 - Completed - -
NCT00577135 - Completed - -
NCT00442572 Hepatitis B, Chronic Phase 2 Completed - Bulgaria ... More >> Mhat St. Ivan Rilski; Clinic of Gastroenterology Sofia, Bulgaria, 1612 Less <<
NCT01290887 Eosinophilic Asthma Phase 3 Terminated(Business decision) - -
NCT00442572 - Completed - -
NCT01494610 - Completed - -
NCT00543647 Healthy Volunteers Phase 1 Completed - United Kingdom ... More >> Site 1 London, United Kingdom Less <<
NCT01290887 - Terminated(Business decision) - -
NCT02464345 Binge Eating Disorder ... More >> Bulimia Nervosa Eating Disorder Less << Phase 2 Phase 3 Unknown December 2018 Brazil ... More >> Universidade Federal de Sao Paulo (UNIFESP) Recruiting Sao Paulo, SP, Brazil Contact: Angelica Claudino, MD, Ph.D    50842187 Less <<
NCT01205451 - Completed - -
NCT02767869 Metabolic Syndrome X Phase 2 Completed - Mexico ... More >> Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 45037 Less <<
NCT01304992 Hypercholesterolemia Not Applicable Completed - Germany ... More >> Friedrich Schiller University Jena, Department of Nutritional Physiology Jena, Thuringia, Germany, 07743 Less <<
NCT02608710 Gout Phase 1 Completed - United States, Texas ... More >> Austin, Texas, United States, 78744 Less <<
NCT01361022 Healthy Phase 1 Completed - Taiwan ... More >> 263.511.1 Boehringer Ingelheim Investigational Site Taipei, Taiwan Less <<
NCT02203890 - Completed - Guatemala ... More >> Center for Studies of Sensory Impairment Aging and Metabolism Guatemala, Quetzaltenango, Guatemala, 09001 Less <<
NCT01195662 Type 2 Diabetes Phase 3 Completed - -
NCT03664167 Gout, Arthritis, Obesity Not Applicable Not yet recruiting June 1, 2019 Denmark ... More >> Department of Rheumatology, the Parker Institute, Frederiksberg and Bispebjerg Hospital Not yet recruiting Frederiksberg, Copenhagen, Denmark, 2000 Contact: Line Rustad          Contact: Lars Erik Kristensen, MD, phd       lars.erik.kristensen@regionh.dk Less <<
NCT01195662 - Completed - -
NCT01602562 Herpes Simplex Phase 3 Completed - Japan ... More >> GSK Investigational Site Aichi, Japan, 446-8602 GSK Investigational Site Aichi, Japan, 453-8511 GSK Investigational Site Aichi, Japan, 466-8560 GSK Investigational Site Hiroshima, Japan, 734-8551 GSK Investigational Site Hyogo, Japan, 650-0047 GSK Investigational Site Hyogo, Japan, 654-0081 GSK Investigational Site Kagoshima, Japan, 890-8520 GSK Investigational Site Kanagawa, Japan, 259-1143 GSK Investigational Site Osaka, Japan, 594-1101 GSK Investigational Site Saitama, Japan, 339-8551 GSK Investigational Site Tokyo, Japan, 162-8655 Less <<
NCT00547521 Rheumatoid Arthritis (RA) Phase 3 Completed - -
NCT03539926 Cystinuria Not Applicable Active, not recruiting February 2019 Spain ... More >> Fundacio Puigvert Barcelona, Spain, 08025 Less <<
NCT00547521 - Completed - -
NCT01921374 Other Diseases or Conditions Not Applicable Completed - Brazil ... More >> University Federal of São Paulo São Paulo, Brazil, 04024001 Less <<
NCT01437540 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT01437540 - Completed - -
NCT01747330 - Completed - -
NCT03621215 Gout Flare Go... More >>ut Attack Less << Not Applicable Not yet recruiting January 2021 United Kingdom ... More >> Food and Nutrition Group, Sheffield Hallam University Not yet recruiting Sheffield, United Kingdom, S1 1WB Contact: Tony Lynn, PhD    0114 2252065    T.Lynn@shu.ac.uk    Contact: Margo Barker, PhD    01142560765    Margo.Barker@shu.ac.uk    Principal Investigator: Margo Barker, PhD          Principal Investigator: Tony Lynn, PhD          Sub-Investigator: Kirstie Lamb, MMedSci Less <<
NCT03348267 Skeletal Muscle Damage ... More >> Muscle Inflammation Muscle Recovery Soccer Performance Less << Not Applicable Completed - Greece ... More >> Exercise Biochemistry Laboratory, School of Physical Education & Sports Sciences, University of Thessaly Tríkala, Greece, 42100 Less <<
NCT01602562 - Completed - -
NCT01321112 Gene Expression ... More >> Immunosuppression Conversion Liver Transplantation Less << Not Applicable Unknown March 2014 Chile ... More >> Gastroenterology Department, Pontificia Universidad Catolica de Chile Recruiting Santiago, Santiago, RM, Chile, 8330024 Contact: Carlos E Benitez, MD    56-02-3543820 ext 3880    cbenitezc@med.puc.cl Less <<
NCT01668654 Epilepsy Phase 3 Terminated(FDA placed a clinic... More >>al hold on the Pediatric Program requiring retigabine discontinuation in subjects; early termination allows for timely reporting of results.) Less << - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90027 United States, Florida GSK Investigational Site Gulf Breeze, Florida, United States, 32561 GSK Investigational Site Port Charlotte, Florida, United States, 33952 GSK Investigational Site Wellington, Florida, United States, 33414 United States, Minnesota GSK Investigational Site Saint Paul, Minnesota, United States, 55102-2534 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Tennessee GSK Investigational Site Memphis, Tennessee, United States, 38105 United States, Texas GSK Investigational Site Austin, Texas, United States, 78723 GSK Investigational Site Dallas, Texas, United States, 75230-2507 Less <<
NCT00401453 Diabetes Mellitus Type 2 ... More >> Insulin Resistance Less << Phase 3 Completed - Germany ... More >> Fifth Medical Clinic Mannheim, Baden-Wuerttemberg, Germany, 68167 Less <<
NCT01747330 Pancreatic Exocrine Insufficie... More >>ncy Less << Phase 3 Completed - Russian Federation ... More >> Site Reference ID/Investigator# 80716 Barnaul, Russian Federation, 656019 Site Reference ID/Investigator# 80693 Moscow, Russian Federation, 117997 Site Reference ID/Investigator# 80698 Novosibirsk, Russian Federation, 630091 Site Reference ID/Investigator# 80713 Novosibirsk, Russian Federation Site Reference ID/Investigator# 80715 Orenburg, Russian Federation, 460000 Site Reference ID/Investigator# 80694 St. Petersburg, Russian Federation, 194156 Site Reference ID/Investigator# 80714 Tomsk, Russian Federation, 634050 Site Reference ID/Investigator# 80697 Voronezh, Russian Federation, 394036 Site Reference ID/Investigator# 80696 Yaroslavl, Russian Federation, 150003 Less <<
NCT00310375 - Completed - -
NCT01668654 - Terminated(FDA placed a clinic... More >>al hold on the Pediatric Program requiring retigabine discontinuation in subjects; early termination allows for timely reporting of results.) Less << - -
NCT00937326 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00310375 Epilepsy Phase 3 Completed - -
NCT03030456 Aging Oxidati... More >>ve Stress Less << Not Applicable Enrolling by invitation February 2017 -
NCT03462121 Mild to Moderate Dementia Due ... More >>to Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease Less << Phase 2 Recruiting April 30, 2019 Canada, Ontario ... More >> Kawartha Centre - Redefining Healthy Aging Recruiting Peterborough, Ontario, Canada, K9H 2P4 Contact: Jennifer K Ingram, MD FRCPC    705-749-3906       Contact: Krista Gillis    05-930-2667 (24 Hr.)       Principal Investigator: Jennifer K Ingram, MD          Toronto Memory Program Recruiting Toronto, Ontario, Canada, M3B 2S7 Principal Investigator: Sharon Cohen, MD          Gerontion Research Inc., The Center for Memory & Aging Recruiting Toronto, Ontario, Canada, M4G 3E8 Principal Investigator: Giovanni Marotta, MD          Canada, Quebec Recherches Neuro-Hippocampe Inc. d/b/a Clinique de la Memoire de l'Outaouais Recruiting Gatineau, Quebec, Canada, J8T 8J1 Principal Investigator: Richard Bergeron, MD          Diex Recherche Sherbrooke Inc. Recruiting Sherbrooke, Quebec, Canada, J1L 0H8 Principal Investigator: Marcel Germain, MD Less <<
NCT03182543 Exercise-induced Oxidative Str... More >>ess Less << Not Applicable Completed - -
NCT00310388 Epilepsy Phase 3 Terminated(No longer any benef... More >>it in collecting data since retigabine has been withdrawn from market.) Less << - -
NCT02496494 CYCLOSPORINE/TACROLIMUS Phase 4 Unknown December 2015 Korea, Republic of ... More >> Kyungpook National University Hospital Recruiting Daegu, Korea, Republic of Contact: Chan-Duck Kim       drcdkim@knu.ac.kr Less <<
NCT01495000 Osteoporosis, Postmenopausal Phase 3 Completed - India ... More >> GSK Investigational Site Ahmedabad, India, 380015 GSK Investigational Site Bangalore, India, 560043 GSK Investigational Site Bangalore, India, 560052 GSK Investigational Site Bangalore, India, 560054 GSK Investigational Site Delhi, India, 110060 GSK Investigational Site Mangalore, India, 575002 GSK Investigational Site Nagpur, India, 440010 GSK Investigational Site Nagpur, India, 440012 GSK Investigational Site Pune, India, 411030 GSK Investigational Site Trivandrum, India, 695011 GSK Investigational Site Vadodra, India, 390007 Less <<
NCT00937326 - Completed - -
NCT01495000 - Completed - -
NCT02469298 Virus Diseases Phase 2 Completed - -
NCT00945282 - Completed - -
NCT00604825 - Completed - -
NCT00945282 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 2 Completed - Argentina ... More >> GSK Investigational Site Buenos Aires, Argentina, B1602DBG Less <<
NCT00310388 - Terminated(No longer any benef... More >>it in collecting data since retigabine has been withdrawn from market.) Less << - -
NCT00604825 Menopausal and Female Climacte... More >>ric States Less << Phase 2 Completed - -
NCT01713920 Hypertension Phase 4 Completed - Korea, Republic of ... More >> The Catholic University of Korea Bucheon St. Mary's Hospital Bucheon, Korea, Republic of The Catholic University of Korea Seoul St. Mary's Hospital Seoul, Korea, Republic of Less <<
NCT03093103 Nephropathy Phase 2 Recruiting December 31, 2018 Switzerland ... More >> Service de Néphrologie Recruiting Lausanne, Vaud, Switzerland, 1011 Contact: Guler Gok-sogut, Ass-med    41 79 556 20 05    guler-gok-sogut@chuv.ch    Contact: Marie-Eve Muller, MD    41 79 556 59 46    Marie-Eve.Muller@chuv.ch    Sub-Investigator: Anne Zanchi, MD          Principal Investigator: Michel Burnier, Prof Less <<
NCT00996840 Lung Injury, Acute Phase 2 Completed - United States, Kentucky ... More >> GSK Investigational Site Lexington, Kentucky, United States, 40536-0293 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 GSK Investigational Site Winston-Salem, North Carolina, United States, 27157 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232-7110 Less <<
NCT02469298 - Completed - -
NCT01453296 Asthma Phase 2 Completed - United States, California ... More >> GSK Investigational Site Cypress, California, United States, 90630 GSK Investigational Site Huntington Beach, California, United States, 92647 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80206 United States, Illinois GSK Investigational Site Normal, Illinois, United States, 61761 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 Less <<
NCT01453296 - Completed - -
NCT02737267 Body Weight Changes Not Applicable Unknown December 2017 Spain ... More >> Centre for Nutrition Research, University of Navarra Pamplona, Navarra, Spain, 31008 Less <<
NCT03441308 Overweight and Obesity Not Applicable Active, not recruiting December 31, 2021 -
NCT00996840 - Completed - -
NCT00515502 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - Germany ... More >> GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Berlin, Germany, 14050 GSK Investigational Site Hamburg, Germany, 22291 Less <<
NCT01364623 Female Sexual Dysfunction Phase 1 Completed - United States, Texas ... More >> Premier Research International LLC Austin, Texas, United States, 78705 Less <<
NCT02705807 Cardiovascular Disease Phase 4 Completed - Japan ... More >> GSK Investigational Site Okayama, Japan, 701-1192 Less <<
NCT02705807 - Completed - -
NCT02282683 Heart Failure ... More >> Hyperuricemia Less << Phase 2 Phase 3 Recruiting December 2017 China, Hebei ... More >> The First Hospital of Hebei Medical University Recruiting Shijiazhuang, Hebei, China, 050031 Contact: Kunshen Liu, M.D.    86 311 85617033    ksliud@sohu.com Less <<
NCT02649400 - Unknown - Brazil ... More >> Federal University of Sao Paulo Sao Paulo, Brazil, 04024002 Less <<
NCT01597635 - Completed - -
NCT01453023 - Completed - -
NCT01332292 Asthma Phase 2 Completed - United States, California ... More >> GSK Investigational Site Cypress, California, United States, 90630 GSK Investigational Site Huntington Beach, California, United States, 92647 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80206 United States, Illinois GSK Investigational Site Normal, Illinois, United States, 61761 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 Less <<
NCT00515502 - Completed - -
NCT01332292 - Completed - -
NCT00416130 Breast Cancer Phase 1 Phase 2 Unknown January 2015 Singapore ... More >> National University Hospital Singapore, Singapore, 149547 National Cancer Centre Singapore, Singapore, 169610 Less <<
NCT02337933 Metabolic Syndrome X Phase 2 Completed - Mexico ... More >> Instituto de Terapéutica Experimental y Clínica Guadalajara, Jalisco, Mexico, 44140 Less <<
NCT02129231 Oxidative Stress ... More >> Diabetic Polyneuropathy Less << Phase 2 Completed - Mexico ... More >> Cardiovascular Research Unit Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT01597635 Lung Injury, Acute Phase 2 Completed - United States, California ... More >> GSK Investigational Site Sacramento, California, United States, 95817 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60611 United States, Massachusetts GSK Investigational Site Springfield, Massachusetts, United States, 01199 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109 United States, New York GSK Investigational Site New York, New York, United States, 10003 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 GSK Investigational Site Greensboro, North Carolina, United States, 27403 GSK Investigational Site Winston-Salem, North Carolina, United States, 27517 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43215 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97239 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19107 United States, South Carolina GSK Investigational Site Charleston, South Carolina, United States, 29425 Canada, British Columbia GSK Investigational Site Vancouver, British Columbia, Canada, V5Z 1M9 GSK Investigational Site Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Nova Scotia GSK Investigational Site Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario GSK Investigational Site Kingston, Ontario, Canada, K7L 2V7 Canada, Quebec GSK Investigational Site Greenfield Park, Quebec, Canada, J4V 2H1 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 Less <<
NCT01370811 Sialorrhoea Phase 2 Completed - United States, Michigan ... More >> QUEST Research Institute Bingham Farms, Michigan, United States, 48025 Less <<
NCT01691794 HIV, Pediatric Phase 4 Completed - United States, Arizona ... More >> Phoenix Children'S Hospital Phoenix, Arizona, United States, 85016 United States, Georgia Grady Health System Ponce Family And Youth Clinic Atlanta, Georgia, United States, 30322 United States, Texas Children'S Medical Center Of Dallas Dallas, Texas, United States, 75235 Argentina Local Institution Buenos Aires, Bs As, Buenos Aires, Argentina, 1141 Local Institution Buenos Aires, Argentina, 1181 Local Institution Buenos Aires, Argentina, 1425 Brazil Local Institution Salvador, Bahia, Brazil, 40110-160 Local Institution Salvador, Bahia, Brazil, 40110 Local Institution Porto Alegre, RIO Grande DO SUL, Brazil, 90035-903 Local Institution Porto Alegre, Rio Grande Do Sul, Brazil, 90035 Local Institution Sao Paulo, SP, Brazil, 01416-901 Local Institution Sao Paulo, Brazil, 01246 Chile Local Institution Santiago, Metropolitana, Chile, 8207257 Local Institution Santiago, Metropolitana, Chile, 8380418 Mexico Local Institution Guadalajara, Jalisco, Mexico, 44280 Local Institution Monterrey, Nuevo LEON, Mexico, 64000 Local Institution Merida, Yucatan, Mexico, 97000 Local Institution Puebla, Mexico, 72000 Peru Local Institution Lima, Peru, 1 Local Institution Lima, Peru, LIMA 10 Russian Federation Local Institution Moscow, Russian Federation, 129110 Local Institution St. Petersburg, Russian Federation, 190103 South Africa Local Institution Port Elizabeth, Eastern CAPE, South Africa, 6001 Local Institution Bloemfontein, FREE State, South Africa, 9301 Local Institution Soweto, Gauteng, South Africa, 2013 Local Institution Cape Town, Western CAPE, South Africa, 7505 Local Institution Cape Town, Western CAPE, South Africa, 7530 Less <<
NCT02170012 Healthy Elderly Phase 1 Terminated(The study was prema... More >>turely terminated on 17th December 2014 due to safety concerns.) Less << - United States, Florida ... More >> Miami Research Associates, Inc. South Miami, Florida, United States, 33143 MRA Clinical Research, LLC South Miami, Florida, United States, 33143 Less <<
NCT01294436 Type2 Diabetes ... More >> High Blood Sugar Less << Phase 3 Completed - Japan ... More >> Research Site Nagoya, Aichi, Japan Research Site Owariasahi, Aichi, Japan Research Site Toyohashi, Aichi, Japan Research Site Hirosaki, Aomori, Japan Research Site Niihama, Ehime, Japan Research Site Itoshima, Fukuoka, Japan Research Site Yukuhashi, Fukuoka, Japan Research Site Annaka, Gunma, Japan Research Site OTA, Gunma, Japan Research Site Aki-gun, Hiroshima, Japan Research Site Sapporo, Hokkaido, Japan Research Site Sanuki, Kagawa, Japan Research Site Takamatsu, Kagawa, Japan Research Site Kamakura, Kanagawa, Japan Research Site Kawasaki, Kanagawa, Japan Research Site Yokohamashi, Kanagawa, Japan Research Site Yokohama, Kanagawa, Japan Research Site Zushi, Kanagawa, Japan Research Site Sendai, Miyagi, Japan Research Site Matsumoto, Nagano, Japan Research Site Suita, Osaka, Japan Research Site Otsu, Shiga, Japan Research Site Atami, Shizuoka, Japan Research Site Komatsushima, Tokushima, Japan Research Site Chiyoda, Tokyo, Japan Research Site Chuo, Tokyo, Japan Research Site Mitaka, Tokyo, Japan Research Site OTA, Tokyo, Japan Research Site Shibuya, Tokyo, Japan Research Site Shinjuku, Tokyo, Japan Research Site Taito, Tokyo, Japan Research Site Takaoka, Toyama, Japan Research Site UBE, Yamaguchi, Japan Research Site Fukuoka, Japan Research Site Hiroshima, Japan Research Site Kochi, Japan Research Site Osaka, Japan Research Site Shizuoka, Japan Research Site Toyama, Japan Less <<
NCT02151617 Healthy Phase 1 Completed - United States, Connecticut ... More >> New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 Less <<
NCT01453023 Asthma Phase 2 Completed - United States, California ... More >> GSK Investigational Site Huntington Beach, California, United States, 92647 Less <<
NCT02695186 - Unknown June 2016 Greece ... More >> General Hospital of Filiates Recruiting Filiates, Epirus, Greece, 46300 Contact: Georgios Pappas-Gogos, MD, MSc    +302663360227    pappasg8@gmail.com    Principal Investigator: Georgios Pappas-Gogos, MD, MSc          Principal Investigator: Spyridon Gogos, MD          Principal Investigator: Panagiota Aggeli, MD          Principal Investigator: Alexandros Tselepis, MD, PhD Less <<
NCT00422318 Heart Failure ... More >> Hyperuricemia Less << Phase 4 Completed - Japan ... More >> Tottori University Hospital Yonago, Japan, 683-8504 Less <<
NCT03230526 Parkinson Disease Phase 2 Recruiting April 20, 2022 France ... More >> CHU de Nantes Recruiting Nantes, France Contact: Anne Gaëlle Corbille          Principal Investigator: Anne Gaëlle Corbille          Centre Eugène Marquis Not yet recruiting Rennes, France Contact: Florence Lejeune          Principal Investigator: Florence Lejeune          CHU de Rennes Not yet recruiting Rennes, France Contact: Marc Verin          Principal Investigator: Marc Verin          CHU de Tours Recruiting Tours, France Contact: Jean-Luc HOUETO          Principal Investigator: Jean-Luc HOUETO Less <<
NCT00812617 Healthy Not Applicable Completed - Japan ... More >> Hiroshima University Hiroshima, Japan, 734-8551 Less <<
NCT03076463 Subjects at Cardiometabolic Ri... More >>sk Less << Not Applicable Completed - Spain ... More >> Institute of Food Science, Technology and Nutrition (ICTAN-CSIC) Madrid, Spain, 28040 Less <<
NCT01691794 - Completed - -
NCT00124982 - Completed - -
NCT01294436 - Completed - -
NCT00124982 Rheumatoid Arthritis Phase 3 Completed - -
NCT03183193 Non-Alcoholic Fatty Liver Dise... More >>ase Obese Overweight Less << Not Applicable Recruiting December 2019 Spain ... More >> Centre for Nutrition Research, University of Navarra Recruiting Pamplona, Navarra, Spain, 31008 Contact: M. Angeles Zulet, PhD    +34948425600 ext 806317    mazulet@unav.es    Contact: Itziar Abete, PhD    +34948425600 ext 806357    iabetego@unav.es Less <<
NCT03216057 Hypertriglyceridemia ... More >> Pediatric Obesity Less << Not Applicable Completed - -
NCT03659890 Healthy Not Applicable Recruiting September 2019 United Kingdom ... More >> University of Exeter - St Luke's Campus Recruiting Exeter, Devon, United Kingdom, EX2 4TH Contact: Mariana Coelho    07521759471    m.coelho@exeter.ac.uk Less <<
NCT01209078 Skin Infections, Bacterial Phase 2 Completed - United States, Alabama ... More >> GSK Investigational Site Anniston, Alabama, United States, 36207 United States, California GSK Investigational Site Chula Vista, California, United States, 91911 GSK Investigational Site La Mesa, California, United States, 91942 GSK Investigational Site Long Beach, California, United States, 90813 GSK Investigational Site Oceanside, California, United States, 92056 United States, Hawaii GSK Investigational Site Honolulu, Hawaii, United States, 96813 United States, Pennsylvania GSK Investigational Site West Reading, Pennsylvania, United States, 19611 Less <<
NCT01295671 Cardiovascular Disease, Obesit... More >>y Less << Not Applicable Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT02114892 - Completed - -
NCT01295671 - Completed - -
NCT02114892 Metabolic Syndrome X Phase 2 Completed - Mexico ... More >> Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 45037 Less <<
NCT03615534 Atherogenic Dyslipidemia ... More >> Obesity Associated Disorder Less << Phase 4 Completed - Iraq ... More >> Al Kindy College of Medicine, University of Baghdad Baghdad, Iraq, 10045 Lewai S Abdulaziz Baghdad, Iraq, 10045 Less <<
NCT03766399 Asthma Phase 1 Recruiting December 5, 2019 United Kingdom ... More >> Research Site Recruiting Harrow, United Kingdom, HA1 3UJ Research Site Not yet recruiting Manchester, United Kingdom, M23 9GP Less <<
NCT03615534 - Completed - -
NCT00234988 Obesity Phase 4 Completed - United States, Illinois ... More >> Global Medical Information - Abbott North Chicago, Illinois, United States, 60064 Less <<
NCT01572792 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT01209078 - Completed - -
NCT01725126 - Completed - -
NCT01725126 Obesity Phase 2 Completed - United States, California ... More >> GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, Kansas GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT01951404 End Stage Renal Disease ... More >> Left Ventricular Hypertrophy Less << Phase 4 Completed - United Kingdom ... More >> NHS Greater Glasgow and Clyde Glasgow, La, United Kingdom, G12 8TA NHS Tayside Dundee, Tayside, United Kingdom, DD9 1SY NHS Ayrshire and Arran Crosshouse, United Kingdom, KA2OBE Less <<
NCT01572792 - Completed - -
NCT01578239 Carcinoid Tumor of the Small B... More >>owel Neuroendocrine Tumour Less << Phase 3 Active, not recruiting February 2021 -
NCT01578239 - Active, not recruiting - -
NCT03441711 - Recruiting June 2022 United States, Tennessee ... More >> Regional One Health Center for High Risk Pregnancies Recruiting Memphis, Tennessee, United States, 38120 Contact: Giancarlo Mari, M.D.    901-448-2531    gmari@uthsc.edu    Contact: , M.D. Less <<
NCT01481584 Men Not Applicable Completed - Germany ... More >> Friedrich Schiller University Jena, Department of Nutritional Physiology Jena, Thuringia, Germany, 07743 Less <<
NCT01908257 Healthy Phase 1 Completed - United States, California ... More >> Cypress, California, United States, 90630 Less <<
NCT01334242 Healthy Phase 1 Completed - United States, Texas ... More >> Lexicon Investigational Site San Antonio, Texas, United States, 78209 Less <<
NCT03435276 Healthy Volunteers Phase 1 Completed - United Kingdom ... More >> Research Site Harrow, United Kingdom, HA1 3UJ Less <<
NCT03496558 Pregnant Woman With Single Pre... More >>gnancy Pregnant Woman With no Assisted Reproduction Less << Not Applicable Recruiting February 2020 Spain ... More >> Universidad de Granda Recruiting Granada, Spain, 18071 Contact: María José Aguilar Cordero, Professor    657841751 ext +34    mariajaguilar@telefonica.net Less <<
NCT02689882 Metabolic Disturbance Phase 1 Completed - United States, Washington ... More >> University of Washington Seattle, Washington, United States, 98195 Less <<
NCT01450709 - Unknown October 2012 United States, New York ... More >> Parkside Dialysis Clinic at Downstate Medical Center Recruiting Brooklyn, New York, United States, 11226 Principal Investigator: Subodh J Saggi, M.D., MPH Less <<
NCT02000856 Pulmonary Arterial Hypertensio... More >>n Less << Not Applicable Completed - Sweden ... More >> Uppsala University Hospital Uppsala, Sweden Less <<
NCT01450670 - Unknown July 2012 United States, Pennsylvania ... More >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Principal Investigator: Stephanie DeLoach, M.D.          Sub-Investigator: Bonita Falkner, M.D. Less <<
NCT00590538 Cystic Fibrosis Phase 1 Phase 2 Terminated(12/15/2008 Voluntar... More >>ily placed on inactive status-requested by the PI) Less << - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00590538 - Terminated(12/15/2008 Voluntar... More >>ily placed on inactive status-requested by the PI) Less << - -
NCT01099579 - Completed - -
NCT01068717 - Completed - -
NCT01925287 Pharmacokinetics of Novel Curc... More >>umin Formulations Safety of Novel Curcumin Formulations Less << Early Phase 1 Completed - Germany ... More >> University of Hohenheim Stuttgart, Germany, 70599 Less <<
NCT01099579 HIV Infections Phase 3 Completed - Brazil ... More >> Local Institution Sao Paolo, SAO Paulo, Brazil, 01246-900 Chile Local Institution Santiago, Metropolitana, Chile, 8380418 Local Institution Santiago, Metropolitana, Chile Mexico Local Institution Df, Distrito Federal, Mexico, 06720 Local Institution Guadalajara, Jalisco, Mexico, 44160 Local Institution Guadalajara, Jalisco, Mexico, 44280 Local Institution Merida, Yucatan, Mexico, 97000 Local Institution Oaxaca, Mexico, 71256 Local Institution Puebla, Mexico, 72000 Peru Local Institution Lima, Peru, 1 Local Institution Lima, Peru South Africa Local Institution Bloemfontein, FREE State, South Africa, 9301 Local Institution Coronationville, Gauteng, South Africa, 2092 Local Institution Soweto, Gauteng, South Africa, 2001 Local Institution Congella, KWA ZULU Natal, South Africa, 4013 Local Institution Cape Town, Western CAPE, South Africa, 7505 Thailand Local Institution Bangkok, Thailand, 10330 Local Institution Bangkok, Thailand, 10700 Less <<
NCT00410410 - Completed - -
NCT00410410 Ulcerative Colitis Phase 3 Completed - -
NCT00664521 - Completed - -
NCT01457950 Osteoporosis, Postmenopausal Phase 3 Completed - Korea, Republic of ... More >> GSK Investigational Site Busan, Korea, Republic of, 602-739 GSK Investigational Site Daegu, Korea, Republic of GSK Investigational Site Gwangju, Korea, Republic of, 501-757 GSK Investigational Site Seoul, Korea, Republic of, 100-380 GSK Investigational Site Seoul, Korea, Republic of, 110-744 GSK Investigational Site Seoul, Korea, Republic of, 120-752 GSK Investigational Site Seoul, Korea, Republic of, 135-710 GSK Investigational Site Seoul, Korea, Republic of, 137-701 GSK Investigational Site songpa-gu, Seoul, Korea, Republic of, 138-736 GSK Investigational Site Suwon, Korea, Republic of, 443-721 Less <<
NCT01068717 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Ppd Development, Lp Austin, Texas, United States, 78744 Less <<
NCT01457950 - Completed - -
NCT01289132 Essential Hypertension Phase 2 Completed - -
NCT00664521 Rheumatoid Arthritis Phase 2 Completed - France ... More >> Research Site Nice, France Research Site Paris, France Research Site Strasbourg, France Netherlands Research Site Amsterdam, Netherlands Sweden Research Site Malmö, Sweden Research Site Stockholm, Sweden United Kingdom Research Site Newcastle, United Kingdom Research Site Norwich, United Kingdom Less <<
NCT00593606 Parkinson's Disease Phase 3 Completed - -
NCT00593606 - Completed - -
NCT00712933 - Completed - -
NCT00712933 Systemic Lupus Erythematosus Phase 3 Completed - -
NCT01513902 Juvenile Idiopathic Arthritis Phase 1 Completed - United States, Minnesota ... More >> Explorer Clinic, University of Minnesota Children's Hospital Minneapolis, Minnesota, United States, 55454 Clinical and Translational Science Institute Masonic Clinical Research Unit (Administration Only) Minneapolis, Minnesota, United States, 55455 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Oregon Randall Children's Hospital at Legacy Emanuel Portland, Oregon, United States, 97227 Germany PRI - Pediatric Rheumatology Research Institute GmbH Bad Bramstedt, Germany, 24576 Hamburger Zentrum fuer Kinder-und Jugendrheumatologie SchoenKlinik Hamburg Eilbek Hamburg, Germany, 22081 Asklepios Klinik Sankt Augustin Gmbh St. Augustin, Germany, 53757 Poland Wojewodzki Specjalistyczny Szpital Dzieciecy im. Sw. Ludwika w Krakowie Krakow, Poland, 31-503 Klinika Kardiologii i Reumatologii Dzieciecej Lodz, Poland, 91-738 Slovakia Narodny ustav reumatickych chorob Piestany, Slovakia, 921 12 Less <<
NCT00724867 Systemic Lupus Erythematosus Phase 3 Completed - -
NCT00724867 - Completed - -
NCT02145442 Overweight Ob... More >>esity Less << Phase 2 Phase 3 Completed - Cuba ... More >> National Institute of Endocrinology Plaza de la Revolución, Havana, Cuba, 10400 Less <<
NCT03672786 Genetic Change ... More >> Athlete Less << Not Applicable Completed - Spain ... More >> Universidad de Granada Granada, Spain, 18071 Less <<
NCT03450759 Healthy Volunteers Phase 1 Completed - United Kingdom ... More >> Research Site London, United Kingdom, HA1 3UJ Less <<
NCT01596309 Cardiovascular Risk Factors Not Applicable Completed - Spain ... More >> Department of Nutrition, Food Science, Physiology and Toxicology. University of Navarra Pamplona, Navarra, Spain, 31008 Less <<
NCT00583362 Systemic Lupus Erythematosus Phase 2 Completed - -
NCT03541005 Overweight and Obesity Phase 3 Recruiting December 1, 2019 Cuba ... More >> National Institute of Endocrinology Recruiting Havana, La Habana, Cuba, 10400 Contact: Eduardo Cabrera Rode, Dr.       diabetes@infomed.sld.cu    Sub-Investigator: Ileana Cubas Dueñas, Dr.          Sub-Investigator: Ana I. Conesa González, Dr.          Sub-Investigator: José Hernández, Dr.          Principal Investigator: Judith Parlá Sardiñas, Dr.          Sub-Investigator: Silvia Marín Julia, Dr.          Sub-Investigator: Yuri Arnold Domínguez, Dr.          Sub-Investigator: Antonio D. Reyes Rodríguez, PD          Sub-Investigator: Aimee Álvarez Álvarez, MD          Sub-Investigator: Ragmila Echevarría Valdés, BSc          Sub-Investigator: Janet Rodríguez Acosta, BSc          Sub-Investigator: Liudmila Jorge Espinosa, CPhT          Sub-Investigator: Kenia Enrique Lugo, BNurs          Sub-Investigator: Masiel Peña Roque, BNurs          Sub-Investigator: Rocío Montes de Oca Somoano, Dr. Less <<
NCT00583362 - Completed - -
NCT01513902 - Completed - -
NCT03687476 Niemann-Pick Disease, Type C Phase 2 Not yet recruiting October 30, 2022 -
NCT03645434 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Recruiting September 23, 2019 Germany ... More >> Research Site Not yet recruiting Berlin, Germany, 14050 Research Site Withdrawn Frankfurt, Germany, 60596 Research Site Not yet recruiting Grosshansdof, Germany, 22927 Research Site Not yet recruiting Wiesbaden, Germany, 65187 United Kingdom Research Site Recruiting London, United Kingdom, HA1 3UJ Research Site Not yet recruiting Manchester, United Kingdom, M23 9QZ Less <<
NCT01784848 Systemic Hypertension ... More >> Obesity Less << Not Applicable Active, not recruiting May 2021 Brazil ... More >> Instituto Dante Pazzanese de Cardiologia São Paulo, SP, Brazil, 04004-060 Instituto do Coração - Hospital das Clínicas de São Paulo São Paulo, SP, Brazil, 04004-060 Hospital do Coração - Research Institute Sao Paulo, Brazil, 04005-000 Less <<
NCT03397888 Hepatic Impairment Phase 1 Completed - United States, Florida ... More >> Clinical Pharmacology of Miami Hialeah, Florida, United States, 33014 Less <<
NCT02113241 Metabolic Syndrome X Phase 4 Completed - Mexico ... More >> Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT01119846 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Arizona ... More >> GSK Investigational Site Phoenix, Arizona, United States, 85013 United States, California GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27705 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43212 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 United States, Washington GSK Investigational Site Tacoma, Washington, United States, 98418 Less <<
NCT03306667 Hepatic Insufficiency ... More >> Healthy Less << Phase 1 Completed - Japan ... More >> Mochida Investigational sites Tokyo, Japan Less <<
NCT02956811 Type 2 Diabetes ... More >> Left Ventricular Hypertrophy Less << Phase 4 Active, not recruiting March 2019 United Kingdom ... More >> Ninewells Hospital Dundee, United Kingdom Less <<
NCT02482402 Chronic Left Ventricular Failu... More >>re Pulmonary Hypertension Less << Phase 2 Withdrawn(Delay in recruitment... More >>) Less << - Germany ... More >> Klinik für Thorax- und Kardiovaskularchirurgie Bad Oeynhausen, Germany, 32545 Thoraxclinic at the University of Heidelberg Heidelberg, Germany, 69126 Less <<
NCT01684332 Postprandial ... More >>Hyperglycemia, Postprandial Feeding Behaviors Antioxidant Lipid Profile Less << Not Applicable Completed - Spain ... More >> Department of Nutrition, Food Science and Physiology Pamplona, Navarra, Spain, 31008 Less <<
NCT00510146 - Completed - -
NCT00510146 Depression, Bipolar Phase 3 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100088 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chengdu, China, 610041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510370 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China, 310003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Harbin, China, 150001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kunming, China, 650032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200030 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wu Han, China, 430060 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Xi'An, China, 710032 Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hiroshima, Japan, 731-0501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shiga, Japan, 525-0037 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 170-0002 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seongnam-Si, Korea, Republic of, 463-707 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 110-744 Less <<
NCT02890966 Gout; Hyperuricemia Phase 1 Completed - China, Chongqing ... More >> The South West Hospital Chongqing, Chongqing, China, 400042 Less <<
NCT01119846 - Completed - -
NCT03706690 Carcinoma, Non-Small-Cell Lung Phase 3 Recruiting January 31, 2025 -
NCT03118713 Type 2 Diabetes Mellitus Phase 4 Active, not recruiting January 2019 Korea, Republic of ... More >> Site 13 Busan, Korea, Republic of Site 02 Deagu, Korea, Republic of Site 11 Guri-si, Korea, Republic of Site 01 Seoul, Korea, Republic of Site 05 Seoul, Korea, Republic of Site 07 Seoul, Korea, Republic of Site 09 Seoul, Korea, Republic of Site 12 Suwon-si, Korea, Republic of Less <<
NCT03320941 Obesity Phase 2 Completed - Japan ... More >> Novartis Investigative Site Matsudo city, Chiba, Japan, 271 0077 Novartis Investigative Site Chikushino-city, Fukuoka, Japan, 818-0036 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 810-0066 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 819-0006 Novartis Investigative Site Kitakyushu-city, Fukuoka, Japan, 807-0857 Novartis Investigative Site Kakogawa-city, Hyogo, Japan, 675-0101 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 231-0023 Novartis Investigative Site Kumamoto City, Kumamoto, Japan, 860-0863 Novartis Investigative Site Kumamoto-city, Kumamoto, Japan, 860-8039 Novartis Investigative Site Kyoto city, Kyoto, Japan, 600-8898 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 615-8125 Novartis Investigative Site Nagasaki city, Nagasaki, Japan, 850 0045 Novartis Investigative Site Higashiosaka-city, Osaka, Japan, 577-0802 Novartis Investigative Site Higashiosaka-city, Osaka, Japan, 577-0803 Novartis Investigative Site Ageo-city, Saitama, Japan, 362-8588 Novartis Investigative Site Kawaguchi-sity, Saitama, Japan, 332 0021 Novartis Investigative Site Tokorozawa-city, Saitama, Japan, 359-0042 Novartis Investigative Site Tokorozawa, Saitama, Japan Novartis Investigative Site Hachioji-city, Tokyo, Japan, 192-0046 Novartis Investigative Site Kiyose-city, Tokyo, Japan, 204-0021 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Novartis Investigative Site Hyogo, Japan, 674-0081 Less <<
NCT02374619 Muscle Damage ... More >> Oxidative Stress Less << Not Applicable Completed - -
NCT01984749 Hyperuricemia Not Applicable Unknown - -
NCT03438617 Type 2 Diabetes Mellitus Not Applicable Active, not recruiting July 31, 2018 China, Shanghai ... More >> Shanghai Sixth People's Hospital Shanghai, Shanghai, China, 200235 An Ting Community Health Center Shanghai, Shanghai, China Cao He Jing Community Health Center Shanghai, Shanghai, China Cao Yang Community Health Center Shanghai, Shanghai, China Hong Mei Community Health Center Shanghai, Shanghai, China Kang Jian Community Health Center Shanghai, Shanghai, China Long Hua Community Health Center Shanghai, Shanghai, China Nan Jing Xi Road Community Health Center Shanghai, Shanghai, China Tao Pu Community Health Center Shanghai, Shanghai, China Tian Lin Community Health Center Shanghai, Shanghai, China Zhen Ru Community Health Center Shanghai, Shanghai, China Less <<
NCT02330341 Glucose Intolerance Phase 2 Completed - Mexico ... More >> Manuel González Ortiz Guadalajara, Jalisco, Mexico, 44140 Less <<
NCT03437525 Type 2 Diabetes Treated With I... More >>nsulin Less << Not Applicable Active, not recruiting April 30, 2018 China, Shanghai ... More >> Shanghai Sixth People's Hospital Shanghai, Shanghai, China, 200235 An Ting Community Health Center Shanghai, Shanghai, China Cao He Jing Community Health Center Shanghai, Shanghai, China Cao Yang Community Health Center Shanghai, Shanghai, China Hong Mei Community Health Center Shanghai, Shanghai, China Kang Jian Community Health Center Shanghai, Shanghai, China Long Hua Community Health Center Shanghai, Shanghai, China Nan Jing Xi Road Community Health Center Shanghai, Shanghai, China Tao Pu Community Health Center Shanghai, Shanghai, China Tian Lin Community Health Center Shanghai, Shanghai, China Zhen Ru Community Health Center Shanghai, Shanghai, China Less <<
NCT00555321 - Terminated - -
NCT00546754 Hypertension Phase 3 Completed - -
NCT00546754 - Completed - -
NCT00555321 Immunosuppression in Solid Org... More >>an Transplant Less << Phase 2 Terminated - -
NCT01729728 - Completed - -
NCT01729728 Postoperative Pain ... More >> Acute Pain Less << Phase 2 Completed - United States, Utah ... More >> Jean Brown Research Salt Lake City, Utah, United States, 84124 Less <<
NCT02498652 Gout Phase 2 Completed - United States, California ... More >> Anaheim, California, United States, 92801 United States, Florida DeLand, Florida, United States, 32720 South Miami, Florida, United States, 33143 United States, Texas Dallas, Texas, United States, 75231 Less <<
NCT03418779 IgA Nephropathy at High Risk o... More >>f Developing ESRD Less << Phase 2 Phase 3 Recruiting August 31, 2021 China, Beijing ... More >> Guang anmen Hospital, China Academy of Chinese Medical Sciences Recruiting Beijing, Beijing, China, 100053 Contact: Shen Li    010-88001057    lishen58173@163.com    Contact: Jinpu Li    +86 18642168989 Less <<
NCT02231333 Non-alcoholic Steatohepatitis Not Applicable Unknown June 2016 India ... More >> Institute of Liver & Biliary Sciences Recruiting New Delhi, Delhi, India, 110070 Contact: Dr Devraj K, MD    011-46300000    drdevurgowda@gmail.com Less <<
NCT01681303 Chronic Kidney Disease ... More >> AST-120 Less << Phase 4 Completed - Taiwan ... More >> Department of Nephrology, Chang Gung Memorial Hospital Keelung, Taiwan, 204 Less <<
NCT02498652 - Completed - -
NCT03523026 Metabolic Syndrome ... More >> Coronary Artery Disease Less << Not Applicable Recruiting December 30, 2018 Turkey ... More >> Kıymet Muammer Recruiting Istanbul, Fatih/Istanbul, Turkey, 34096 Contact: Kıymet Muammer, MSc PT    0090212 4592000 ext 29530    kiymetmuammar@yahoo.com    Contact: Fatma Karantay Mutluay, Professor    0090216 4448544    fmutluay@medipol.edu.tr Less <<
NCT02354339 Metabolic Syndrome X Phase 2 Completed - Mexico ... More >> Instituto de Terapéutica Experimental y Clínica Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT01290458 Muscle Damage ... More >> Oxidative Stress Hemolysis Less << Not Applicable Completed - Greece ... More >> University of Thessaly Trikala, Greece, 42100 Less <<
NCT02205476 - Terminated(B5301001 study did ... More >>not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified.) Less << - -
NCT03596567 Renal Impairment Phase 1 Completed - United States, Florida ... More >> University of Miami Division of Clinical Pharmacology Miami, Florida, United States, 33136 University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 United States, Minnesota Prism Clinical Research LLC Saint Paul, Minnesota, United States, 55114 Less <<
NCT02817256 Complications of Other Bariatr... More >>ic Procedure Less << Not Applicable Unknown November 2018 United Arab Emirates ... More >> Faculty of Medicine and Health Sciences UAE University Al Ain, AB, United Arab Emirates Faculty of Medicine and Health Sciences Al Ain, United Arab Emirates Less <<
NCT00261443 Bipolar Disorder Phase 4 Completed - -
NCT01925547 Metabolic Syndrome, Protection... More >> Against Less << Phase 2 Completed - Germany ... More >> Institute of Biological Chemistry and Nutrition, University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 Less <<
NCT03416127 Diabetes Mellitus, Type 2 Phase 2 Not yet recruiting May 1, 2019 Mexico ... More >> Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Not yet recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: MANUEL GONZALEZ, PhD    +523310585200 ext 34212    uiec@prodigy.net.mx    Contact: KARINA PEREZ RUBIO, PhD    +523310585200 ext 34212    karina2410@hotmail.com Less <<
NCT03444142 Diabetes Mellitus, Type 2 Phase 4 Recruiting December 30, 2018 Mexico ... More >> Instituto de terapeutica Experimental y Clinica. Centro universitario de Ciencias de la Salud. Universidad de Guadalajara Recruiting Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT00261443 - Completed - -
NCT03006471 PreDiabetes P... More >>rehypertension Less << Phase 4 Active, not recruiting December 2018 Mexico ... More >> Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT03682627 Kidney Transplantation Not Applicable Not yet recruiting December 2020 Germany ... More >> Division of Visceral Transplantation, Department of General, Visceral and Transplantation Surgery, University of Heidelberg Heidelberg, Baden-Württemberg, Germany, 69120 Less <<
NCT03592667 Hypertension Phase 4 Enrolling by invitation May 2019 Mexico ... More >> Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT02700334 Prediabetes I... More >>mpaired Fasting Glucose Impaired Glucose Tolerance Less << Phase 4 Completed - Mexico ... More >> Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT03710460 Obesity Phase 4 Recruiting June 30, 2019 Mexico ... More >> Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: Manuel Gonzalez, PhD    +52-10-58-52-00 ext 34212    uiec@prodigy.net.mx    Contact: Esperanza Martinez, PhD    +52-10-58-52-00 ext 34212    esperanzamartnezabundi@yahoo.com Less <<
NCT02205476 Hypertrophic Scars Resulting F... More >>rom Prior Breast Scar Revision Surgery Less << Phase 2 Terminated(B5301001 study did ... More >>not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified.) Less << - United States, Florida ... More >> Stephan Baker MD PA Coral Gables, Florida, United States, 33146 Bayside Ambulatory Center Miami, Florida, United States, 33133 United States, Georgia Kavali Plastic Surgery and Skin Renewal Center Atlanta, Georgia, United States, 30328 Primeter outpatient surgery center Atlanta, Georgia, United States, 30328 United States, Missouri Body Aesthetic Research Center Saint Louis, Missouri, United States, 63141 Less <<
NCT01018017 Diabetes Mellitus, Type 2 Phase 2 Completed - Germany ... More >> GSK Investigational Site Neuss, Nordrhein-Westfalen, Germany, 41460 Less <<
NCT03444233 Non-Alcoholic Fatty Liver Dise... More >>ase Obesity Less << Phase 4 Completed - -
NCT03612778 Kidney Transplant; Complicatio... More >>ns Less << Not Applicable Recruiting September 2019 Slovenia ... More >> University Medical Centre Recruiting Ljubljana, Slovenia Contact: Jernej Pajek, PhD Less <<
NCT00115063 Obesity Phase 4 Terminated(ethical issues of c... More >>ontinuing control group without treatment) Less << - United States, Louisiana ... More >> Pennington Management of Clinical Trials Baton Rouge, Louisiana, United States, 70808 Less <<
NCT00646776 - Completed - -
NCT00115063 - Terminated(ethical issues of c... More >>ontinuing control group without treatment) Less << - -
NCT02210156 Respiratory Tract Infection Not Applicable Completed - Mexico ... More >> Omnilife Guadalajara, Jalisco, Mexico, 44500 Less <<
NCT00767520 - Completed - -
NCT02775175 Healthy Volunteers Not Applicable Completed - Germany ... More >> Department of Internal and Integrative Medicine, Kliniken Essen-Mitte Essen, Germany, 45276 Less <<
NCT00646776 Antivirals/HIV Phase 1 Completed - United States, New Jersey ... More >> Bristol-Myers Squibb Clinical Pharmacology Unit Hamilton, New Jersey, United States, 08690 Less <<
NCT01817036 Vitamin D Deficiency Phase 1 Completed - China, Shanghai ... More >> Institute for Nutritional Sciences, Chinese Academy of Sciences Shanghai, Shanghai, China, 200031 Less <<
NCT01899703 Cholestasis, Intrahepatic Phase 2 Completed - United Kingdom ... More >> GSK Investigational Site Birmingham, West Midlands, United Kingdom, B15 2WB GSK Investigational Site Cambridge, United Kingdom GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP Less <<
NCT00639756 Metabolic Syndrome Phase 2 Completed - Spain ... More >> Renal Unit, Mateo Orfila Hospital Menorca, Balearic Islands, Spain, 07703 Less <<
NCT00207090 - Completed - -
NCT00767520 Breast Cancer Phase 2 Completed - United States, California ... More >> Compassionate Cancer Care Medical Group, Inc Fountain Valley, California, United States, 92708 Compassionate Cancer Care Medical Group Inc Riverside, California, United States, 92501 United States, Pennsylvania Pennsylvania Oncology/Hematology Associates Philadelphia, Pennsylvania, United States, 19106 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 Czech Republic Local Institution Hradec Kralove, Czech Republic, 500 05 Local Institution Prague 5, Czech Republic, 150 06 France Local Institution Lille, France, 59000 Local Institution Paris Cedex 13, France, 75651 Local Institution Saint-Cloud Cedex, France, 92211 Ireland Local Institution Dublin, Ireland, 24 Poland Local Institution Gdansk, Poland, 80-462 Local Institution Gdansk, Poland, 80-952 Local Institution Lodz, Poland, 93-509 Local Institution Opole, Poland, 45-060 Spain Local Institution Madrid, Spain, 28033 Local Institution Madrid, Spain, 28041 Local Institution Torrevieja, Spain, 03186 Sweden Local Institution Vasteras, Sweden, 72189 United Kingdom Local Institution Chelmsford, Essex, United Kingdom, CM1 7ET Local Institution London, Greater London, United Kingdom, NW1 2BU Local Institution Coventry, Warwickshire, United Kingdom, CV22DX Less <<
NCT00207090 Advanced Solid Tumors ... More >> Neoplasms Less << Phase 1 Completed - United States, Ohio ... More >> The Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Less <<
NCT00457002 Venous Thrombosis ... More >> Pulmonary Embolism Less << Phase 3 Completed - -
NCT01424514 - Completed - -
NCT00457002 - Completed - -
NCT03771729 CKD Early Phase 1 Not yet recruiting June 15, 2019 -
NCT03272230 Apathy Fronto... More >>temporal Dementia Parkinson Disease Depressive Symptoms Less << Not Applicable Recruiting July 31, 2019 France ... More >> ICM / Pitié-Salpêtrière Hospital AP-HP / CIC Recruiting Paris, France, 75013 Contact: Armelle Ramettilacroux, Master       armelle.ramettilacroux@icm-institute.org Less <<
NCT03351530 - Enrolling by invitation February 9, 2019 Taiwan ... More >> General Biologicals Corporation Hsinchu, Taiwan Less <<
NCT00263302 Heart Failure, Congestive Phase 1 Suspended - China, Hebei ... More >> Kunshen Liu Shijiazhuang, Hebei, China, 050031 The First Hospital of Hebei Medical University Shijiazhuang, Hebei, China, 050031 Less <<
NCT01424514 Rhinitis Phase 2 Completed - Canada, Ontario ... More >> GSK Investigational Site Mississauga, Ontario, Canada, L4W 1N2 Less <<
NCT02343107 Abdominal Obesity ... More >> Type 2 Diabetes Less << Not Applicable Completed - France ... More >> Groupe Hospitalier Pitié Salpetrière Paris, France, 75013 Less <<
NCT01316887 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT01316887 - Completed - -
NCT02261376 Healthy Phase 1 Completed - United Kingdom ... More >> Hammersmith Medicines Research Ltd London, United Kingdom, NW10 7EW Less <<
NCT02014467 Osteoporosis, Postmenopausal Phase 3 Completed - China, Sichuan ... More >> GSK Investigational Site Chengdu, Sichuan, China, 610041 GSK Investigational Site Chengdu, Sichuan, China, 610072 China GSK Investigational Site Beijing, China, 100035 GSK Investigational Site Beijing, China, 100050 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Chengdu, China, 610083 GSK Investigational Site Shanghai, China, 200040 GSK Investigational Site Shanghai, China, 200233 Less <<
NCT00603278 Asthma Phase 2 Completed - -
NCT01934192 - Terminated - -
NCT00603278 - Completed - -
NCT03593785 Hypercholesterolemia Phase 1 Recruiting July 23, 2019 United States, California ... More >> Research Site Recruiting Glendale, California, United States, 91206 Less <<
NCT00603382 Asthma Phase 2 Completed - -
NCT01934192 Gastroparesis Phase 2 Terminated - United States, Colorado ... More >> GSK Investigational Site Aurora, Colorado, United States, 80045 United States, Georgia GSK Investigational Site Augusta, Georgia, United States, 30909 United States, Kentucky GSK Investigational Site Louisville, Kentucky, United States, 40202 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 Australia, New South Wales GSK Investigational Site Randwick, New South Wales, Australia, 2031 Australia, Queensland GSK Investigational Site Southport, Queensland, Australia, 4215 Australia, South Australia GSK Investigational Site Adelaide, South Australia, Australia, 5000 GSK Investigational Site Woodville, South Australia, Australia, 5011 Canada, Alberta GSK Investigational Site Calgary, Alberta, Canada, T1Y 6J4 GSK Investigational Site Calgary, Alberta, Canada, T2N 2T9 Canada, Ontario GSK Investigational Site Hamilton, Ontario, Canada, L8L 2X2 GSK Investigational Site Kingston, Ontario, Canada, K7L 2V7 GSK Investigational Site Ottawa, Ontario, Canada, K1H 8L6 GSK Investigational Site Ottawa, Ontario, Canada, K1Y 4E9 GSK Investigational Site Toronto, Ontario, Canada, M5G 1X5 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2X 3J4 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 GSK Investigational Site Sherbrooke, Quebec, Canada, J1H 5N4 Canada GSK Investigational Site Quebec, Canada, G1J 1Z4 Less <<
NCT00603746 Asthma Phase 2 Completed - -
NCT02014467 - Completed - -
NCT02158481 Vascular Diseases ... More >> Impaired Glucose Tolerance Less << Not Applicable Completed - United Kingdom ... More >> Aspect Clinical Ledbury, United Kingdom Less <<
NCT00603382 - Completed - -
NCT00796991 Advanced Melanoma Phase 1 Completed - United States, California ... More >> The Angeles Clinic & Research Inst. Los Angeles, California, United States, 90025 United States, Florida H Lee Moffit Cancer Cnt And Res Inst Tampa, Florida, United States, 33612 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 United States, North Carolina Blumenthal Cancer Center, Carolinas Medical Center Charlotte, North Carolina, United States, 28204 Less <<
NCT00796991 - Completed - -
NCT00603746 - Completed - -
NCT01262898 - Completed - -
NCT01586364 - Completed - -
NCT00643201 Venous Thrombosis Phase 3 Completed - -
NCT01585948 - Active, not recruiting December 2017 Greece ... More >> Cardiology Department, University Hospital of Ioannina Ioannina, Greece, 45110 Less <<
NCT01262898 Gastroparesis Phase 2 Completed - -
NCT01586364 Atrophy Vagin... More >>al Diseases Less << Phase 3 Completed - -
NCT03768245 Obesity Diabe... More >>tes Mellitus, Type 2 Cardiovascular Function Kidney Diseases Liver Diseases Physical Fitness Less << Not Applicable Completed - Mexico ... More >> Hospital Regional Adolfo Lopez Matelos Mexico City, Distrito Federal, Mexico, 01620 Less <<
NCT00311311 Atherosclerosis ... More >> Kidney Failure Less << Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, New York ... More >> Pfizer Investigational Site Rochester, New York, United States, 14642 Canada, Alberta Pfizer Investigational Site Calgary, Alberta, Canada, T2N 2T9 Pfizer Investigational Site Edmonton, Alberta, Canada, T6G 2B7 Canada, Ontario Pfizer Investigational Site Hamilton, Ontario, Canada, L8N 4A6 Pfizer Investigational Site London, Ontario, Canada, N6A 5A5 Pfizer Investigational Site Toronto, Ontario, Canada, M5B 1W8 Pfizer Investigational Site Toronto, Ontario, Canada, M5C 2T2 Canada, Quebec Pfizer Investigational Site Montreal, Quebec, Canada, H1T 2M4 Less <<
NCT03384290 Healthy Subjects Phase 1 Active, not recruiting November 2018 Australia, Victoria ... More >> Nucleus Network Limited Melbourne, Victoria, Australia, 3004 Less <<
NCT00643201 - Completed - -
NCT00311311 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02497937 Heart Failure Phase 2 Completed - United States, Minnesota ... More >> GSK Investigational Site Minneapolis, Minnesota, United States, 55415 GSK Investigational Site Rochester, Minnesota, United States, 55905 Less <<
NCT00502996 Rheumatoid Arthritis Phase 3 Completed - -
NCT00502996 - Completed - -
NCT02497937 - Completed - -
NCT03574805 Asthma Phase 1 Recruiting October 20, 2019 Australia, South Australia ... More >> CMAX Recruiting Adelaide, South Australia, Australia, 500 Contact: Kate Richardson    61 8 7088 7900    Kathryn.Richardson@cmax.com.au    Principal Investigator: Thomas Polasek, MD          Australia, Victoria Nucleus Network Limited Recruiting Melbourne, Victoria, Australia, 3004 Contact: Jessica Faggian    61 3 9076 8900    j.faggian@nucleusnetwork.com.au    Principal Investigator: Oscar Walsh, MD          Australia Linear Recruiting Perth, Australia Contact: Nicola Norton, RN    61 0 414 416 034    nnorton@linear.org.au    Contact: Simon Scott, BSc, MPharmMed    61 0 432 149 680    sscott@linear.org.au    Principal Investigator: Lara Hatchuel, MD Less <<
NCT01271218 Knee Osteoarthritis Phase 4 Completed - United States, Texas ... More >> Exercise & Sport Nutrition Lab College Station, Texas, United States, 78843 Less <<
NCT02751424 Infections, Bacterial Phase 1 Terminated(Study data is curre... More >>ntly under review.) Less << - Australia, South Australia ... More >> GSK Investigational Site Adelaide, South Australia, Australia, 5000 Less <<
NCT01549626 Adult Women O... More >>verweight Obese Less << Not Applicable Completed - Brazil ... More >> Clementino Fraga Filho University Hospital Rio de Janeiro, Brazil, 21.941-913 Less <<
NCT01223365 Chronic Pain Phase 3 Completed - -
NCT01382212 End-Stage Renal Disease ... More >> Secondary Hyperparathyroidism Less << Phase 3 Completed - -
NCT01223365 - Completed - -
NCT01439971 - Completed - -
NCT01382212 - Completed - -
NCT03217604 Healthy Volunteers Phase 1 Completed - Belgium ... More >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT02099968 Hypertension ... More >>Metabolic Syndrome Less << Not Applicable Completed - Germany ... More >> Immanuel Hospital Berlin, Department of Internal and Complementary Medicine Berlin, Germany, 45276 Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen Essen, Germany, 45276 Less <<
NCT00394394 Hypertension Phase 2 Completed - Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 Less <<
NCT02751424 - Terminated(Study data is curre... More >>ntly under review.) Less << - -
NCT02595684 Obesity Phase 4 Completed - Mexico ... More >> Instituto de Terapéutica Experimental y Clínica Guadalajara, Jalisco, Mexico, 44140 Less <<
NCT01439971 Hemophilia A Phase 1 Completed - United States, California ... More >> University of California San Diego Medical Center San Diego, California, United States, 92103-8651 United States, Connecticut New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Oregon Doernbecher Children's Hospital Portland, Oregon, United States, 97239 OHSU Investigational Pharmacy Portland, Oregon, United States, 97239 Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania CTRC Philadelphia, Pennsylvania, United States, 19104 Penn Comprehensive Hemophilia Program - Center for Blood Disorders Philadelphia, Pennsylvania, United States, 19104 Belgium Pfizer Clinical Research Unit Bruxelles, Belgium, B-1070 Hungary Semmelweis Egyetem Altalanos Orvostudomanyi Kar/ I.sz. Belgyogyaszati Klinika Budapest, Hungary, 1083 Italy Dipartimento di Medicina Clinica 1-Centro Regionale per le Malattie del Sangue Castelfranco Veneto (TV), Italy, 31033 Servizio Farmacia- Ospedale Castelfranco Veneto Castelfranco Veneto - Treviso, Italy, 31033 Centro Emofilia e Trombosi "Angelo Bianchi Bonomi" U.O.S. Dipartimentale per la Diagnosi e la Terapi Milano, Italy, 20122 Servizio Farmacia Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Milano, Italy, 20122 Centro Malattie Emorragiche e Trombotiche - Ematologia Vicenza, Italy, 36100 Farmacia Ospedaliera Ospedale San Bortolo Vicenza, Italy, 36100 New Zealand Christchurch Clinical Studies Trust Christchurch, New Zealand, 08011 South Africa Phoenix Pharma (Pty) Ltd Port Elizabeth, Eastern Cape, South Africa, 6001 Turkey Ege University Tip Fakultesi Izmir, Turkey, 35100 United Kingdom Royal Free Hampstead NHS Trust, Royal Free Hospital London, United Kingdom, NW3 2QG Haematology Department London, United Kingdom, W12 0HS Central Manchester Universtiy Hospitals NHS Foundation Trust Manchester, United Kingdom, M13 9WL Less <<
NCT00298272 Rheumatoid Arthritis Phase 2 Terminated(Sponsor decided to ... More >>end long term extension phase for business reasons unrelated to safety.) Less << - United States, Alabama ... More >> Research Site Huntsville, Alabama, United States, 35801 United States, Arizona Research Site Paradise Valley, Arizona, United States, 85253 United States, California Research Site Palm Desert, California, United States, 92260 United States, Florida Research Site Jupiter, Florida, United States, 33458 Research Site Sarasota, Florida, United States, 34239 United States, Idaho Research Site Boise, Idaho, United States, 83702 United States, Michigan Research Site Kalamazoo, Michigan, United States, 49048 United States, Missouri Research Site St. Louis, Missouri, United States, 63141 United States, Ohio Research site Chardon, Ohio, United States, 44024 Research Site Mayfield Village, Ohio, United States, 44143 United States, Oklahoma Research Site Oklahoma City, Oklahoma, United States, 73103 Research Site Tulsa, Oklahoma, United States, 74135 United States, Pennsylvania Research Site Duncansville, Pennsylvania, United States, 16635 United States, Texas Research Site Dallas, Texas, United States, 75231 Research Site Houston, Texas, United States, 77074 Research Site San Antonio, Texas, United States, 78217 United States, Utah Research Site Salt Lake City, Utah, United States, 84132 United States, Vermont Research Site Burlington, Vermont, United States, 05401 Less <<
NCT01483781 Diabetes Mellitus, Type 2 ... More >> Plasma Volume Less << Phase 1 Completed - Germany ... More >> Neuss, Germany Less <<
NCT00298272 - Terminated(Sponsor decided to ... More >>end long term extension phase for business reasons unrelated to safety.) Less << - -
NCT03429478 Music Therapy ... More >> Cholecystitis/Cholelithiasis Inflammatory Response Surgical Injury Less << Not Applicable Recruiting November 1, 2019 India ... More >> Prof. Brij Bushan Agarwal Recruiting Delhi, India, 110058 Contact: Neeraj Dhamija, DNB Surgery    +919811377332    neerajdhamija@icloud.com Less <<
NCT03394664 Obesity Not Applicable Recruiting July 2021 United States, Massachusetts ... More >> Warren Conference Center and Inn Recruiting Ashland, Massachusetts, United States, 01721 Less <<
NCT03714438 Glucose Tolerance Phase 2 Completed - Mexico ... More >> Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT02323100 Cystic Fibrosis Phase 1 Phase 2 Recruiting April 2020 United States, Alabama ... More >> University of Alabama at Birmingham Not yet recruiting Birmingham, Alabama, United States, 35294-0006 Contact: Steven M Rowe, MD, MSPH    205-934-9640    smrowe@uab.edu    Principal Investigator: Steven M Rowe, MD, MSPH          United States, Colorado National Jewish Health Recruiting Denver, Colorado, United States, 80206 Contact: Connie StClair    303-270-2321    shiven@njhealth.org    Principal Investigator: Noah Lechtzin, MD          Sub-Investigator: Peter Mogazel, MD, PhD          United States, Pennsylvania Children's Hospital of Philadelphia Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Ron Rubenstein, MD, PhD    215-590-1281    rrubenst@mail.med.upenn.edu    Principal Investigator: Ron Rubenstein, MD, PhD Less <<
NCT00424593 - Completed - -
NCT02616510 - Completed - Netherlands ... More >> University Medical Center Utrecht Utrecht, Netherlands Less <<
NCT02000817 Diabetes Mellitus, Type 1 Phase 2 Completed - Belgium ... More >> GSK Investigational Site Brussels, Belgium, 1090 GSK Investigational Site Bruxelles, Belgium, 1070 GSK Investigational Site Edegem, Belgium, 2650 GSK Investigational Site Gent, Belgium, 9000 GSK Investigational Site Leuven, Belgium, 3000 GSK Investigational Site Liège, Belgium, 4000 Less <<
NCT01376388 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 802-0083 GSK Investigational Site Gunma, Japan, 371-0048 GSK Investigational Site Hiroshima, Japan, 732-0052 GSK Investigational Site Hiroshima, Japan, 732-0057 GSK Investigational Site Hokkaido, Japan, 064-0915 GSK Investigational Site Hokkaido, Japan, 080-0805 GSK Investigational Site Hyogo, Japan, 665-0827 GSK Investigational Site Hyogo, Japan, 670-0849 GSK Investigational Site Ibaraki, Japan, 300-0053 GSK Investigational Site Kagawa, Japan, 763-8502 GSK Investigational Site Kanagawa, Japan, 239-0821 GSK Investigational Site Kyoto, Japan, 615-8087 GSK Investigational Site Oita, Japan, 870-0921 GSK Investigational Site Oita, Japan, 876-0047 GSK Investigational Site Osaka, Japan, 576-0016 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Osaka, Japan, 590-0064 GSK Investigational Site Shizuoka, Japan, 436-0022 GSK Investigational Site Tokyo, Japan, 105-0004 GSK Investigational Site Tokyo, Japan, 185-0014 GSK Investigational Site Tokyo, Japan, 187-0024 GSK Investigational Site Wakayama, Japan, 641-8510 GSK Investigational Site Yamanashi, Japan, 400-0031 Less <<
NCT00105989 Depressive Disorder, Major Phase 3 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Newport Beach, California, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sherman Oaks, California, United States United States, Maryland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baltimore, Maryland, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gaithersburg, Maryland, United States United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brooklyn, New York, United States France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Angouleme, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Douai, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fains, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Rochelle, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nimes, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Roubaix, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Strasbourg, France Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ellwangen, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hildesheim, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leipzig, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munchen, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wurzburg, Germany Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Catania, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ferrara, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Firenze, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Parma, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Roma, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Torino, Italy Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St. Petersburg, Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Village Nikolskoe, Russian Federation Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halmstad, Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lund, Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Malmo, Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stockholm, Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sundsvall, Sweden Less <<
NCT00424593 Back Pain Without Radiation Phase 3 Completed - Brazil ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Curitiba, Brazil, 80060240 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p San Paulo, Brazil, 04027-000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Sao Paulo, Brazil, 04026-000 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Amiens, France, 80054 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Marseille, France, 13008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Paris, France, 75014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Saint Affrique, France, 12400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Saint-Etienne, France, 42055 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Ellwangen, Germany, 73479 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Graefelfing, Germany, 82166 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Hamburg, Germany, 22143 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Wiesbaden, Germany, 65191 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Mexico City, Mexico, 06700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Monterrey, Mexico, 64460 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p San Pedro Garza Garcia, Mexico, 66260 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Amsterdam, Netherlands, 1105 AZ For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Rotterdam, Netherlands, 3039 BD Less <<
NCT00536471 Major Depressive Disorder Phase 4 Completed - -
NCT01025115 Metabolic Syndrome Phase 3 Completed - Cuba ... More >> National Institute of Endocrinology Havana City, Havana, Cuba, 10400 Less <<
NCT03304938 Diabetes Mellitus, Type 2 ... More >> Sleep Disturbance Less << Not Applicable Recruiting February 18, 2018 Iran, Islamic Republic of ... More >> Shiraz University of Medical Sciences Recruiting Shiraz, Fars, Iran, Islamic Republic of Contact: Zeinab Nasiri Lari, M.D.    09173139409    dr.znasiri@gmail.com Less <<
NCT01376388 - Completed - -
NCT00536471 - Completed - -
NCT01244984 - Completed - -
NCT01244984 Asthma Phase 3 Completed - Japan ... More >> GSK Investigational Site Chiba, Japan, 277-0863 GSK Investigational Site Fukuoka, Japan, 802-0083 GSK Investigational Site Fukuoka, Japan, 816-0813 GSK Investigational Site Gifu, Japan, 501-6062 GSK Investigational Site Gunma, Japan, 373-0021 GSK Investigational Site Hiroshima, Japan, 730-0844 GSK Investigational Site Hiroshima, Japan, 732-0062 GSK Investigational Site Hiroshima, Japan, 739-0402 GSK Investigational Site Hyogo, Japan, 665-0827 GSK Investigational Site Hyogo, Japan, 670-0046 GSK Investigational Site Hyogo, Japan, 672-8064 GSK Investigational Site Ibaraki, Japan, 302-0022 GSK Investigational Site Kanagawa, Japan, 231-8682 GSK Investigational Site Kanagawa, Japan, 253-0041 GSK Investigational Site Kyoto, Japan, 601-1495 GSK Investigational Site Kyoto, Japan, 615-8087 GSK Investigational Site Miyagi, Japan, 983-0824 GSK Investigational Site Miyagi, Japan, 983-8520 GSK Investigational Site Nagano, Japan, 390-0303 GSK Investigational Site Nagano, Japan, 390-8510 GSK Investigational Site Okayama, Japan, 700-0862 GSK Investigational Site Okayama, Japan, 701-0304 GSK Investigational Site Okayama, Japan, 714-0081 GSK Investigational Site Osaka, Japan, 545-8586 GSK Investigational Site Osaka, Japan, 569-1192 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Tokyo, Japan, 105-0004 GSK Investigational Site Tokyo, Japan, 134-0083 GSK Investigational Site Tokyo, Japan, 185-0014 GSK Investigational Site Toyama, Japan, 937-0066 Less <<
NCT01702363 - Completed - -
NCT00408993 Diabetic Neuropathies Phase 3 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100101 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410011 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Harbin, China, 150086 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjin, China, 210012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200233 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wu Han, China, 430022 Less <<
NCT00573794 Ulcerative Colitis Phase 3 Completed - -
NCT01702363 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 811-1347 GSK Investigational Site Gunma, Japan, 371-0048 GSK Investigational Site Hokkaido, Japan, 080-0805 GSK Investigational Site Hyogo, Japan, 670-0849 GSK Investigational Site Ibaraki, Japan, 300-0053 GSK Investigational Site Ibaraki, Japan, 302-0022 GSK Investigational Site Ishikawa, Japan, 920-8610 GSK Investigational Site Kanagawa, Japan, 239-0821 GSK Investigational Site Kyoto, Japan, 601-1495 GSK Investigational Site Miyagi, Japan, 983-0824 GSK Investigational Site Nagano, Japan, 391-0011 GSK Investigational Site Oita, Japan, 870-0921 GSK Investigational Site Oita, Japan, 876-0047 GSK Investigational Site Osaka, Japan, 530-0001 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Shizuoka, Japan, 436-0022 GSK Investigational Site Tokyo, Japan, 103-0027 GSK Investigational Site Tokyo, Japan, 153-8934 GSK Investigational Site Tokyo, Japan, 192-0903 GSK Investigational Site Yamanashi, Japan, 400-0031 Less <<
NCT00408993 - Completed - -
NCT00105989 - Completed - -
NCT03516721 Obesity Adole... More >>scent Obesity Less << Not Applicable Completed - Belgium ... More >> Jessa Ziekenhuis Hasselt, Belgium, 3500 Less <<
NCT01602549 Gastroparesis Phase 2 Completed - Australia, New South Wales ... More >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Germany GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Bochum, Nordrhein-Westfalen, Germany, 44791 GSK Investigational Site Bonn, Nordrhein-Westfalen, Germany, 53105 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 50937 GSK Investigational Site Jena, Thueringen, Germany, 07747 GSK Investigational Site Berlin, Germany, 13088 Sweden GSK Investigational Site Uppsala, Sweden, SE-751 85 United Kingdom GSK Investigational Site Cambridge, United Kingdom, C2B 2PY GSK Investigational Site Newcastle Upon Tyne, United Kingdom, NE4 5PL GSK Investigational Site Norwich, United Kingdom, NR4 7UY Less <<
NCT01301456 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Less << Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Elite Research Institute Miami, Florida, United States, 33169 Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Miramar, Florida, United States, 33025 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30308 United States, Nebraska ICON Clinical Pharmacology, LLC Omaha, Nebraska, United States, 68154 United States, Pennsylvania CRI Worldwide, LLC Philadelphia, Pennsylvania, United States, 19139 United States, Texas Healthcare Discoveries LLC d/b/a ICON Development Solutions San Antonio, Texas, United States, 78209 Less <<
NCT00573794 - Completed - -
NCT01453049 Diabetes Mellitus, Type 2 Phase 3 Terminated(US FDA/EMA/SFDA dec... More >>isions to rosiglitazone-containing medicines, ethic) Less << - China, Hubei ... More >> GSK Investigational Site Wuhan, Hubei, China, 430030 China, Jiangsu GSK Investigational Site Suzhou, Jiangsu, China, 215004 China, Liaoning GSK Investigational Site Dalian, Liaoning, China, 116027 China, Zhejiang GSK Investigational Site Hangzhou, Zhejiang, China, 310003 GSK Investigational Site Hangzhou, Zhejiang, China, 310009 China GSK Investigational Site Beijing, China, 100029 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Chongqing, China, 400016 GSK Investigational Site Shanghai, China, 200080 GSK Investigational Site Shenyang, China, 110003 GSK Investigational Site Tianjin, China, 300052 GSK Investigational Site Wuhan, China, 430022 Less <<
NCT01602549 - Completed - -
NCT01453049 - Terminated(US FDA/EMA/SFDA dec... More >>isions to rosiglitazone-containing medicines, ethic) Less << - -
NCT01721317 Seizures Phase 4 Terminated(After reevaluation ... More >>of the benefit risk profile of ezogabine/retigabine, GSK does not believe the early adjunctive treatment study population is appropriate.) Less << - United States, California ... More >> GSK Investigational Site Fresno, California, United States, 93710 GSK Investigational Site Newport Beach, California, United States, 92658 GSK Investigational Site Newport Beach, California, United States, 92663 GSK Investigational Site Santa Monica, California, United States, 90404 United States, Colorado GSK Investigational Site Colorado Springs, Colorado, United States, 80907 United States, Florida GSK Investigational Site Pensacola, Florida, United States, 32514 GSK Investigational Site Port Charlotte, Florida, United States, 33952 United States, Illinois GSK Investigational Site Peoria, Illinois, United States, 61637 United States, Maryland GSK Investigational Site Bethesda, Maryland, United States, 20817 United States, Minnesota GSK Investigational Site Golden Valley, Minnesota, United States, 55422 United States, New Jersey GSK Investigational Site Hackensack, New Jersey, United States, 07601 GSK Investigational Site Livingston, New Jersey, United States, 07039 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 United States, Texas GSK Investigational Site Arlington, Texas, United States, 76017 GSK Investigational Site Dallas, Texas, United States, 75251 GSK Investigational Site Kingwood, Texas, United States, 77339 GSK Investigational Site San Antonio, Texas, United States, 78229 GSK Investigational Site Temple, Texas, United States, 76508 United States, Washington GSK Investigational Site Spokane, Washington, United States, 99204 Greece GSK Investigational Site Athens, Greece, 10676 GSK Investigational Site Thessaloniki, Greece, 57010 Less <<
NCT01721317 - Terminated(After reevaluation ... More >>of the benefit risk profile of ezogabine/retigabine, GSK does not believe the early adjunctive treatment study population is appropriate.) Less << - -
NCT01301456 - Completed - -
NCT01494584 Epilepsy Phase 2 Terminated(Terminated after pl... More >>acing the study on hold at the request of the FDA) Less << - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90027 United States, Florida GSK Investigational Site Gulf Breeze, Florida, United States, 32561 GSK Investigational Site Port Charlotte, Florida, United States, 33952 GSK Investigational Site Wellington, Florida, United States, 33414 United States, Minnesota GSK Investigational Site Saint Paul, Minnesota, United States, 55102-2534 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Tennessee GSK Investigational Site Memphis, Tennessee, United States, 38105 United States, Texas GSK Investigational Site Austin, Texas, United States, 78723 GSK Investigational Site Dallas, Texas, United States, 75230-2507 Less <<
NCT02299375 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - -
NCT01494584 - Terminated(Terminated after pl... More >>acing the study on hold at the request of the FDA) Less << - -
NCT00408876 - Completed - -
NCT00408876 Back Pain Without Radiation Phase 3 Completed - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Fort Myers, Florida, United States, 33912 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Orlando, Florida, United States, 32806 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph South Miami, Florida, United States, 33143 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Tampa, Florida, United States, 33606 Less <<
NCT00406848 Major Depressive Disorder Phase 4 Completed - -
NCT02299375 - Completed - -
NCT00767806 Chronic Low Back Pain Phase 3 Completed - United States, Arizona ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chandler, Arizona, United States, 85225 United States, Connecticut For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cromwell, Connecticut, United States, 06416 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Deland, Florida, United States, 32720 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States, 32216 United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brighton, Massachusetts, United States, 02135 United States, Oklahoma For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oklahoma City, Oklahoma, United States, 73109 United States, Oregon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Portland, Oregon, United States, 97210 Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sa Coma, Brazil, 04230000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. São Paulo, Brazil, 04026-000 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aalen, Germany, 73430 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alzenau, Germany, 63755 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 10629 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ellwangen, Germany, 73479 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 20255 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wiesbaden, Germany, 65189 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rotterdam, Netherlands, 3039 BD Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Krakow, Poland, 30-349 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lublin, Poland, 20-093 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland, 61-289 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Szczecin, Poland, 70-376 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 119992 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08025 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bilboa, Spain, 48013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Getafe, Spain, 28905 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Coruña, Spain, 15006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28009 Less <<
NCT00406848 - Completed - -
NCT00711009 Human Immunodeficiency Virus I... More >>nfection Less << Phase 3 Completed - -
NCT01932203 Cerebral Small Vessel Disease Phase 4 Unknown October 2018 Korea, Republic of ... More >> Myongji Hospital Goyang-si, Gyeonggi-do, Korea, Republic of, 412-270 National Health Insurance Corporation Ilsan Hospital Goyang-si, Gyeonggi-do, Korea, Republic of Dongtan Sacred Heart Hospital, Hallym University College of Medicine Hwaseong-si, Gyeonggi-do, Korea, Republic of Wonkwang University Iksan Hospital Iksan, Jeollabuk-do, Korea, Republic of Hallym University Medical Center Anyang, Korea, Republic of Bucheon St.Mary's Hospital Bucheon, Korea, Republic of Soonchunhyang University Bucheon Hospital Bucheon, Korea, Republic of Eulji University School of Medicine Daejeon, Korea, Republic of Konyang University Hospital Daejeon, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of, 400-711 Gachon University Gil Medical Incheon, Korea, Republic of Dong-A University Hospital Pusan, Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Chungang University Hospital Seoul, Korea, Republic of Ewha Womans University Mokdong Hospital Seoul, Korea, Republic of Kyung Hee University Hospital Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT02064881 Type 2 Diabetes Phase 2 Phase 3 Recruiting August 2020 Mexico ... More >> Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán Recruiting México, Distrito Federal, Mexico, 14000 Contact: Francisco Gómez, Doctor    55133891    gomezperezfco@gmail.com    Contact: Paloma Almeda, Doctor    56554523    palomaalmeda@yahoo.com    Principal Investigator: Francisco J Gómez, Doctor Less <<
NCT00767806 - Completed - -
NCT03010514 - Recruiting October 2019 China ... More >> Beijing Anzhen Hospital Recruiting Beijing, China, 100029 Contact: ke-xu Yang    86-010-64426153    EC@anzhenGCP.com Less <<
NCT02621060 Impaired Glucose Tolerance Phase 2 Unknown February 2017 Mexico ... More >> Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara Recruiting Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT00168831 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT02545777 Acute Gouty Arthritis Phase 2 Unknown - China, Beijing ... More >> No.3 Hospital Affiliated to Beijing University of Chinese Medicine Recruiting Beijing, Beijing, China, 100029 Contact: Lou Xi Nen, Doctor    13601181885    13601181885@163.com    Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine Recruiting Beijing, Beijing, China, 100700 Contact: Zhao Jiu Li, Doctor    84013229    dzmk@163.net Less <<
NCT01262781 - Completed - United States, California ... More >> San Francisco General Hospital San Francisco, California, United States, 94110 Less <<
NCT02956655 Type 2 Diabetes Mellitus Not Applicable Unknown - China, Guangdong ... More >> The First Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Jian Qin, Doctor    020-87330751    himybox@yeah.net Less <<
NCT00168831 - Completed - -
NCT00168844 - Completed - -
NCT00711009 - Completed - -
NCT00775437 Juvenile Idiopathic Arthritis Phase 3 Completed - -
NCT02780908 Hypoxia Altit... More >>ude Sickness Tolerance Less << Not Applicable Unknown December 2018 Slovenia ... More >> Jozef Stefan Institute Recruiting Ljubljana, Slovenia, 1000 Contact: Tadej Debevec, PhD    +38641278954    tadej.debevec@ijs.si    Contact: Igor B. Mekjavic, PhD    +386 1 477 3358    igor.mekjavic@ijs.si    University Children's Hospital Ljubljana Department of Pediatric Neurology Recruiting Ljubljana, Slovenia, 1000 Contact: Damjan Osredkar, MD PhD    +386.1.522.9273    damjan.osredkar@kclj.si    Contact: Minca Mramor, MD PhD    +386.1.522.9286    minca.mramor@gmail.com Less <<
NCT01623453 - Terminated(Difficulty recruiti... More >>ng subjects) Less << - Korea, Republic of ... More >> DaeHang Hospital Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00168844 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT00775437 - Completed - -
NCT02929498 Myelodysplastic Syndrome Phase 2 Recruiting May 15, 2019 United States, Pennsylvania ... More >> GSK Investigational Site Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT01485887 Major Depressive Disorder Phase 3 Completed - Japan ... More >> Nippon Medical School Chiba Hokusoh Hospital Inzai, Chiba, Japan, 270-1694 Nakamoto Clinic Noda City, Chiba, Japan, 278-0033 Stress Care Yoshimura Clinic Fukuoka-shi, Fukuoka, Japan, 810-0041 Hatakeyama Clinic Kitakyushu, Fukuoka, Japan, 802-0064 Shiranui Hospital Omuta, Fukuoka, Japan, 836-0004 Fujikawa Clinic Hatsukaichi, Hiroshima, Japan, 738-0023 Takahashi Psychiatric Clinic Ashiya, Hyogo, Japan, 659-0093 Ikeuchi Psycho Induced Internal Med.Clinic Kobe, Hyogo, Japan, 655-0037 National Hospital Organization Kanazawa Medical Center Kanazawa, Ishikawa, Japan, 920-8650 Medical Corporation Seishinkai Kishiro Mental Clinic Kawasaki, Kanagawa, Japan, 214-0014 Yutaka Clinic Sagamihara-shi, Kanagawa, Japan, 252-0303 Tawara Clinic Yokohama, Kanagawa, Japan, 221-0835 Shioiri Mental Clinic Yokosuka city, Kanagawa, Japan, 238-0042 Shibamoto Clinic Osakasayama-shi, Osaka, Japan, 589-0011 Suzuki Hospital Adachi-ku, Tokyo, Japan, 120-0033 Sangenjaya Nakamura Mental Clinic Setagaya-ku, Tokyo, Japan, 154-0004 Omotesando Mental Clinic Shibuya-ku, Tokyo, Japan, 150-0001 Maynds Tower Mental Clinic Shibuya-ku, Tokyo, Japan, 151-0053 Tokyo Kosei Nenkin Hospital Shinjuku-ku, Tokyo, Japan, 162-8543 Himorogi Psychiatric Institute Toshima-ku, Tokyo, Japan, 170-0002 Tenjin Mental Clinic Fukuoka, Japan, 810-0004 Stress Care Yoshimura Clinic Fukuoka, Japan, 810-0041 Kuranari Psychiatry Clinic Fukuoka, Japan, 810-0801 Medical Corporation Toyokokai Tawara Clinic Kanagawa, Japan, 221-0835 Sagaarashiyama-Tanaka Clinic Kyoto, Japan, 616-8421 Less <<
NCT01485887 - Completed - -
NCT01928940 Solid Tumours Phase 2 Completed - Japan ... More >> GSK Investigational Site Shizuoka, Japan, 411-8777 GSK Investigational Site Tokyo, Japan, 104-0045 Less <<
NCT02015988 Acute Coronary Syndrome ... More >> Diabetes Mellitus, Type 2 Hypertriglyceridemia Less << Phase 4 Unknown May 2017 Ukraine ... More >> State Institution "Dnipropetrovsk Medical Academy of Health Ministry of Ukraine" Dnipropetrovsk, Ukraine Less <<
NCT02177812 Leukaemia, Myelocytic, Acute Phase 1 Terminated(The risk benefit in... More >> relapsed refractory AML does not favor continuation of the study.) Less << - United States, Georgia ... More >> GSK Investigational Site Augusta, Georgia, United States, 30912 United States, New York GSK Investigational Site Bronx, New York, United States, 10461 GSK Investigational Site Bronx, New York, United States, 10467 GSK Investigational Site New York, New York, United States, 10065 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 Australia, Victoria GSK Investigational Site Melbourne, Victoria, Australia, 3004 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M5G 2M9 GSK Investigational Site Toronto, Ontario, Canada, M5G 2M Less <<
NCT01928940 - Completed - -
NCT03544281 Multiple Myeloma Phase 2 Recruiting November 28, 2022 United States, Alabama ... More >> GSK Investigational Site Recruiting Birmingham, Alabama, United States, 35294 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT02728414 Diabetes Mellitus, Type 2 Not Applicable Recruiting December 2017 China, Shanghai ... More >> Shanghai 10th People's Hospital Recruiting Shanghai, Shanghai, China, 200072 Contact: Cuiling Zhu, MD    18817951953l    1263856671@qq.com    Principal Investigator: Renyuan Gao, MD Less <<
NCT02733484 Obesity Not Applicable Recruiting December 2017 China, Shanghai ... More >> Shanghai 10th People's Hospital Recruiting Shanghai, Shanghai, China, 200072 Contact: Cuiling Zhu, MD    18817951953    1263856671@qq.com    Contact: Renyuan Gao, MD       renyuangao@126.com    Principal Investigator: Huanlong Qin, PhD          Principal Investigator: Shen Qu, PhD Less <<
NCT00408421 Osteoarthritis Knee Pain Phase 3 Completed - United States, Arizona ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chandler, Arizona, United States, 85225 United States, California For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beverly Hills, California, United States, 90211 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Northridge, California, United States, 91325 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Walnut Creek, California, United States, 94598 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Deland, Florida, United States, 32720 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fort Myers, Florida, United States, 33916 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. S. Miami, Florida, United States, 33143 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stuart, Florida, United States, 34996 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States, 60611 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Morton Grove, Illinois, United States, 60053 United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Billerica, Massachusetts, United States, 01821 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Waltham, Massachusetts, United States, 02453 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Westborough, Massachusetts, United States, 01581 United States, Nevada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Reno, Nevada, United States, 89502 United States, New Jersey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edison, New Jersey, United States, 08817 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stratford, New Jersey, United States, 08084 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toms River, New Jersey, United States, 08755 United States, Oklahoma For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tulsa, Oklahoma, United States, 74135 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lake Jackson, Texas, United States, 77566 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Waco, Texas, United States, 76708 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wichita Falls, Texas, United States, 76309 Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hato Rey, Puerto Rico, 00917 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Juan, Puerto Rico, 00935 Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brasov, Romania, 500365 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucharest, Romania, 70266 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cluj-Napoca, Romania, 400132 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Iasi, Romania, 700656 Less <<
NCT01417624 Heart Failure Phase 3 Unknown June 2013 United Kingdom ... More >> Royal Brompton Hospital Recruiting London, United Kingdom, SW3 6NP Principal Investigator: Rakesh Sharma, MRCP PhD          Sub-Investigator: Kaushik Guha, MBBS MRCP          Sub-Investigator: Martin R Cowie, MD FRCP FESC          Sub-Investigator: Raad Mohiaddin, MD PhD FRCP          Sub-Investigator: Ranil de Silva, PhD FRCP Less <<
NCT03515122 - Enrolling by invitation December 2019 Sweden ... More >> Rehabilitation medicine Research Group Lund, Sweden Less <<
NCT02888691 Type 1 Diabetes Not Applicable Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT03422172 HIV Infections Phase 1 Active, not recruiting April 28, 2020 China, Zhejiang ... More >> GSK Investigational Site Hangzhou, Zhejiang, China, 310000 China GSK Investigational Site Beijing, China, 100069 GSK Investigational Site Shanghai, China, 201508 Less <<
NCT01705210 - Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Netherlands, 6202 AZ Less <<
NCT01222949 Malaria, Falciparum Phase 1 Completed - Australia ... More >> CMAX, a division of IDT Australia Limited Adelaide, Australia, SA 5000 Nucleus Network Limited Melbourne, Australia, VIC 3004 Less <<
NCT01222962 Malaria, Falciparum Phase 1 Completed - Australia ... More >> CMAX, a division of IDT Australia Limited Adelaide, Australia, SA 5000 Less <<
NCT03460795 Liver Cirrhosis Phase 1 Phase 2 Not yet recruiting September 1, 2020 China, Jiangsu ... More >> Nanjing Medical University Not yet recruiting Nanjing, Jiangsu, China, 210029 Contact: Ling Lu, M.D, PH. D.    86-025-68136053    lvling@njmu.edu.cn Less <<
NCT01222078 Diabetes Mellitus, Type 1 Phase 2 Terminated(A Phase 3 study rec... More >>ently reported and demonstrated that the dose of otelixizumab in OTX113390 is not effective.) Less << - France ... More >> GSK Investigational Site Paris Cedex 18, France, 75877 Germany GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Leipzig, Sachsen, Germany, 04103 Less <<
NCT03593707 Healthy Volunteers Phase 1 Suspended(Sponsor elected to v... More >>oluntarily pause study.) Less << February 12, 2019 Belgium ... More >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT01222078 - Terminated(A Phase 3 study rec... More >>ently reported and demonstrated that the dose of otelixizumab in OTX113390 is not effective.) Less << - -
NCT03743519 Patellofemoral Pain Not Applicable Not yet recruiting April 1, 2020 -
NCT00787137 - Terminated(poor recruitment) - -
NCT02292771 Obstetric Labour, Premature Phase 3 Terminated(The study was stopp... More >>ed due to the feasibility of recruiting the study in a timely manner) Less << - -
NCT00146328 - Completed - -
NCT00146328 HIV Infections Phase 2 Phase 3 Completed - -
NCT00408421 - Completed - -
NCT01549210 - Completed - Italy ... More >> Dept of Rheumatology - IRCCS San Matteo Foundation Pavia, Italy, 27100 Less <<
NCT00736099 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00787137 Arthritis, Psoriatic Phase 1 Terminated(poor recruitment) - Serbia ... More >> Professor Nemanja Damjanov Belgrade, Serbia Less <<
NCT00742508 - Completed - -
NCT00742508 Heart Failure, Congestive Phase 1 Completed - Japan ... More >> GSK Investigational Site Chiba, Japan, 296-8602 GSK Investigational Site Ehime, Japan, 794-0006 GSK Investigational Site Hiroshima, Japan, 737-0023 GSK Investigational Site Hokkaido, Japan, 060-0033 GSK Investigational Site Hokkaido, Japan, 063-0005 GSK Investigational Site Kanagawa, Japan, 210-0852 GSK Investigational Site Kanagawa, Japan, 238-8558 GSK Investigational Site Mie, Japan, 511-0068 GSK Investigational Site Nagano, Japan, 397-8555 GSK Investigational Site Nagasaki, Japan, 859-3615 GSK Investigational Site Oita, Japan, 879-5593 GSK Investigational Site Osaka, Japan, 565-8565 GSK Investigational Site Saga, Japan, 843-0393 GSK Investigational Site Saitama, Japan, 364-8501 GSK Investigational Site Shizuoka, Japan, 410-2295 GSK Investigational Site Shizuoka, Japan, 411-8611 GSK Investigational Site Shizuoka, Japan, 427-8502 GSK Investigational Site Shizuoka, Japan, 430-8502 GSK Investigational Site Tokyo, Japan, 141-0001 GSK Investigational Site Tokyo, Japan, 142-8666 GSK Investigational Site Tokyo, Japan, 153-8515 GSK Investigational Site Tokyo, Japan, 196-0003 GSK Investigational Site Wakayama, Japan, 640-8158 Less <<
NCT02377466 Obstetric Labour, Premature Phase 3 Terminated(Asset terminated by... More >> PIB) Less << - -
NCT02292771 - Terminated(The study was stopp... More >>ed due to the feasibility of recruiting the study in a timely manner) Less << - -
NCT00623597 HIV Infections Phase 2 Completed - Argentina ... More >> Buenos Aires, Argentina, 1202 Buenos Aires, Argentina, 1425 Santa Fe, Argentina, 3000 Spain Madrid, Spain, 28046 Madrid, Spain, 28905 Valencia, Spain, 46009 Thailand Bangkok, Thailand, 10400 Khon Kaen, Thailand, 40002 Pathumwan, Thailand, 10330 Payathai, Thailand, 10400 Less <<
NCT00736099 - Completed - -
NCT02533817 Healthy Not Applicable Completed - -
NCT03563846 Lactose Intolerance Phase 1 Completed - United States, Florida ... More >> Syneos Health Miami, Florida, United States, 33136 Less <<
NCT02377466 - Terminated(Asset terminated by... More >> PIB) Less << - -
NCT00623597 - Completed - -
NCT02045797 Infections, Bacterial Phase 2 Completed - -
NCT02564055 Dermatitis, Atopic Phase 2 Completed - -
NCT02045797 - Completed - -
NCT02564042 Psoriasis Phase 2 Completed - -
NCT02279641 Gout Phase 1 Completed - United States, Kansas ... More >> Overland Park, Kansas, United States, 66212 Less <<
NCT02880852 Systemic Lupus Erythematosus Phase 1 Completed - China ... More >> GSK Investigational Site Shanghai, China GSK Investigational Site Suzhou, China, 215004 Less <<
NCT01356602 Acute Gouty Arthritis Phase 3 Completed - -
NCT02279641 - Completed - -
NCT01265498 Nonalcoholic Fatty Liver Disea... More >>se (NAFLD) Nonalcoholic Steatohepatitis (NASH) Less << Phase 2 Completed - United States, California ... More >> University of California, San Diego San Diego, California, United States, 92103 University of California, San Francisco San Francisco, California, United States, 94143 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Missouri St. Louis University Saint Louis, Missouri, United States, 63104 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44109 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 Less <<
NCT02880852 - Completed - -
NCT02564055 - Completed - -
NCT03684122 Parkinson Disease Phase 1 Phase 2 Recruiting April 2019 Jordan ... More >> Cell Therapy Center, University of Jordan Recruiting Amman, Jordan, 11942 Contact: Fatima Jamali, PhD    009625355000 ext 23960    ftmjamali@gmail.com Less <<
NCT01431638 Acute Gouty Arthritis Phase 3 Completed - -
NCT01710722 Obesity Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT01356602 - Completed - -
NCT01156220 Healthy Male and Female Volunt... More >>eers Less << Phase 4 Unknown June 2012 Germany ... More >> Clinical Trial Center North Not yet recruiting Hamburg, Germany, 20246 Contact: Alen Jambrecina, Dr. med.    +49 40 7410 51603    a.jambrecina@uke.de Less <<
NCT02564042 - Completed - -
NCT01265498 - Completed - -
NCT01552590 Hyponatremia and Extracellular... More >> Fluid in Cirrhotic Less << Phase 4 Unknown January 2013 Korea, Republic of ... More >> Hallym Univ. Chuncheon Sacred Heart Hospital Recruiting Bucheon, Korea, Republic of Contact: KiTae Suk, Assistant professor          Principal Investigator: KiTae Suk, Assistant professor          Soonchunhyang Univ. Bucheon Hospital Recruiting Bucheon, Korea, Republic of Contact: YoungSeok Kim, Associate professor          Principal Investigator: YoungSeok Kim, Associate professor          Wonju Christian Hospital Recruiting Wonju, Korea, Republic of Contact: SoonKoo Baik, Professor          Principal Investigator: SoonKoo Baik, Professor Less <<
NCT01594567 - Unknown December 2015 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT01608620 - Unknown September 2016 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT02057731 - Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32608 Less <<
NCT01777256 Systemic Lupus Erythematosus Phase 2 Terminated(This study met a pr... More >>otocol defined futility criterion and will be terminated following completion of the Follow Up Visit on the last subject randomised.) Less << - -
NCT01671124 - Unknown November 2013 Taiwan ... More >> Taipei Mecical University Hospital Recruiting Taipei, Taiwan, 100 Contact: Yu-Ru Guo, master    886227361661 ext 6549    dinyty@hotmail.com    Sub-Investigator: Chih-Chiang Chiu, Ph.D          Sub-Investigator: Hsin-Chien Lee, Ph.D          Principal Investigator: Shih-Yi Huang, Ph.D Less <<
NCT03015948 Gout Phase 1 Completed - Australia, New South Wales ... More >> Atridia Pty Limited Sydney, New South Wales, Australia, 2000 Less <<
NCT01460797 Obesity Not Applicable Completed - Brazil ... More >> School of Health Sciences, University of Brasília Brasília, DF, Brazil, 70910-900 Less <<
NCT02147041 Diabetes Mellitus ... More >> Hyperlipidemia Less << Phase 2 Phase 3 Unknown August 2014 Taiwan ... More >> Taipei City Hospital Taipei, Taiwan Less <<
NCT00077636 Hepatitis C, Chronic Phase 4 Completed - -
NCT00077636 - Completed - -
NCT02310750 - Completed - -
NCT02205333 Advanced Solid Tumors ... More >> Aggressive B-cell Lymphomas Less << Phase 1 Phase 2 Terminated(The study was termi... More >>nated early at the sponsor's discretion.) Less << - United States, Arizona ... More >> Research Site Scottsdale, Arizona, United States, 85259 United States, California Research Site Sacramento, California, United States, 95817 Research Site Santa Monica, California, United States, 90404 United States, District of Columbia Research Site Washington, D.C., District of Columbia, United States, 20007 United States, Florida Research Site Tampa, Florida, United States, 33612 United States, Illinois Research Site Chicago, Illinois, United States, 60611 United States, Michigan Research Site Detroit, Michigan, United States, 48202 United States, Nevada Research Site Las Vegas, Nevada, United States, 89169 United States, New Jersey Research Site Hackensack, New Jersey, United States, 7601 United States, North Carolina Research Site Huntersville, North Carolina, United States, 28078 United States, Oregon Research Site Portland, Oregon, United States, 97213 United States, Tennessee Research Site Memphis, Tennessee, United States, 38120 United States, Texas Research Site Houston, Texas, United States, 77030 Less <<
NCT02014272 Healthy Volunteers Phase 1 Completed - Singapore ... More >> Pfizer Investigational Site Singapore, Singapore, 188770 Less <<
NCT02310750 Plaque Psoriasis Phase 1 Completed - United States, California ... More >> Anaheim Clinical Trials, LLC Anaheim, California, United States, 92801 Less <<
NCT02014272 - Completed - -
NCT02262754 Chronic Low Back Pain Phase 2 Completed - -
NCT02228395 Healthy Phase 1 Completed - United States, Connecticut ... More >> New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 Less <<
NCT02205333 - Terminated(The study was termi... More >>nated early at the sponsor's discretion.) Less << - -
NCT01449110 Cardiovascular Diseases Phase 2 Completed - Spain ... More >> University Hospital Morales Meseguer Murcia, Spain, 30008 Less <<
NCT02228395 - Completed - -
NCT02262754 - Completed - -
NCT00419146 Schizophrenia ... More >> Schizophreniform Disorders Schizoaffective Disorder Psychotic Disorders Less << Phase 2 Phase 3 Completed - Norway ... More >> Aker University Hospital Oslo, Norway, 0320 Less <<
NCT01369225 Alzheimer's Disease Phase 1 Completed - United States, Florida ... More >> MD Clinical Hallandale Beach, Florida, United States, 33009 Munroe Regional Medical Center Ocala, Florida, United States, 34471 Renstar Medical Research Ocala, Florida, United States, 34471 Trinity Care Solutions Ocala, Florida, United States, 34471 Advanced Imaging of Ocala Ocala, Florida, United States, 34481 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30308 United States, Maryland Foers Medical Arts Pharmacy Bethesda, Maryland, United States, 20814 CBH Health, LLC Rockville, Maryland, United States, 20850 United States, Michigan Borgess Medical Center Kalamazoo, Michigan, United States, 49048 Borgess Research Institute Kalamazoo, Michigan, United States, 49048 KNI Southwest Michigan Imaging Center, LLC Kalamazoo, Michigan, United States, 49048 United States, Missouri Millennium Psychiatric Associates, LLC Creve Coeur, Missouri, United States, 63141 DePaul Health Center-MRI Department St. Louis, Missouri, United States, 63044 United States, New Jersey Memory Enhancement Center of America, Inc. Eatontown, New Jersey, United States, 07724 Central Jersey Radiology Oakhurst, New Jersey, United States, 07755 Korea, Republic of Seoul National University Hospital, Department Neurology Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Inha University Hospital, Department of Neurology Incheon, Korea, Republic of, 400-711 Samsung Medical Center, Department of Neurology Seoul, Korea, Republic of, 1350710 Korea University Anam Hospital IRB Seoul, Korea, Republic of, 136-705 ASAN Medical Center Seoul, Korea, Republic of, 138-736 Konkuk University Medical Center, Department of Neurology Seoul, Korea, Republic of, 143914 Less <<
NCT02443740 Healthy Phase 1 Completed - United States, Connecticut ... More >> New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 Less <<
NCT02224664 Parkinson`s Disease Phase 1 Completed - United States, California ... More >> Orange Coast Memorial Medical Center Fountain Valley, California, United States, 92708 The Parkinson's and Movement Disorder Institute Fountain Valley, California, United States, 92708 Collaborative Neuroscience Network, LLC Long Beach, California, United States, 90806 United States, Colorado Rocky Mountain Movement Disorders Center Englewood, Colorado, United States, 80113 Davita Clinical Research Center Lakewood, Colorado, United States, 80228 United States, Florida MD Clinical Hallandale Beach, Florida, United States, 33009 Compass Research, LLC Orlando, Florida, United States, 32806 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30331 United States, Massachusetts Massachusetts General Hospital -- FOR DRUG SHIPMENT ONLY Boston, Massachusetts, United States, 02114 Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Quest Research Institute Farmington Hills, Michigan, United States, 48334 United States, New Jersey PRA International Marlton, New Jersey, United States, 08053 United States, North Carolina Carolina Phase I Research, LLC Raleigh, North Carolina, United States, 27612 United States, Oklahoma Lynn Health Science Institute Oklahoma City, Oklahoma, United States, 73112 United States, Texas Neurology Consultants of Dallas, PA Dallas, Texas, United States, 75231 Walnut Hill Medical Center Dallas, Texas, United States, 75231 Belgium Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT02443740 - Completed - -
NCT01673178 Diabetes Melliuts, Type 2 Phase 1 Completed - United States, California ... More >> Anaheim Clinical Trials, LLC Anaheim, California, United States, 92801 Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Diablo Clinical Research, Inc. Walnut Creek, California, United States, 94598 United States, Florida Avail Clinical Research, LLC DeLand, Florida, United States, 32720 Elite Research Institute Miami, Florida, United States, 33169 Miami Research Associates, Inc. South Miami, Florida, United States, 33143 MRA Clinical Research, LLC South Miami, Florida, United States, 33143 United States, Kentucky Central Kentucky Research Associates, Inc. Lexington, Kentucky, United States, 40509 L-MARC Research Center Louisville, Kentucky, United States, 40213 United States, Minnesota Prism Research Saint Paul, Minnesota, United States, 55114 United States, North Carolina High Point Clinical Trials Center, LLC High Point, North Carolina, United States, 27265 Carolina Phase 1 Research Raleigh, North Carolina, United States, 27612 Wake Internal Medicine Consultants Raleigh, North Carolina, United States, 27612 United States, Ohio Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45227 Community Research Cincinnati, Ohio, United States, 45255 Mercy Hospital Pharmacy Cincinnati, Ohio, United States, 45255 United States, Texas Covance Clinical Research Unit Dallas, Texas, United States, 75247 Less <<
NCT02224664 - Completed - -
NCT01806896 Huntington's Disease Phase 2 Completed - France ... More >> Centre d'Investigation Clinique (CIC)/ Institut du Cerveau et de la Möelle Epinière (ICM) Paris Cedex 13, France, 75651 Less <<
NCT01806896 - Completed - -
NCT02259244 Obesity Not Applicable Completed - -
NCT00983437 - Terminated(Study has been stop... More >>ped by sponsor decision) Less << - -
NCT01369225 - Completed - -
NCT03680105 Critical Limb Ischemia Phase 1 Recruiting March 2019 United States, Texas ... More >> ICON Early Phase Services Recruiting San Antonio, Texas, United States, 78209 Contact: Dennis A Ruff, MD Less <<
NCT03493191 Acute Pain Phase 1 Recruiting September 2018 Australia ... More >> Linear Clinical Research Limited Recruiting Nedlands, Australia Contact: Sarah Powell    +61 (0) 411 062 165    spowell@linear.org.au Less <<
NCT01673178 - Completed - -
NCT01258712 Rheumatoid Arthritis (RA) Phase 3 Completed - Taiwan ... More >> Buddhist Dalin Tzu Chi General Hospital Chiayi, Taiwan Chang Gung Memorial Hospital -Kaohsiung Kaohsiung, Taiwan Kaohsiung Medical University Hospital Kaohsiung, Taiwan Kaohsiung Veterans General Hospital Kaohsiung, Taiwan Chung Shan Medical University Hospital Taichung, Taiwan Taichung Veterans General Hospital Taichung, Taiwan National Cheng Kung University Hospital Tainan, Taiwan Cathay General Hospital Taipei, Taiwan National Taiwan University Hospital Taipei, Taiwan Taipei Veterans General Hospital Taipei, Taiwan Tri-Service General Hospital Taipei, Taiwan Chang Gung Memorial Hospital - Linkou Taoyuan, Taiwan Less <<
NCT00983437 Traumatic Brain Injury Phase 3 Terminated(Study has been stop... More >>ped by sponsor decision) Less << - -
NCT00703755 Patients With Metabolic Syndro... More >>me Less << Phase 2 Completed - -
NCT02956577 - Completed - Denmark ... More >> Cardiovascular Research Unit, OUH Svendborg Hospital Svendborg, Denmark, 5700 Less <<
NCT01922739 Low Back Pain Phase 3 Completed - -
NCT01899755 Psoriasis Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site London, United Kingdom, NW10 7EW Less <<
NCT01922739 - Completed - -
NCT03686722 Diabetes Mellitus, Type 2 ... More >> Hepatitis C Drug Interactions Less << Phase 1 Completed - Egypt ... More >> Drug research centre Cairo, Egypt Less <<
NCT00903201 Cystic Fibrosis Phase 2 Completed - -
NCT00903201 - Completed - -
NCT02992106 Endothelial Dysfunction ... More >> Childhood Obesity Less << Not Applicable Enrolling by invitation August 2020 Belgium ... More >> University Hospital of Brussels Brussels, Belgium, 1090 Less <<
NCT03433248 Type2 Diabetes Phase 4 Recruiting December 1, 2020 Netherlands ... More >> VU University Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081HV Contact: Michaël JB van Baar, MD    +31 20 444 4709    m.vanbaar@vumc.nl    Contact: Daniël H van Raalte, MD PhD    +31 20 444 0534    d.vanraalte@vumc.nl    Principal Investigator: Mark HH Kramer, MD PhD          Principal Investigator: Daniël H van Raalte, MD PhD Less <<
NCT02358668 Pre-Diabetes Phase 2 Completed - Hong Kong ... More >> The Chinese University of Hong Kong Shatin, Hong Kong Less <<
NCT00546052 Hypertension ... More >>Metabolic Disorder Less << Phase 3 Completed - -
NCT02795754 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT01173120 Rheumatoid Arthritis (RA) Phase 3 Completed - -
NCT01396187 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> Pfizer Investigational Site Chula Vista, California, United States, 91911 United States, Florida Pfizer Investigational Site Miami, Florida, United States, 33169 Pfizer Investigational Site South Miami, Florida, United States, 33143 United States, Kansas Pfizer Investigational Site Overland Park, Kansas, United States, 66212 United States, Texas Pfizer Investigational Site San Antonio, Texas, United States, 78229 Less <<
NCT01173120 - Completed - -
NCT02090621 Hepatic Insufficiency Phase 2 Completed - Spain ... More >> Jose Antonio Pons, MD Murcia, El Palmar, Spain, 30120 Less <<
NCT02358668 - Completed - -
NCT01396187 - Completed - -
NCT01637675 Pulmonary Hypertension ... More >> Pulmonary Arterial Hypertension Cardiovascular Diseases Lung Diseases Tanshinone IIA Sulfonate Less << Phase 2 Phase 3 Unknown December 2014 China, Guangdong ... More >> The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Jian Wang, MD    +8615013388183    jwang31@jhmi.edu Less <<
NCT02845622 Cardiovascular Diseases ... More >> Glucose Metabolism Disorders Less << Not Applicable Completed - Italy ... More >> San Donato Hospital San Donato Milanese, Italy, 20097 Less <<
NCT00546052 - Completed - -
NCT01916239 Colorectal Cancer Phase 1 Phase 2 Completed - Spain ... More >> Hospital General Universitario Reina Sofía Murcia, Spain, 30003 Less <<
NCT02729662 Autosomal Dominant Polycystic ... More >>Kidney Disease Less << Not Applicable Active, not recruiting September 30, 2021 Japan ... More >> Kyorin University Hospital Mitaka, Tokyo, Japan, 181-8611 Less <<
NCT03458650 Healthy Phase 1 Completed - China, Shanghai ... More >> Huashan Hospital, Fudan University Shanghai, Shanghai, China, 200040 Less <<
NCT00402168 Renal Transplant Phase 2 Completed - -
NCT02427347 Abdominal Obesity ... More >> Metabolic Syndrome Less << Not Applicable Completed - China, Beijing ... More >> Department of Acupuncture and Moxibustion, Dongfang Hospital, Beijing University of Chinese Medicine Beijing, Beijing, China, 100078 Less <<
NCT03198585 Heart Failure With Reduced Eje... More >>ction Fraction Less << Phase 2 Recruiting October 2019 Denmark ... More >> Herlev and Gentofte University Hospital Recruiting Copenhagen, Denmark, 2730 Contact: Jesper Jensen, MD    +45 38686258    jesper.jensen.06@regionh.dk    Principal Investigator: Morten Schou, MD          Sub-Investigator: Jesper Jensen, MD          Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Massar Omar, MD    +45 608400609    massar.omar@rsyd.dk    Principal Investigator: Jacob E Moller, MD          Sub-Investigator: Massar Omar, MD Less <<
NCT00402168 - Completed - -
NCT03061851 Diabetes Mellitus, Type 2 Not Applicable Recruiting December 2018 China, Shandong ... More >> Qingdao University Hospital Recruiting Qingdao, Shandong, China Contact: Nailong Yang    0086-18661806185    nailongyang@163.com Less <<
NCT00272779 HIV Infections Phase 3 Completed - -
NCT03050229 Nocturnal Hypertension ... More >> T2DM (Type 2 Diabetes Mellitus) Less << Phase 4 Completed - Japan ... More >> Fukuoka University Chikushi Hospital Fukuoka, Japan Kotake Hospital Fukuoka, Japan Onga Hospital Fukuoka, Japan Ishiguro Clinic Gifu, Japan Higashiagatsuma-machi National Health Insurance Clinic Gunma, Japan Katsuya Iin Hyogo, Japan Minamisanriku Hospital Miyagi, Japan Shibuya Clinic Saitama, Japan International University of Health and Welfare Hospital Tochigi, Japan Jichi Medical University hospital Tochigi, Japan Utsunomiya higashi hospital Tochigi, Japan Kato Clinic Tokyo, Japan Less <<
NCT01894165 Molybdenum Cofactor Deficiency... More >> (MoCD) Rare Autosomal Recessive Disorder Deficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase) Less << Phase 1 Completed - United States, Maryland ... More >> Parexel Baltimore EPCU Baltimore, Maryland, United States, 21225 Less <<
NCT03449199 Diabetic Kidney Disease Phase 2 Recruiting June 30, 2019 -
NCT01072175 Cancer Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Los Angeles, California, United States, 90025 Novartis Investigative Site San Francisco, California, United States, 94115 United States, Colorado Novartis Investigative Site Aurora, Colorado, United States, 80045 United States, Connecticut Novartis Investigative Site New Haven, Connecticut, United States, 06520 United States, Florida Novartis Investigative Site Tampa, Florida, United States, 33612 United States, Maryland Novartis Investigative Site Lutherville-Timonium, Maryland, United States, 21093 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02114 Novartis Investigative Site Boston, Massachusetts, United States, 02215 United States, Minnesota Novartis Investigative Site Rochester, Minnesota, United States, 55905 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37203 Novartis Investigative Site Nashville, Tennessee, United States, 37232 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030-4009 Australia, New South Wales Novartis Investigative Site Westmead, New South Wales, Australia, 2145 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3084 Less <<
NCT03446053 Healthy Volunteers ... More >> Anti-Bacterial Agents Methicillin-Resistant Staphylococcus Aureus Methicillin-Sensitive Staphylococcus Aureus Infection Less << Phase 1 Recruiting October 2019 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: In Jin Jang, M.D., Ph. D    82-2-740-8290    ijjang@snu.ac.kr    Contact: Jun Gi Hwang Hwang, M.D    82-2-742-9252    hjk17@snu.ac.kr    Principal Investigator: In Jin Jang, M.D., Ph. D          Sub-Investigator: Jun Gi Hwang, M.D Less <<
NCT00204230 Immunosuppressive Agents ... More >> Kidney Failure, Chronic Kidney Transplantation Less << Not Applicable Terminated - -
NCT02433717 Schizophrenia ... More >> Schizoaffective Disorder Less << Phase 4 Unknown February 2016 Taiwan ... More >> Department of Psychiatry, National Taiwan University Hospital Not yet recruiting Taipei, Test2, Taiwan, test3 Contact: Yi-Ting Lin    +886-972-653-797    p98421013@ntu.edu.tw    Sub-Investigator: Ming H. Hsieh          Sub-Investigator: Yi-Lin Chien          Sub-Investigator: Chih-Min Liu          Sub-Investigator: Tzung-Jeng Hwang          Sub-Investigator: Chen-Chung Liu          National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Yi-Ting Lin, MD    +886-2-23123456 ext 67990    p98421013@ntu.edu.tw    Principal Investigator: Yi-Ting Lin, MD          Sub-Investigator: Chin-Min Liu, MD, PhD          Sub-Investigator: Ming H Hsieh, MD, PhD          Sub-Investigator: Tzung-Jeng Hwang, MD, PhD          Sub-Investigator: Chen-Chung Liu, MD, PhD          Principal Investigator: Yi-Ling Chien, MD, PhD Less <<
NCT00272779 - Completed - -
NCT00823199 - Completed - -
NCT02972905 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 813-0017 Less <<
NCT02594514 - Completed - Brazil ... More >> HCFUMSP Sao Paulo, SP, Brazil, 0543-010 Less <<
NCT02377427 Asthma Phase 2 Completed - United States, California ... More >> GSK Investigational Site San Diego, California, United States, 92123 United States, North Carolina GSK Investigational Site Chapel Hill, North Carolina, United States, 27599-7310 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73112 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 United States, Wisconsin GSK Investigational Site Madison, Wisconsin, United States, 53792-9988 Japan GSK Investigational Site Fukuoka, Japan, 811-1394 GSK Investigational Site Hiroshima, Japan, 720-8520 GSK Investigational Site Hiroshima, Japan, 721-8511 GSK Investigational Site Wakayama, Japan, 646-8558 Poland GSK Investigational Site Lodz, Poland, 90-329 GSK Investigational Site Tarnow, Poland, 33-100 GSK Investigational Site Wroclaw, Poland, 53-201 United Kingdom GSK Investigational Site Glasgow, United Kingdom, G514TF GSK Investigational Site Leicester, United Kingdom, LE27LX GSK Investigational Site Liverpool, United Kingdom, L12 2AP GSK Investigational Site London, United Kingdom, SE5 9RS GSK Investigational Site London, United Kingdom, SW3 6NP GSK Investigational Site Oxford, United Kingdom, OX3 9DU GSK Investigational Site Sheffield, United Kingdom, S10 2TH Less <<
NCT00823199 Schizophrenia Not Applicable Completed - -
NCT02377427 - Completed - -
NCT02122211 Men Carrying 2 Minor Alleles f... More >>or Choline Dehydrogenase rs12676 Male Infertility Less << Phase 1 Completed - United States, North Carolina ... More >> UNC Nutrition Research Institute Kannapolis, North Carolina, United States, 28081 Less <<
NCT01072175 - Completed - -
NCT02625207 Healthy Subjects Phase 1 Completed - United States, Connecticut ... More >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 Less <<
NCT01806506 Morbid Obesity ... More >> Metabolic Syndrome X Diabetes Mellitus Dyslipidemia Hypertension Less << Not Applicable Unknown - Poland ... More >> Department of General, Transplant and Liver Surgery, Public Central Teaching Hospital, Medical University of Warsaaw Warsaw, Poland, 02-097 Less <<
NCT01982734 Pharmacokinetics of New Curcum... More >>in Formulations Safety of New Curcumin Formulations Less << Early Phase 1 Completed - Germany ... More >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 Less <<
NCT02625207 - Completed - -
NCT02944097 Safety After Oral Intake ... More >> Pharmacokinetics After Oral Intake Less << Early Phase 1 Completed - Germany ... More >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 Less <<
NCT02197130 Huntington's Disease Phase 2 Completed - -
NCT02663089 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site London, United Kingdom, NW10 7EW Less <<
NCT02197130 - Completed - -
NCT03140397 Safety After Oral Intake ... More >> Pharmacokinetics After Oral Intake Immune Cells Activity Less << Early Phase 1 Completed - Germany ... More >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 Eberhard Karls University Tuebingen Tübingen, Baden-Württemberg, Germany, 72076 Less <<
NCT03286777 Safety of Native vs. Micellar ... More >>6-PN After Oral Intake Pharmacokinetics of Native vs. Micellar 6-PN After Oral Intake PBMC Activity After Native vs. Micellar 6-PN Oral Intake Less << Not Applicable Completed - Germany ... More >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 Eberhard Karls University Tuebingen Tübingen, Baden-Württemberg, Germany, 72076 Less <<
NCT02460783 Alzheimer's Disease ... More >> Obesity Diabetes Mellitus Less << Phase 2 Recruiting July 1, 2019 United States, Maryland ... More >> National Institute of Aging, Clinical Research Unit Recruiting Baltimore, Maryland, United States, 21224 Less <<
NCT02832414 Sleep Apnea, Obstructive ... More >> Obesity Less << Not Applicable Recruiting - Spain ... More >> Hospital Universitari de Bellvitge Recruiting L'Hospitalet de Llobregat, Barcelona, Spain Contact: Carmen Monasterio Less <<
NCT03739242 Hypercholesterolemia Not Applicable Completed - Italy ... More >> Policlinico S.Orsola - Malpighi Medicina Interna Borghi Bologna, Italy, 40138 Less <<
NCT02226354 Healthy Phase 1 Completed - Canada, New Brunswick ... More >> Université de Moncton Moncton, New Brunswick, Canada, E1A 3E9 Less <<
NCT02540759 Healthy Phase 1 Completed - Canada, New Brunswick ... More >> Université de Moncton Moncton, New Brunswick, Canada, E1A 3E9 Less <<
NCT01022060 Recurrent Calcic Urolithiasis Phase 3 Completed - Cuba ... More >> Institute of Nephrology Havana City, Havana, Cuba, 10400 Less <<
NCT00978224 Chronic Inflammatory Syndrome Phase 3 Suspended(Decision of the inve... More >>stigator) Less << September 2011 Cuba ... More >> Institute of Nephrology "Dr. Abelardo Buch López" Havana, Cuba, 10400 Less <<
NCT01142726 Rheumatoid Arthritis Phase 3 Completed - -
NCT02944084 Safety After Oral Intake ... More >> Pharmacokinetics After Oral Intake Less << Early Phase 1 Completed - Germany ... More >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 Less <<
NCT02964715 Type2 Diabetes ... More >> NAFLD Less << Phase 4 Recruiting November 2018 Malaysia ... More >> University of Malaya Recruiting Kuala Lumpur, Wilayah Persekutuan, Malaysia Contact: Shireene R Vethakkan, MD    0162093355    shireene.vethakkan@gmail.com    Sub-Investigator: Wah K Chan, MRCP Less <<
NCT02434497 Homozygous Familial Hyperchole... More >>sterolemia (HoFH) Less << Phase 3 Completed - Belgium ... More >> Research Site Brussels (Woluwé-St-Lambert), Belgium, 1200 Canada, Quebec Research Site Chicoutimi, Quebec, Canada, G7H 7K9 Denmark Research Site Copenhagen, Denmark, DK-2100 Israel Research Site Halfa, Israel, 31096 Malaysia Research Site Kubang Kerian, Malaysia, 16150 Taiwan Research Site Taipei City, Taiwan, 11217 Less <<
NCT02434497 - Completed - -
NCT02425020 Dietary Modification Not Applicable Completed - -
NCT02109445 Metastatic Cancer Pancreas Phase 2 Terminated(The study was termi... More >>nated on 24JUN15 due to change in strategy of PF-03084014 development.No safety/efficacy concerns were behind the reason of trial termination) Less << - United States, Colorado ... More >> Anschutz Inpatient Pavilion Aurora, Colorado, United States, 80045 Drug Shipment: Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Cancer Center Aurora, Colorado, United States, 80045 University of Colorado Denver, CTO (CTRC) Aurora, Colorado, United States, 80045 United States, New York University of Rochester Investigational Drug Pharmacy Rochester, New York, United States, 14642 University of Rochester Rochester, New York, United States, 14642 Less <<
NCT01142726 - Completed - -
NCT01636778 - Completed - -
NCT02109445 - Terminated(The study was termi... More >>nated on 24JUN15 due to change in strategy of PF-03084014 development.No safety/efficacy concerns were behind the reason of trial termination) Less << - -
NCT02970838 Obesity Diabe... More >>tes Type 2 Weight Loss Less << Not Applicable Completed - Germany ... More >> University Medicine Greifswald Greifswald, Germany, 17475 Less <<
NCT03417674 Overweight and Obesity Not Applicable Active, not recruiting December 31, 2018 Germany ... More >> West-German Centre of Diabetes and Health Düsseldorf, Germany, 40591 Less <<
NCT01728675 Aging Muscle ... More >>Damage Oxidative Stress Less << Not Applicable Completed - Cyprus ... More >> European University Cyprus Nicosia, Cyprus, 1516 Less <<
NCT03665636 Glycogen Storage Disease Type ... More >>I Less << Early Phase 1 Not yet recruiting June 2019 United States, Pennsylvania ... More >> UPMC Children's Hospital of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15210 Contact: Angela Leshinski, MBA, RD, LDN    412-692-5232    angela.leshinski@chp.edu    Contact: Elizabeth McCracken, MS, LCGC    412-692-5662    elizabeth.mccracken@chp.edu    Principal Investigator: Areeg El-Gharbawy, MD Less <<
NCT01636778 Hepatitis C, Chronic Phase 2 Completed - Japan ... More >> GSK Investigational Site Aichi, Japan, 467-8602 GSK Investigational Site Fukui, Japan, 918-8503 GSK Investigational Site Fukuoka, Japan, 803-8505 GSK Investigational Site Fukuoka, Japan, 830-0011 GSK Investigational Site Gunma, Japan, 370-0829 GSK Investigational Site Hyogo, Japan, 663-8501 GSK Investigational Site Ibaraki, Japan, 317-0077 GSK Investigational Site Kagawa, Japan, 760-0017 GSK Investigational Site Kagawa, Japan, 760-8557 GSK Investigational Site Kagoshima, Japan, 899-5112 GSK Investigational Site Kanagawa, Japan, 213-8587 GSK Investigational Site Nagasaki, Japan, 856-8562 GSK Investigational Site Oita, Japan, 879-5593 GSK Investigational Site Osaka, Japan, 540-0006 GSK Investigational Site Tokyo, Japan, 105-8470 GSK Investigational Site Wakayama, Japan, 646-8558 Less <<
NCT00237588 Hypertension Phase 4 Completed - Norway ... More >> Cardiovascular and Renal Research Center/ Department of Cardiology, Ullevaal University Hospital Oslo, Norway, 0407 Less <<
NCT03671733 Obesity Phase 3 Recruiting September 1, 2020 China, Hunan ... More >> Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410008 Contact: Jing Wu    +86-13574120508    wujing0731@163.com Less <<
NCT02119260 Oedema, Pulmonary Phase 2 Completed - United Kingdom ... More >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG GSK Investigational Site London, United Kingdom, NW10 7EW Less <<
NCT03627494 Muscular Dystrophies Phase 1 Recruiting June 30, 2019 United States, Maryland ... More >> GSK Investigational Site Recruiting Baltimore, Maryland, United States, 21225 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT02581345 Chronic Plaque Psoriasis ... More >> Psoriasis Less << Phase 3 Completed - -
NCT02537834 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Atsuta-ku, Aichi, Japan, 456-0058 Minato-ku, Aichi, Japan, 455-0018 Kisarazu, Chiba, Japan, 292-0038 Annaka, Gunma, Japan, 379-0116 Naka, Ibaraki, Japan, 311-0113 Sagamihara, Kanagawa, Japan, 252-0302 Kasaoka, Okayama, Japan, 714-0043 Shimono, Tochigi, Japan, 329-0433 Adachi-ku, Tokyo, Japan, 123-0845 Chuo-ku, Tokyo, Japan, 103-0027 Mitaka, Tokyo, Japan, 181-0013 Less <<
NCT02130193 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - United States, Alabama ... More >> GSK Investigational Site Birmingham, Alabama, United States, 35294 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80206 United States, Iowa GSK Investigational Site Iowa City, Iowa, United States, 52242 United States, Pennsylvania GSK Investigational Site Oaks, Pennsylvania, United States, 19456 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19140 United States, South Carolina GSK Investigational Site Spartanburg, South Carolina, United States, 29303 Germany GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Neu isenburg, Hessen, Germany, 63263 GSK Investigational Site Dueren, Nordrhein-Westfalen, Germany, 52349 GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45359 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39112 GSK Investigational Site Leipzig, Sachsen, Germany, 04207 GSK Investigational Site Leipzig, Sachsen, Germany, 04275 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Berlin, Germany, 10787 GSK Investigational Site Berlin, Germany, 10789 Less <<
NCT02119260 - Completed - -
NCT00338689 Infant Development Not Applicable Unknown September 2015 Belgium ... More >> CHC St. Vincent, Liège / Universite Libre de Bruxelles Liège, Belgium, BE-4000 Germany Ludwig-Maximilians-Universitaet Muenchen, Germany, D 80337 Italy Universita degli Studi di Milano Milan, Italy, I-20122 Poland Children´s Memorial Healzj Institute Warsaw, Poland, P 04736 Spain Universitat Rovira i Virgili Tarragona, Spain, S 43003 Less <<
NCT02222493 - Completed - -
NCT02581345 - Completed - -
NCT02222493 Rheumatoid Arthritis Phase 3 Completed - -
NCT03414294 Healthy Phase 1 Recruiting February 27, 2020 Australia, South Australia ... More >> CMAX, Clinical Research Pty Ltd Recruiting Adelaide, South Australia, Australia, 5000 Less <<
NCT02130193 - Completed - -
NCT03151837 Diabetes Mellitus, Type 2 Not Applicable Completed - Taiwan ... More >> Chung Shan Medical University Hospital Taichung, Taiwan, 40201 Less <<
NCT02691325 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT02512900 Asthma Phase 1 Completed - Poland ... More >> Research Site Kielce, Poland, 25-040 Research Site Wrocław, Poland, 51-162 Research Site Wrocław, Poland, 53-201 Research Site Łódź, Poland, 71-329 Less <<
NCT01856595 - Completed - -
NCT01369550 Healthy Volunteers ... More >> Markers of Cardiovascular Risk Less << Not Applicable Completed - United States, Florida ... More >> Meridien Research St. Petersburg, Florida, United States, 33709 United States, Illinois Provident Clinical Research & Consulting, Inc. Addison, Illinois, United States Less <<
NCT01856595 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> Anaheim Clinical Trials Anaheim, California, United States, 92801 Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida MRA Clinical Research, LLC South Miami, Florida, United States, 33143 Less <<
NCT02836184 Hyperphosphatemia Phase 4 Unknown September 2016 China, Jiangxi ... More >> Jiujiang NO.1 People's Hospital Recruiting Jiujiang, Jiangxi, China, 332000 Less <<
NCT02512900 - Completed - -
NCT02778477 Normal Healthy Phase 1 Terminated(Preliminary analysi... More >>s of accrued data failed to indicate any meaningful pharmacodynamic response.) Less << - Belgium ... More >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT00315354 Obesity Insul... More >>in Resistance Less << Not Applicable Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT00533897 - Completed - -
NCT00533897 Rheumatoid Arthritis Phase 3 Completed - -
NCT02342548 - Terminated(Study terminated on... More >> 15DEC2016 due to study A8241021 showing no significant difference on primary endpoint between PF-02545920 & placebo. No safety concerns.) Less << - -
NCT02342548 Huntington's Disease Phase 2 Terminated(Study terminated on... More >> 15DEC2016 due to study A8241021 showing no significant difference on primary endpoint between PF-02545920 & placebo. No safety concerns.) Less << - -
NCT02563899 Hyperhidrosis Phase 2 Completed - United States, North Carolina ... More >> GSK Investigational Site Raleigh, North Carolina, United States, 27612 United States, Texas GSK Investigational Site Austin, Texas, United States, 78759 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2K 4L5 Less <<
NCT02229227 - Completed - -
NCT02229227 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01622283 Rhinitis, Allergic, Perennial ... More >>and Seasonal Less << Phase 1 Completed - Japan ... More >> GSK Investigational Site Kagoshima, Japan, 890-0081 Less <<
NCT02216097 - Terminated(The study stopped b... More >>ased on Pfizer portfolio prioritization and not due to safety and/or efficacy concern or change in benefitrisk assessment of PF-04457845.) Less << - -
NCT00420056 - Completed - -
NCT01347866 - Terminated(Refer to Detailed D... More >>escription for documentaion of Termination Statement.) Less << - -
NCT01347866 Advanced Cancer Phase 1 Terminated(Refer to Detailed D... More >>escription for documentaion of Termination Statement.) Less << - United States, California ... More >> Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095-6984 Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095 UCLA Medical Center Los Angeles, California, United States, 90095 UCLA Oncology Center Los Angeles, California, United States, 90095 Santa Monica - UCLA Medical Center and Orthopaedic Hospital Santa Monica, California, United States, 90404 UCLA Santa Monica Hematology Oncology Santa Monica, California, United States, 90404 United States, Colorado Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver (CTRC) Aurora, Colorado, United States, 80045 University of Colorado Hospital Anschutz Inpatient Pavilion Aurora, Colorado, United States, 80045 University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, South Carolina Medical University of South Carolina, Hollings Cancer Center Charleston, South Carolina, United States, 29425 Medical University of South Carolina Charleston, South Carolina, United States, 29425 MUSC, Investigational Drug Services Charleston, South Carolina, United States, 29425 MUSC Health East Cooper Mount Pleasant, South Carolina, United States, 29464 MUSC Specialty Care-North North Charleston, South Carolina, United States, 29406 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Italy Ospedale San Raffaele Milano, Italy, 20132 Spain Hospital General Vall d'Hebron Barcelona, Spain, 08035 Less <<
NCT00855465 - Completed - -
NCT02216097 Post-Traumatic Stress Disorder Phase 2 Terminated(The study stopped b... More >>ased on Pfizer portfolio prioritization and not due to safety and/or efficacy concern or change in benefitrisk assessment of PF-04457845.) Less << - United States, New York ... More >> Clinical and Translational Science Institute (CTSI) New York, New York, United States, 10016 NYU CTSI Research Pharmacy (Drug Shipment Address) New York, New York, United States, 10016 NYU School of Medicine New York, New York, United States, 10016 Less <<
NCT00855465 Pulmonary Hypertension Phase 3 Completed - -
NCT00496769 Atrial Fibrillation Phase 3 Completed - -
NCT03044353 Amyloidosis Phase 2 Suspended(Pending data review.... More >>) Less << September 23, 2021 United States, Massachusetts ... More >> GSK Investigational Site Boston, Massachusetts, United States, 02115 United Kingdom GSK Investigational Site Cambridge, United Kingdom, CB2 0GG GSK Investigational Site London, United Kingdom, NW10 7EW Less <<
NCT03590613 Autoimmune Diseases Phase 1 Active, not recruiting September 21, 2018 Japan ... More >> GSK Investigational Site Fukuoka, Japan, 812-0025 Less <<
NCT00057811 Childhood Burkitt Lymphoma ... More >> Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Stage I Childhood Large Cell Lymphoma Stage I Childhood Small Noncleaved Cell Lymphoma Stage II Childhood Large Cell Lymphoma Stage II Childhood Small Noncleaved Cell Lymphoma Stage III Childhood Large Cell Lymphoma Stage III Childhood Small Noncleaved Cell Lymphoma Stage IV Childhood Large Cell Lymphoma Stage IV Childhood Small Noncleaved Cell Lymphoma Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT01607372 Asthma and Rhinitis Phase 2 Completed - Canada, Ontario ... More >> GSK Investigational Site Toronto, Ontario, Canada, M5V 2T3 Less <<
NCT01920594 Surgical Procedures Phase 2 Completed - United States, Alabama ... More >> GSK Investigational Site Birmingham, Alabama, United States, 35233 United States, California GSK Investigational Site Los Angeles, California, United States, 90048 United States, Colorado GSK Investigational Site Aurora, Colorado, United States, 80045 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30322 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109-5864 United States, Minnesota GSK Investigational Site Rochester, Minnesota, United States, 55905 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 GSK Investigational Site Pittsburgh, Pennsylvania, United States, 308902 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 United States, Virginia GSK Investigational Site Charlottesville, Virginia, United States, 22908 GSK Investigational Site Richmond, Virginia, United States, 23298 Canada, Alberta GSK Investigational Site Calgary, Alberta, Canada, T2N 2T9 Canada, Quebec GSK Investigational Site Quebec City, Quebec, Canada, G1V 4G5 Less <<
NCT00057811 - Completed - -
NCT01920594 - Completed - -
NCT00496769 - Completed - -
NCT00077649 Hepatitis C, Chronic Phase 4 Completed - -
NCT00077649 - Completed - -
NCT01332331 Hypertension, Pulmonary Phase 2 Suspended(Ongoing juvenile rat... More >> toxicology studies.) Less << February 1, 2019 -
NCT01342952 Hypertension, Pulmonary Phase 2 Recruiting October 24, 2024 -
NCT03101722 Presbycusis T... More >>innitus Cognitive Impairment Less << Not Applicable Enrolling by invitation December 1, 2021 China, Shanghai ... More >> Huadong Hospital Shanghai, Shanghai, China, 200040 Jinshan Zhong Ren geriatric care hospital Shanghai, Shanghai, China, 200040 Jiuting Community Health Service Shanghai, Shanghai, China, 200040 Less <<
NCT00993967 Freidreich's Ataxia Phase 3 Completed - Austria ... More >> Universitätsklinik Innsbruck Innsbruck, Austria Belgium Hôpital Erasme - Univeristé Libre de Bruxelles Bruxelles, Belgium, 1070 France Hôpital de la Salpétrière - INSERM U679, Neurologie et Thérapeutique expérimentale Paris, France, 75651 Germany HELIOS Klinikum Berlin Berlin, Germany, 13125 Neurologische Universitätsklinik und Ploklinik - Universitätsklimikum Bonn Bonn, Germany, 53105 Klinik II, Neuropädiatrie und Muskelerkrankungen - Universitätsklinik Freiburg Freiburg, Germany, 79106 Zentrum für Neurologische Medizin Göttingen, Germany, 37073 UKE Hamburg Neuropädiatrie - Zentrum für Frauen, Kinder und Jugendmedizin Hamburg, Germany, 20246 Neurologische Klinik - Klinikum Grosshadern München, Germany, 81377 Neurologische Universitätsklinik und Poliklinik Tübingen, Germany, 72076 Netherlands University medical Center Groningen Groningen, Netherlands, 9700 RB Less <<
NCT03027726 Overweight Children With Type ... More >>2 Diabetes Risk Less << Not Applicable Completed - Spain ... More >> Pediatric Endocrinology Unit of the University Hospital of Araba (HUA) Vitoria-Gasteiz, Araba, Spain, 01009 Less <<
NCT00993967 - Completed - -
NCT01920555 Treatment Resistant Depression Phase 2 Completed - United States, California ... More >> Stanford University Palo Alto, California, United States, 94304 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Texas University of Texas Southwestern Dallas, Texas, United States, 75390 Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00424294 Arthritis, Rheumatoid Phase 2 Terminated(See Detailed Descri... More >>ption field) Less << - -
NCT01175135 Schizophrenia Phase 2 Completed - -
NCT00853112 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00759564 Pneumonia Phase 1 Completed - United States, Indiana ... More >> Centurion Clinical Research Indianapolis, Indiana, United States, 46260 Belgium Pfizer Clinical Research Unit Bruxelles, Belgium, 1070 Less <<
NCT01920555 - Completed - -
NCT00777647 Obesity Metab... More >>olic; Complications Dietary Habits Less << Not Applicable Completed - Denmark ... More >> Department of Internal Medicine/Endocrinology C, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT01175135 - Completed - -
NCT01192191 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 811-2201 GSK Investigational Site Fukuoka, Japan, 819-8555 GSK Investigational Site Fukushima, Japan, 964-0871 GSK Investigational Site Gunma, Japan, 371-0048 GSK Investigational Site Hiroshima, Japan, 732-0057 GSK Investigational Site Hokkaido, Japan, 001-0901 GSK Investigational Site Hokkaido, Japan, 064-0915 GSK Investigational Site Hokkaido, Japan, 070-8644 GSK Investigational Site Hyogo, Japan, 651-0073 GSK Investigational Site Ibaraki, Japan, 300-0053 GSK Investigational Site Ibaraki, Japan, 310-0015 GSK Investigational Site Ishikawa, Japan, 920-8610 GSK Investigational Site Kagawa, Japan, 760-0073 GSK Investigational Site Kagawa, Japan, 763-8502 GSK Investigational Site Kanagawa, Japan, 239-0821 GSK Investigational Site Kyoto, Japan, 601-1495 GSK Investigational Site Kyoto, Japan, 615-8087 GSK Investigational Site Miyagi, Japan, 981-8563 GSK Investigational Site Miyagi, Japan, 984-8560 GSK Investigational Site Nagano, Japan, 390-0303 GSK Investigational Site Nagano, Japan, 390-0832 GSK Investigational Site Nagano, Japan, 390-8601 GSK Investigational Site Nagano, Japan, 391-0011 GSK Investigational Site Oita, Japan, 870-0921 GSK Investigational Site Oita, Japan, 876-0047 GSK Investigational Site Okayama, Japan, 701-0304 GSK Investigational Site Osaka, Japan, 530-0012 GSK Investigational Site Osaka, Japan, 545-8586 GSK Investigational Site Osaka, Japan, 576-0016 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Tokyo, Japan, 185-0014 GSK Investigational Site Tokyo, Japan, 187-0024 GSK Investigational Site Toyama, Japan, 930-0194 GSK Investigational Site Wakayama, Japan, 641-8510 GSK Investigational Site Yamanashi, Japan, 400-0031 Less <<
NCT00759564 - Completed - -
NCT01192191 - Completed - -
NCT01475461 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT00853112 Hypertension, Pulmonary Phase 2 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00424294 - Terminated(See Detailed Descri... More >>ption field) Less << - -
NCT02578004 - Completed - Tunisia ... More >> Latifa KHLIFI Sousse, Tunisia, 4000 Less <<
NCT02193815 Psoriasis Vulgaris Phase 1 Completed - Germany ... More >> Bioskin GmbH Hamburg, Germany, 20095 Less <<
NCT01342211 Hypercholesterolemia ... More >> Dyslipidemia Less << Phase 2 Completed - -
NCT01475461 - Completed - -
NCT01517373 - Completed - -
NCT02193815 - Completed - -
NCT01342211 - Completed - -
NCT02363634 Mood Anxiety Not Applicable Completed - United States, Florida ... More >> Miami Research Associates Miami, Florida, United States, 33143 Less <<
NCT03669757 Psoriasis Vulgaris Phase 1 Recruiting February 2019 Germany ... More >> Investigational Site Recruiting Schwerin, Mecklenburg-Vorpommern, Germany, 19055 Investigational Site Recruiting Hamburg, Germany, 20095 Less <<
NCT01370018 HIV Disease Not Applicable Completed - United States, New York ... More >> Cabrini Medical Center New York, New York, United States, 10003 Less <<
NCT01517373 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT02082977 Cancer Phase 1 Terminated(The maximal dose an... More >>d schedule attained with GSK2816126 has shown insufficient evidence of clinical activity, and does not justify further clinical investigation) Less << - United States, Illinois ... More >> GSK Investigational Site Chicago, Illinois, United States, 60611 United States, New York GSK Investigational Site New York, New York, United States, 10021 France GSK Investigational Site Villejuif cedex, France, 94805 United Kingdom GSK Investigational Site Sutton, Surrey, United Kingdom, SM2 5PT GSK Investigational Site Southampton, United Kingdom, SO16 6YD Less <<
NCT00989235 Rheumatoid Arthritis Phase 3 Completed - -
NCT00989235 - Completed - -
NCT01342926 Atrophy, Geographic Phase 2 Completed - -
NCT00894322 - Completed - -
NCT01396148 - Completed - -
NCT00471237 Osteoporosis Phase 2 Terminated(Terminated for futi... More >>lity by sponsor after a pre-planned interim review of data) Less << - -
NCT01342926 - Completed - -
NCT01684215 Neoplasms Bre... More >>ast Neoplasms Less << Phase 2 Completed - Japan ... More >> Aichi Cancer Center Hospital Nagoya, Aichi, Japan, 464-8681 National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 National Hospital Organization Hokkaido Cancer Center Sapporo, Hokkaido, Japan, 003-0804 Kumamoto Shinto General Hospital Kumamoto-city, Kumamoto, Japan, 862-8655 Saitama Cancer Center Kita-adachi-gun, Saitama, Japan, 362-0806 National Cancer Center Hospital Chuo-Ku, Tokyo, Japan, 104-0045 Chiba Cancer Center Chiba, Japan, 260-8717 National Hospital Organization Shikoku Cancer Center Ehime, Japan, 791-0280 National Hospital Organization Kyushu Cancer Center Fukuoka, Japan, 811-1395 Hiroshima City Hiroshima Citizens Hospital Hiroshima, Japan, 730-8518 Iwate Medical University Hospital Iwate, Japan, 020-8505 Hakuaikai Medical Corporation Sagara Hospital Kagoshima, Japan, 892-0833 Kumamoto University Hospital Kumamoto, Japan, 860-8556 Kumamoto City Hospital Kumamoto, Japan, 862-8505 Kyoto University Hospital Kyoto, Japan, 606-8507 National Hospital Organization Osaka National Hospital Osaka, Japan, 540-0006 Less <<
NCT00894322 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - United States, Nebraska ... More >> Research Site Lincoln, Nebraska, United States Less <<
NCT03310190 - Recruiting June 15, 2020 Canada, Alberta ... More >> University of Calgary /ID# 166416 Recruiting Calgary, Alberta, Canada, T2N 4Z6 Cross Cancer Institute /ID# 166417 Not yet recruiting Edmonton, Alberta, Canada, T6G 1Z2 Canada, New Brunswick The Moncton Hospital /ID# 166043 Recruiting Moncton, New Brunswick, Canada, E1C 6Z8 Saint John Regional Hospital /ID# 202190 Not yet recruiting Saint John, New Brunswick, Canada, E2L 4L2 Canada, Ontario William Osler Health System /ID# 202049 Not yet recruiting Brampton, Ontario, Canada, L6R 3J7 Michael Garron Hospital/Toronto East Health Network /ID# 209463 Not yet recruiting East York, Ontario, Canada, M4C 3E7 Kingston Health Sciences Centr /ID# 169252 Recruiting Kingston, Ontario, Canada, K7L 2V7 The Ottawa Hospital Research /ID# 166041 Recruiting Ottawa, Ontario, Canada, K1H 8L6 Health Sciences North /ID# 205817 Recruiting Sudbury, Ontario, Canada, P3N 1H5 Canada, Quebec Jewish General Hospital /ID# 166418 Recruiting Montreal, Quebec, Canada, H3T 1E2 Cisss Du Bas-Saint-Laurent Hopital Regional de Rimouski /Id# 201202 Recruiting Rimouski, Quebec, Canada, G5L 5T1 Canada CancerCare Manitoba /ID# 170751 Recruiting Manitoba, Canada, R3E 0V9 Thunder Bay Regional Health Re /ID# 204740 Not yet recruiting Thunder Bay, Canada, P7B 6V4 Less <<
NCT01396148 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - United States, California ... More >> Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles Los Angeles, California, United States, 90027 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Czechia Fakultni nemocnice Brno Brno, Czechia, 613 00 FN Brno Brno, Czechia, 625 00 Masarykuv onkologicky ustav Brno, Czechia, 656 33 France CHU de La Timone, Hopital enfants Marseille cedex 5, France, 13385 Hopital d'Enfants de la Timone Marseille cedex 5, France, 13385 Hopital de la Timone Marseille cedex 5, France, 13385 Less <<
NCT01684215 - Completed - -
NCT00471237 - Terminated(Terminated for futi... More >>lity by sponsor after a pre-planned interim review of data) Less << - -
NCT01366521 Asthma Phase 2 Completed - United States, North Carolina ... More >> GSK Investigational Site Winston-Salem, North Carolina, United States, 27103 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 Estonia GSK Investigational Site Tallinn, Estonia, 13619 GSK Investigational Site Tartu, Estonia, 51014 France GSK Investigational Site Marseille cedex 20, France, 13915 GSK Investigational Site Montpellier, France, 34295 GSK Investigational Site Pessac Cedex, France, 33604 Germany GSK Investigational Site Gauting, Bayern, Germany, 82131 GSK Investigational Site Frankfurt am Main, Hessen, Germany, 60596 GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39112 GSK Investigational Site Berlin, Germany, 14050 Less <<
NCT01512160 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01366521 - Completed - -
NCT01512160 Post-surgical Dental Pain Phase 2 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, Texas ... More >> Pfizer Investigational Site Austin, Texas, United States, 78744 Less <<
NCT02319148 Healthy Volunteers Phase 1 Completed - Belgium ... More >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT02319148 - Completed - -
NCT01529346 Postoperative Dental Pain Phase 2 Completed - United States, Texas ... More >> Central Texas Oral Surgery Associates Austin, Texas, United States, 78705 Premier Research Group Limited Austin, Texas, United States, 78705 PPD Development, LP Austin, Texas, United States, 78744 Less <<
NCT00404768 Obstetric Labour, Premature Phase 2 Completed - -
NCT01529346 - Completed - -
NCT02341482 - Completed - -
NCT00404768 - Completed - -
NCT01577381 Age-Related Maculopathy Phase 2 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01819922 Healthy Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT03274648 BehçEt Disease Not Applicable Not yet recruiting January 2018 -
NCT00903617 Dyslipidaemias Phase 2 Completed - United States, Florida ... More >> GSK Investigational Site Pembroke Pines, Florida, United States, 33026 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46260 United States, Kentucky GSK Investigational Site Louisville, Kentucky, United States, 40213 United States, Maine GSK Investigational Site Auburn, Maine, United States, 04210 United States, Minnesota GSK Investigational Site Brooklyn Center, Minnesota, United States, 55430 United States, North Carolina GSK Investigational Site Statesville, North Carolina, United States, 28677 United States, Ohio GSK Investigational Site Cincinnati, Ohio, United States, 45246 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78205 United States, Virginia GSK Investigational Site Richmond, Virginia, United States, 23294 United States, Washington GSK Investigational Site Olympia, Washington, United States, 98502 GSK Investigational Site Seattle, Washington, United States, 98104 Less <<
NCT01577381 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02341482 Healthy Phase 1 Completed - United States, Connecticut ... More >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 Less <<
NCT01819922 - Completed - -
NCT01121536 Depression Phase 3 Terminated(Business decision r... More >>elated to efficacy rather than tolerability limitations, not stopped for any safety reasons.) Less << - -
NCT00903617 - Completed - -
NCT01121536 - Terminated(Business decision r... More >>elated to efficacy rather than tolerability limitations, not stopped for any safety reasons.) Less << - -
NCT01925274 Metastatic Colorectal Cancer Phase 2 Terminated(Enrollment to the s... More >>tudy was terminated on 11Nvo2014 due to slow recruitment. There were no safety or efficacy issues that contributed to this decision.) Less << - United States, California ... More >> CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 Drug Management Only: UCLA West Medical Pharmacy, Att: Steven L Wong, Pharm D Los Angeles, California, United States, 90095-7349 Drug Management Only: UCLA West Medical Pharmacy Los Angeles, California, United States, 90095-7349 UCLA West Medical Pharmacy Los Angeles, California, United States, 90095-7349 Regulatory Management Only: TRIO-US Central Administration Los Angeles, California, United States, 90095 TRIO-US Central Administration (Regulatory Management only) Los Angeles, California, United States, 90095 TRIO_US Los Angeles, California, United States, 90095 West Valley Hematology/Oncology Med Group Northridge, California, United States, 91328 United States, Missouri Siteman Cancer Center - West County Creve Coeur, Missouri, United States, 63141 Barnes-Jewish Hospital Saint Louis, Missouri, United States, 63110 Drug Shipping Address: Washington University Infusion Center Pharmacy Saint Louis, Missouri, United States, 63110 Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Siteman Cancer Center - South County Saint Louis, Missouri, United States, 63129 Siteman Cancer Center - St Peters Saint Peters, Missouri, United States, 63376 United States, Nevada Regulatory Office: Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89014 Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89052 Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89074 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89128 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89148 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89169 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Washington Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States, 99336 Kadlec Medical Center Richland, Washington, United States, 99352 Outpatient Imaging Center Richland, Washington, United States, 99352 Spokane Valley Cancer Center Spokane Valley, Washington, United States, 99216 Medical Oncology Associates, PS Spokane, Washington, United States, 99208 Japan Aichi cancer center central hospital Nagoya, Aichi, Japan, 464-8681 National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 Korea, Republic of National Cancer Center Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Seoul National University Hospital / Department of Internal Medicine Seoul, Korea, Republic of, 110-744 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center Seoul, Korea, Republic of, 138-736 Spain Hospital General Universitario Gregorio Marañón Madrid, Spain, 28009 Less <<
NCT02373202 Rheumatoid Arthritis Phase 3 Completed - Japan ... More >> Investigational Site Number 392010 Asahi-Shi, Japan Investigational Site Number 392001 Asahikawa-Shi, Japan Investigational Site Number 392070 Beppu-Shi, Japan Investigational Site Number 392036 Chiba-Shi, Japan Investigational Site Number 392083 Chuo-Ku, Japan Investigational Site Number 392004 Fukui-Shi, Japan Investigational Site Number 392039 Fukuoka-Shi, Japan Investigational Site Number 392030 Ichinomiya-Shi, Japan Investigational Site Number 392002 Iizuka-Shi, Japan Investigational Site Number 392019 Kagoshima-Shi, Japan Investigational Site Number 392066 Kamakura-Shi, Japan Investigational Site Number 392050 Kato-Shi, Japan Investigational Site Number 392037 Kawachi-Nagano-Shi, Japan Investigational Site Number 392099 Kawasaki-Shi, Japan Investigational Site Number 392013 Kitakyushu-Shi, Japan Investigational Site Number 392097 Kochi-Shi, Japan Investigational Site Number 392065 Kushiro-Shi, Japan Investigational Site Number 392026 Matsuyama-Shi, Japan Investigational Site Number 392034 Miyagi-Gun, Japan Investigational Site Number 392076 Nagoya-Shi, Japan Investigational Site Number 392080 Nagoya-Shi, Japan Investigational Site Number 392046 Narashino-Shi, Japan Investigational Site Number 392059 Oita-Shi, Japan Investigational Site Number 392062 Okayama-Shi, Japan Investigational Site Number 392027 Osaki-Shi, Japan Investigational Site Number 392049 Sagamihara-Shi, Japan Investigational Site Number 392014 Sapporo-Shi, Japan Investigational Site Number 392041 Sapporo-Shi, Japan Investigational Site Number 392073 Sapporo-Shi, Japan Investigational Site Number 392006 Sasebo-Shi, Japan Investigational Site Number 392021 Sendai-Shi, Japan Investigational Site Number 392022 Sendai-Shi, Japan Investigational Site Number 392033 Sendai-Shi, Japan Investigational Site Number 392071 Sendai-Shi, Japan Investigational Site Number 392029 Shizuoka-Shi, Japan Investigational Site Number 392023 Takaoka-Shi, Japan Investigational Site Number 392003 Tomakomai-Shi, Japan Investigational Site Number 392074 Urasoe-Shi, Japan Investigational Site Number 392079 Urayasu-Shi, Japan Investigational Site Number 392048 Yokohama-Shi, Japan Less <<
NCT02373202 - Completed - -
NCT00893789 Traumatic Brain Injury Phase 3 Terminated(Study has been stop... More >>ped by sponsor decision.) Less << - -
NCT03726671 Healthy Not Applicable Recruiting March 2021 United States, North Carolina ... More >> UNC Chapel Hill Nutrition Research Institute Recruiting Kannapolis, North Carolina, United States, 28081 Contact: Julie Stegall, MSW    704-250-5048    julie_stegall@unc.edu    Principal Investigator: Steven H Zeisel, MD, PhD Less <<
NCT03754920 Fasting Not Applicable Active, not recruiting September 9, 2019 China, Shanghai ... More >> Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai, Shanghai, China, 200030 Less <<
NCT00893789 - Terminated(Study has been stop... More >>ped by sponsor decision.) Less << - -
NCT01925274 - Terminated(Enrollment to the s... More >>tudy was terminated on 11Nvo2014 due to slow recruitment. There were no safety or efficacy issues that contributed to this decision.) Less << - -
NCT01792635 Diabetes Mellitus, Type 2 Phase 2 Terminated(The study was termi... More >>nated prematurely on 16 May 2014 due to a safety concern.) Less << - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Less <<
NCT00910962 Acute Coronary Syndrome Phase 2 Completed - -
NCT01792635 - Terminated(The study was termi... More >>nated prematurely on 16 May 2014 due to a safety concern.) Less << - -
NCT02477410 Hunger Satiet... More >>y Response Protein Synthesis Less << Not Applicable Completed - Denmark ... More >> Department of Nutrition, Exercise and Sports Frederiksberg, Denmark, 1958 Less <<
NCT01970865 ALK-positive Non Small Cell Lu... More >>ng Cancer (NSCLC) and ROS1-positive NSCLC Less << Phase 2 Active, not recruiting February 19, 2019 -
NCT02565628 Idiopathic Parkinson's Disease Phase 1 Completed - United States, Connecticut ... More >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 United States, Florida MD Clinical Hallandale Beach, Florida, United States, 33009 QPS-MRA, LLC (Broward Research Group) Hollywood, Florida, United States, 33024 Qps-Mra Llc South Miami, Florida, United States, 33143 QPS-MRA, LLC (Miami research Associates) South Miami, Florida, United States, 33143 QPS-MRA, LLC (MRA Clinical Research) South Miami, Florida, United States, 33143 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30331 United States, New Jersey CRI Worldwide, LLC Marlton, New Jersey, United States, 08053 United States, Ohio CTI Clinical Research Center Cincinnati, Ohio, United States, 45255 Less <<
NCT02565628 - Completed - -
NCT00453479 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - Netherlands ... More >> GSK Investigational Site Eindhoven, Netherlands, 5623 EJ GSK Investigational Site Harderwijk, Netherlands, 3844 DG GSK Investigational Site Utrecht, Netherlands, 3584 CJ GSK Investigational Site Zuidlaren, Netherlands, 9471 GP Less <<
NCT00453479 - Completed - -
NCT00239356 Schizophrenia Phase 3 Completed - Canada, Ontario ... More >> Local Institution Ottawa, Ontario, Canada Canada, Quebec Local Institution Sherbrooke, Quebec, Canada Croatia Local Institution Rijeka, Croatia Local Institution Zagreb, Croatia Czech Republic Local Institution Hradec Kralove, Czech Republic Local Institution Prague 6, Czech Republic France Local Institution Nantes Orvault, France Local Institution Rennes Cedex, France Local Institution Uzes, France Hungary Local Institution Budapest, Hungary Local Institution Gyor, Hungary Netherlands Local Institution Vught, Netherlands Poland Local Institution Krakow, Poland Local Institution Poznan, Poland Romania Local Institution Bucharest, Romania Russian Federation Local Institution St. Petersburg, Russian Federation South Africa Local Institution Westdene, Free State, South Africa Local Institution Johannesburg, Gauteng, South Africa Local Institution Cape Town, Western Cape, South Africa United Kingdom Local Institution Antrim, United Kingdom Less <<
NCT01929863 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Florida ... More >> GSK Investigational Site Miami, Florida, United States, 33169 Less <<
NCT00239356 - Completed - -
NCT00048932 Rheumatoid Arthritis Phase 3 Completed - -
NCT01929863 - Completed - -
NCT00048932 - Completed - -
NCT01970865 - Active, not recruiting - -
NCT00910962 - Completed - -
NCT02202161 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, California ... More >> GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21225 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 Less <<
NCT00048568 Rheumatoid Arthritis Phase 3 Completed - -
NCT00451321 Diabetes Mellitus, Type 1 Phase 2 Terminated - United States, Alabama ... More >> GSK Investigational Site Birmingham, Alabama, United States, 35294 United States, California GSK Investigational Site Walnut Creek, California, United States, 94598 United States, Colorado GSK Investigational Site Aurora, Colorado, United States, 80045 United States, District of Columbia GSK Investigational Site Washington, D.C., District of Columbia, United States, 20037 United States, Florida GSK Investigational Site Jacksonville, Florida, United States, 32207 GSK Investigational Site Pinellas Park, Florida, United States, 33781 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60637 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21201 United States, Massachusetts GSK Investigational Site Worcester, Massachusetts, United States, 1655 United States, Michigan GSK Investigational Site Kalamazoo, Michigan, United States, 49048 United States, Minnesota GSK Investigational Site Minneapolis, Minnesota, United States, 55455 United States, Mississippi GSK Investigational Site Gulfport, Mississippi, United States, 39501 United States, Nebraska GSK Investigational Site Omaha, Nebraska, United States, 68131 United States, Ohio GSK Investigational Site Mentor, Ohio, United States, 44060 United States, South Dakota GSK Investigational Site Rapid City, South Dakota, United States, 57701 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229-4801 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M4G 3E8 Less <<
NCT02693366 Glomerulosclerosis, Focal Segm... More >>ental Renal Insufficiency, Chronic Less << Phase 1 Active, not recruiting March 2018 Brazil ... More >> Universitary Hospital Clementino Fraga Filho - UFRJ Rio de Janeiro, Brazil, 21941913 Less <<
NCT02202161 - Completed - -
NCT03263962 - Completed - Italy ... More >> IRCCS Policlinico San Matteo Pavia, Italy, 27100 Less <<
NCT01734993 Rheumatoid Arthritis Phase 3 Completed - France ... More >> Bordeaux, France, 33076 Montpellier, France, 34295 Nantes, France, 44035 Paris, France, 75679 Strasbourg, France, 67098 Toulouse, France, 31059 Less <<
NCT01376323 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Alabama ... More >> GSK Investigational Site Anniston, Alabama, United States, 36207 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 GSK Investigational Site Miramar, Florida, United States, 33025 France GSK Investigational Site Nantes cedex 01, France, 44093 GSK Investigational Site Pierre-Bénite Cedex, France, 69495 GSK Investigational Site Rennes Cedex, France, 35046 GSK Investigational Site Rueil-Malmaison, France, 92502 Spain GSK Investigational Site Alicante, Spain, 03114 GSK Investigational Site Badalona, Spain, 08916 GSK Investigational Site Granada, Spain, 18004 GSK Investigational Site Madrid, Spain, 28046 United Kingdom GSK Investigational Site Edinburgh, Midlothian, United Kingdom, EH4 2XU GSK Investigational Site Cambridge, United Kingdom, CB2 0GG GSK Investigational Site Coventry, United Kingdom, CV2 2DX GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP Less <<
NCT02114203 Phase 1 Sickle Cell Phase 1 Completed - United States, Illinois ... More >> University of Illinois Hospital and Health Sciences System Chicago, Illinois, United States, 60612-5836 University of Illinois at Chicago Clinical Research Center Chicago, Illinois, United States, 60612 University of Illinois Hospital and Health Sciences System Chicago, Illinois, United States, 60612 United States, Massachusetts Boston Medical Center E7E Boston, Massachusetts, United States, 02118 Boston Medical Center Boston, Massachusetts, United States, 02118 Boston University Medical Center Boston, Massachusetts, United States, 02118 United States, New York Interfaith Medical Center Brooklyn, New York, United States, 11213 Interfaith Medical Center Brooklyn, New York, United States, 11238 United States, North Carolina UNC Hospitals' Investigational Drug Service Pharmacy Chapel Hill, North Carolina, United States, 27514 UNC School of Medicine Clinical and Translational Research Center Chapel Hill, North Carolina, United States, 27599 United States, Virginia Investigational Drug Services Richmond, Virginia, United States, 23298 Virginia Commonwealth University Richmond, Virginia, United States, 23298 Belgium Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Italy Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico Milano, Italy, 20122 A.O.O.R Villa Sofia - V. Cervello Palermo, Italy, 90146 Netherlands Centre for Human Drug Research Leiden, Netherlands, 2333 CL United Kingdom Royal Liverpool and Broadgreen University Hospital Trust Liverpool, Merseyside, United Kingdom, L7 8XP Guy's and St Thomas' NHS Foundation Trust London, United Kingdom, SE1 9RT King's College Hospital NHS Foundation Trust London, United Kingdom, SE5 9RS Imperial College Healthcare NHS Trust London, United Kingdom, W12 0HS Central Manchester University Hospitals NHS Foundation Trust Manchester, United Kingdom, M13 9WL Manchester Royal Infirmary Manchester, United Kingdom, M13 9WL Oxford University Hospitals NHS Trust Oxford, United Kingdom, OX3 7LE Less <<
NCT00048568 - Completed - -
NCT00451321 - Terminated - -
NCT02114203 - Completed - -
NCT00138424 - Terminated - -
NCT00138424 BK Virus (Nephropathy) Phase 1 Phase 2 Terminated - United States, Alabama ... More >> University of Alabama Hospital - Nephrology Birmingham, Alabama, United States, 35249-0001 United States, California California Pacific Medical Center - Sutter Pacific Medical Foundation - Transplant Nephrology San Francisco, California, United States, 94115-1932 University of California San Francisco Medical Center at Parnassus - Organ Transplant San Francisco, California, United States, 94143-2204 United States, Colorado University of Colorado Denver Aurora, Colorado, United States, 80045-2541 United States, Illinois Northwestern University - Comprehensive Transplant Center Chicago, Illinois, United States, 60611-2927 The University of Chicago Medical Center - Kindney Trasnplant - Nephrology Chicago, Illinois, United States, 60637-1447 United States, Minnesota University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine Minneapolis, Minnesota, United States, 55455-0356 Mayo Clinic, Rochester - Infectious Diseases Rochester, Minnesota, United States, 55905-0001 United States, New Hampshire Dartmouth-Hitchcock Medical Center - Infectious Disease Lebanon, New Hampshire, United States, 03756-1000 United States, Texas Dallas Nephrology Associates - Dallas Transplant Institute Dallas, Texas, United States, 75204-6168 United States, Washington University of Washington - Medicine Seattle, Washington, United States, 98195-7110 United States, Wisconsin University of Wisconsin Hospital and Clinics - Clinical Science Center - Nephrology Madison, Wisconsin, United States, 53792-0001 Less <<
NCT01376323 - Completed - -
NCT03228459 Kidney Diseases ... More >> Subclinical Disease and/or Syndrome Atherosclerosis Early Diagnosis Ultrasound Less << Not Applicable Recruiting December 31, 2027 Spain ... More >> Primary Care centre Recruiting Lleida, Spain, 25007 Contact: Cristina Farrás Salles    0034661343421    cfarras.lleida.ics@gencat.cat    Contact: Marcelino Bermudez Lopez    0034973702482 ext 2482    mbermudez@irblleida.cat    Institut de recerca Biomèdica de Lleida Recruiting Lleida, Spain, 25198 Contact: Àngels Betriu Bars    0034973702481 ext 2481    abetriu@irblleida.cat    Contact: Jose Manuel Valdivielso Revilla    0034973703560 ext 3560    valdivielso@medicina.udl.cat    Principal Investigator: Ferran Barbé Illa          Principal Investigator: Manuel Portero Otín          Principal Investigator: Francisco Purroy Garcia          Principal Investigator: Albert Lecube Torelló Less <<
NCT01734993 - Completed - -
NCT03506581 - Completed - -
NCT02871570 Moderate Hepatic Impairment ... More >> Normal Hepatic Function Less << Phase 1 Completed - United States, Florida ... More >> Orlando Clincial Research Center Orlando, Florida, United States, 32809 Less <<
NCT02563899 - Completed - -
NCT02871570 - Completed - -
NCT01028911 Alzheimer's Disease Phase 1 Terminated(This study terminat... More >>ed 27Apr2010 due to slow recruitment and the need to use the existing information to determine dosing for another study.) Less << - United States, Kansas ... More >> Pfizer Investigational Site Wichita, Kansas, United States, 67207 Pfizer Investigational Site Wichita, Kansas, United States, 67211 Less <<
NCT01285518 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Ft. Meyers, Florida, United States, 33901 Elite Research Institute Miami, Florida, United States, 33169 Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Miramar, Florida, United States, 33025 United States, Texas Cetero Research San Antonio, Texas, United States, 78229 Less <<
NCT01285518 - Completed - -
NCT03077048 Renal Insufficiency, Chronic Phase 1 Phase 2 Completed - Czechia ... More >> Thomayer Hospital Clinical - Pharmacology Unit (CPU) Prague, Czechia, 140 59 Less <<
NCT01577745 - Completed - -
NCT01036022 Colitis, Ulcerative Phase 2 Completed - Belgium ... More >> GSK Investigational Site Bonheiden, Belgium, 2820 GSK Investigational Site Brussels, Belgium, 1200 GSK Investigational Site Gent, Belgium, 9000 Canada, Alberta GSK Investigational Site Edmonton, Alberta, Canada, T6G 2C8 Canada, Ontario GSK Investigational Site Kingston, Ontario, Canada, K7L 5G2 GSK Investigational Site London, Ontario, Canada, N6A 4G5 GSK Investigational Site Vaughan, Ontario, Canada, L4L 4Y7 Canada GSK Investigational Site Quebec, Canada, G1S 4L8 Germany GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48149 GSK Investigational Site Ludwigshafen, Rheinland-Pfalz, Germany, 67067 GSK Investigational Site Dresden, Sachsen, Germany, 01307 GSK Investigational Site Leipzig, Sachsen, Germany, 04129 GSK Investigational Site Kiel, Schleswig-Holstein, Germany, 24105 GSK Investigational Site Jena, Thueringen, Germany, 07747 GSK Investigational Site Berlin, Germany, 10117 GSK Investigational Site Hamburg, Germany, 20148 GSK Investigational Site Hamburg, Germany, 20246 Norway GSK Investigational Site Lørenskog, Norway, 1478 GSK Investigational Site Oslo, Norway, 0514 GSK Investigational Site Oslo, Norway, N-0456 GSK Investigational Site Tønsberg, Norway, 3116 Sweden GSK Investigational Site Göteborg, Sweden, SE-416 85 GSK Investigational Site Lund, Sweden, SE-221 85 GSK Investigational Site Stockholm, Sweden, SE-111 86 GSK Investigational Site Stockholm, Sweden, SE-171 76 Less <<
NCT01028911 - Terminated(This study terminat... More >>ed 27Apr2010 due to slow recruitment and the need to use the existing information to determine dosing for another study.) Less << - -
NCT00635089 - Completed - -
NCT01577745 Solid Tumors Phase 1 Completed - United States, California ... More >> Research Site Los Angeles, California, United States, 90404 United States, Connecticut Research Site New Haven, Connecticut, United States, 06513 United States, Massachusetts Research Site Boston, Massachusetts, United States United States, Michigan Research Site Ann Arbor, Michigan, United States, 48103 United States, Minnesota Research Site Minneapolis, Minnesota, United States United States, New York Research Site New York, New York, United States, 10002 United States, Ohio Research Site Cincinnati, Ohio, United States, 45201 Research Site Cleveland, Ohio, United States, 44105 United States, Texas Research Site Houston, Texas, United States, 77030 United States, Washington Research Site Seattle, Washington, United States, 98112 Research Site Tacoma, Washington, United States, 98405 Less <<
NCT03260166 Cutaneous Lupus Erythematosus ... More >> Systemic Lupus Erythematosus Rash Less << Phase 2 Recruiting February 2019 China, Hunan ... More >> The Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Xiangqi Tang, MD, PhD    +86-731-84896038    xiangyagcp@126.com    Principal Investigator: Qianjin Lu, MD, PhD          Sub-Investigator: Hai Long, MD, PhD Less <<
NCT00397891 Alzheimer Disease Phase 1 Completed - Japan ... More >> Pfizer Investigational Site Chiba, Japan Pfizer Investigational Site Saitama, Japan Pfizer Investigational Site Shizuoka, Japan Pfizer Investigational Site Tokyo, Japan Less <<
NCT00635089 Eosinophilic Esophagitis Phase 3 Completed - -
NCT00420056 Lymphoma, Mantle-Cell Phase 1 Completed - United States, Massachusetts ... More >> Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 New York Presbyterian Hospital New York, New York, United States, 10021 Weill Medical College of Cornell University - New York Presbyterian Hospital New York, New York, United States, 10021 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00397891 - Completed - -
NCT01235741 Obesity Phase 2 Terminated(Results from previo... More >>us study DFA102 demonstrated neutralizing activity to metreleptin in invitro assay in 2 participants.) Less << - United States, California ... More >> Research Site Greenbrae, California, United States Research Site La Jolla, California, United States United States, Colorado Research Site Denver, Colorado, United States United States, Florida Research Site Winter Park, Florida, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Louisiana Research Site Baton Rouge, Louisiana, United States United States, Maryland Research Site Hyattsville, Maryland, United States United States, Massachusetts Research Site Boston, Massachusetts, United States United States, Missouri Research Site St. Louis, Missouri, United States United States, Montana Research Site Butte, Montana, United States United States, New York Research Site New York, New York, United States United States, Oklahoma Research Site Tulsa, Oklahoma, United States United States, Pennsylvania Research Site Philadelphia, Pennsylvania, United States United States, Texas Research Site Austin, Texas, United States United States, Utah Research Site Salt Lake City, Utah, United States United States, Virginia Research Site Arlington, Virginia, United States Research Site Norfolk, Virginia, United States Research Site Richmond, Virginia, United States Less <<
NCT02038764 Diabetes Mellitus, Type 1 Phase 1 Completed - United States, California ... More >> VA San Diego Healthcare System (Drug Shipment) San Diego, California, United States, 92161 Veterans Administration San Diego Healthcare System San Diego, California, United States, 92161 University of California, San Francisco San Francisco, California, United States, 94143 United States, Colorado Barbara Davis Center Aurora, Colorado, United States, 80045 United States, Connecticut Yale School of Medicine New Haven, Connecticut, United States, 06510 Yale New Haven Hospital - Investigational Drug Services New Haven, Connecticut, United States, 06511 Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 United States, Illinois Duchossois Center for Advanced Medicine Chicago, Illinois, United States, 60637 The University of Chicago Medical Center Chicago, Illinois, United States, 60637 University of Chicago Clinical Resource Center Chicago, Illinois, United States, 60637 University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Massachusetts Umass Memorial Medical Center Worcester, Massachusetts, United States, 01655 University of Massachusetts Medical School Worcester, Massachusetts, United States, 01655 United States, Minnesota University Of Minnesota Fairview Pharmacy Services Minneapolis, Minnesota, United States, 55454 University Of Minnesota Medical School Minneapolis, Minnesota, United States, 55455 United States, Missouri Barnes- Jewish HOSP Att: Kathryn Vehe Saint Louis, Missouri, United States, 63110 Washington University - Center for Advanced Medicine Saint Louis, Missouri, United States, 63110 Washington University Saint Louis, Missouri, United States, 63110 United States, North Carolina Duke Clinical Research Unit Durham, North Carolina, United States, 27710 Duke University Health Systems (DUHS) Investigational Drug Services Durham, North Carolina, United States, 27710 Less <<
NCT02038764 - Completed - -
NCT01036022 - Completed - -
NCT02509117 Healthy Subjects Phase 1 Completed - United States, California ... More >> California Clinical Trials Medical Group, Inc Glendale, California, United States, 91206 Glendale Adventist Medical Center Glendale, California, United States, 91206 Less <<
NCT00365859 - Completed - -
NCT02637115 Metabolic Syndrome x ... More >> Glucose Metabolism Disorders Dyslipidemias Obesity Less << Not Applicable Completed - Belgium ... More >> Cliniques universitaires Saint-Luc Brussels, Belgium, 1200 Less <<
NCT02332798 Schizophrenia Phase 1 Completed - United States, California ... More >> Collaborative Neuroscience Network, LLC. Long Beach, California, United States, 90806 Less <<
NCT00365859 Autistic Disorder ... More >> Behavioral Symptoms Less << Phase 3 Completed - -
NCT01235741 - Terminated(Results from previo... More >>us study DFA102 demonstrated neutralizing activity to metreleptin in invitro assay in 2 participants.) Less << - -
NCT02793232 Healthy Subjects Phase 1 Completed - Belgium ... More >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT02190721 Neutropenia Phase 2 Completed - -
NCT02750930 - Terminated(The termination was... More >> result of GSK business considerations and not due to quality, safety or efficacy concerns with any albiglutide formulations or study conduct) Less << - -
NCT02793232 - Completed - -
NCT02509117 - Completed - -
NCT02750930 Diabetes Mellitus, Type 2 Phase 4 Terminated(The termination was... More >> result of GSK business considerations and not due to quality, safety or efficacy concerns with any albiglutide formulations or study conduct) Less << - -
NCT02190721 - Completed - -
NCT03493386 Anaemia Phase 1 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 813-0017 Less <<
NCT03041961 Healthy Young Men Not Applicable Completed - United Kingdom ... More >> Department of Life Sciences and Medecine London, Central London, United Kingdom, SE1 9NH Less <<
NCT03006289 - Unknown November 2017 -
NCT02332798 - Completed - -
NCT03555890 Rhinitis Phase 1 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 812-0025 Less <<
NCT02041299 Iron Overload ... More >> Sickle Cell Disease Other Anemias Less << Phase 4 Recruiting September 2019 -
NCT03472742 - Recruiting July 31, 2021 Japan ... More >> Niigata University Medical & Dental Hospital Recruiting Niigata, Japan, 951-8510 Contact: Division of Gastroenterology and Hepatology Less <<
NCT02322450 Essential Hypertension Phase 2 Completed - France ... More >> Hôpital Arthur Gardiner Dinard, France, 35800 Hôpital Cardiologique, CHRU de Lille Lille, France, 59037 Hospices Civils de Lyon - Hôpital de la Croix Rousse Lyon, France, 69317 Hôpital Européen Georges Pompidou Paris, France, 75015 Less <<
NCT03677596 Leukemia Prec... More >>ursor b-Cell Lymphoblastic Leukemia-Lymphoma ACUTE LYMPHOBLASTIC LEUKEMIA Less << Phase 4 Not yet recruiting May 16, 2025 -
NCT02666287 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site London, United Kingdom, NW10 7EW Less <<
NCT03483090 Osteoarthritis, Knee Phase 2 Recruiting July 30, 2020 Australia, Queensland ... More >> University of the Sunshine Coast Clinical Trials Centre, Morayfield Health Hub Recruiting Morayfield, Queensland, Australia, 4506 Contact: Jessica Baird    +61 7 5456 3797    trials@usc.edu.au    Contact: Georgina Street    +61 7 5456 3798    gstreet@usc.edu.au    Principal Investigator: Susan Thackwray          University of the Sunshine Coast Clinical Trials Centre, USC Health Clinics Recruiting Sippy Downs, Queensland, Australia, 4556 Contact: Jessica Baird    +61 7 5456 3797    trials@usc.edu.au    Contact: Georgina Street    +61 7 5456 3798    gstreet@usc.edu.au    Principal Investigator: Susan Thackwray          Australia, South Australia CSIRO Nutrition and Health Research Clinic Recruiting Adelaide, South Australia, Australia, 5000 Contact: Bianca Benassi-Evans          Australia, Victoria Emeritus Research Recruiting Camberwell, Victoria, Australia, 3124 Contact: Edwin Young    +61 3 950 96166    edwinyoung@emeritusresearch.com    Contact: Teresa Ringeri    +61 3 950 96166    teresaringeri@emeritusresearch.com    Principal Investigator: Andrew Ostor Less <<
NCT03470441 Acute Myocardial Infarction ... More >> STEMI Less << Phase 2 Not yet recruiting December 2018 -
NCT02837380 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - China ... More >> GSK Investigational Site Shanghai, China, 200030 Less <<
NCT00162305 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Florida ... More >> Local Institution Fort Lauderdale, Florida, United States, 33301 Local Institution Miami, Florida, United States, 33169 Local Institution Orlando, Florida, United States, 32809 United States, Louisiana Local Institution New Orleans, Louisiana, United States, 70119 United States, Texas Local Institution San Antonio, Texas, United States, 78229-3894 Less <<
NCT02698553 Depressive Disorder, Major Phase 1 Completed - China ... More >> GSK Investigational Site Shanghai, China, 200030 Less <<
NCT02027857 Brain Electrical Impedance; ... More >> Non-invasive Intracranial Pressure Less << Not Applicable Unknown June 2015 China, Shaanxi ... More >> Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University Not yet recruiting Xi'an City, Shaanxi, China, 710032 Contact: Hu Shijie, M.D.,Ph.D.    086-29-84773307    hushijie@fmmu.edu.cn    Contact: Fei Zhou, M.D.,Ph.D.    086-13992888996    feizhou@fmmu.edu.cn    Principal Investigator: Hu Shijie, M.D.,Ph.D. Less <<
NCT02578953 Prostatic Hyperplasia Phase 1 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 813-0017 Less <<
NCT02925546 Heart Failure, Congestive Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT03479892 Metabolism and Nutrition Disor... More >>der Obesity Less << Phase 1 Recruiting May 4, 2019 United States, Texas ... More >> Novo Nordisk Investigational Site Recruiting San Antonio, Texas, United States, 78209 Less <<
NCT03159442 Chronic Obstructive Pulmonary ... More >>Disease - COPD Less << Phase 1 Completed - United Kingdom ... More >> Research Site London, United Kingdom, HA1 3UJ Less <<
NCT02283047 Hypertension ... More >>Overweight Sedentary Less << Not Applicable Completed - Spain ... More >> Faculty of Physical Activity and Sport Sciences Vitoria-gasteiz, Araba/alava, Spain, 01007 Less <<
NCT03534752 - Recruiting April 1, 2020 Switzerland ... More >> Lausanne University Hospitals Recruiting Lausanne, Vaud, Switzerland, 1011 Contact: F , MD Less <<
NCT02333240 Pre-Eclampsia ... More >> Hypertension, Pregnancy-Induced Less << Not Applicable Completed - United Kingdom ... More >> Royal Berkshire NHS Foundation Trust Reading, Berkshire, United Kingdom, RG1 5AN Northampton General Hospital NHS Trust Northampton, Northamptonshire, United Kingdom, NN1 5BD Oxford University Hospitals NHS Foundation Trust Oxford, Oxfordshire, United Kingdom, OX3 9DU Stoke Mandeville Hospital Aylesbury, United Kingdom, HP21 8AL Horton General Hospital Banbury, United Kingdom, OX16 9AL Less <<
NCT00254293 Rheumatoid Arthritis Phase 1 Phase 2 Completed - United States, Florida ... More >> Orlando Clinical Research Center Orlando, Florida, United States, 32806 United States, Georgia Winship Cancer Institute, Emory University Atlanta, Georgia, United States, 30322 United States, Louisiana New Orleans Center For Clinical Research New Orleans, Louisiana, United States, 70119 United States, Minnesota Davita Clinical Research Minneapolis, Minnesota, United States, 55404 United States, North Carolina The Arthritis Clinic & Carolina Bone & Joint Charlotte, North Carolina, United States, 28210 Less <<
NCT02732444 - Completed - Brazil ... More >> Hospital of clinics of the federal university of uberlândia Uberlandia, Minas Gerais, Brazil Less <<
NCT03394651 - Recruiting April 1, 2022 China, Shanghai ... More >> Changhai Hospital Recruiting Shanghai, Shanghai, China, 200433 Contact: Qi-Xiang Song, MD    8615021223013    rex_song918@qq.com Less <<
NCT00087607 Hepatitis C, Chronic Phase 4 Completed - -
NCT00254293 - Completed - -
NCT00087607 - Completed - -
NCT03395704 Hereditary Hemochromatosis Phase 2 Recruiting December 2018 United States, Arkansas ... More >> Investigative Site Recruiting North Little Rock, Arkansas, United States, 72117 United States, California Investigative Site Recruiting Palo Alto, California, United States, 94305 Investigative Site Recruiting Rialto, California, United States, 92377 Investigational Site Recruiting San Diego, California, United States, 91942 United States, Michigan Investigative Site Recruiting Wyoming, Michigan, United States, 49519 United States, Mississippi Investigative Site Recruiting Jackson, Mississippi, United States, 39216 United States, New York Investigative Site Recruiting East Setauket, New York, United States, 11733 Investigative Site Recruiting Manhasset, New York, United States, 11030 Investigative Site Recruiting New York, New York, United States, 10029 United States, Texas Investigative Site Recruiting Dallas, Texas, United States, 75246 Investigative Site Recruiting Fort Worth, Texas, United States, 76104 Investigative Site Recruiting Houston, Texas, United States, 77058 Investigative Site Recruiting San Antonio, Texas, United States, 78215 United States, Washington Investigative Site Recruiting Seattle, Washington, United States, 98104 Australia, New South Wales Investigative Site Recruiting Westmead, New South Wales, Australia, 2145 Australia, Queensland Investigative Site Recruiting Brisbane, Queensland, Australia, 4120 Investigative Site Recruiting Herston, Queensland, Australia, 4029 Australia, Victoria Investigative Site Recruiting Melbourne, Victoria, Australia, 3004 France Investigative Site Recruiting Bondy, France, 93140 Investigative Site Recruiting Orléans, France, 45000 Investigative Site Recruiting Pessac, France, 33604 Investigative Site Recruiting Rennes Cedex 9, France, 35033 United Kingdom Investigative Site Recruiting Bradford, England, United Kingdom, BD9 6RJ Investigative Site Recruiting Newcastle Upon Tyne, England, United Kingdom, NE7 7DN Investigative Site Recruiting Portsmouth, England, United Kingdom, PO6 3LY Less <<
NCT00611455 Arthritis, Rheumatoid Phase 3 Terminated(Ofatumumab IV trial... More >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) Less << - -
NCT01449253 Pulmonary Hypertension Seconda... More >>ry to Lung Disease and/or Hypoxia Less << Phase 4 Unknown July 2013 India ... More >> All India Institute Of Medical Sciences Recruiting New Delhi, Delhi, India, 110029 Contact: Sajal Ajmani, MBBS    9873570408    sajalajmani@gmail.com    Principal Investigator: Surendra K Sharma, MD, Ph D Less <<
NCT00048165 Heart Transplantation Phase 4 Completed - -
NCT00048165 - Completed - -
NCT00603525 Arthritis, Rheumatoid Phase 3 Terminated(Ofatumumab IV trial... More >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) Less << - -
NCT02832362 Common Cold Phase 1 Completed - Canada, Quebec ... More >> GSK Investigational Site Quebec City, Quebec, Canada, G1P 0A2 Less <<
NCT00392925 Overweight Ob... More >>esity Less << Phase 2 Completed - United States, Florida ... More >> Research Site Deland, Florida, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Indiana Research Site Indianapolis, Indiana, United States United States, Kansas Research Site Overland Park, Kansas, United States United States, Louisiana Research Site Baton Rouge, Louisiana, United States United States, Michigan Research Site Detroit, Michigan, United States United States, Minnesota Research Site Edina, Minnesota, United States United States, Montana Research Site Butte, Montana, United States United States, Ohio Research Site Cincinnati, Ohio, United States United States, Oregon Research Site Portland, Oregon, United States United States, Utah Research Site Salt Lake City, Utah, United States United States, Washington Research Site Olympia, Washington, United States Less <<
NCT00611455 - Terminated(Ofatumumab IV trial... More >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) Less << - -
NCT00364793 HIV Infections Phase 1 Phase 2 Completed - Argentina ... More >> Local Institution Buenos Aires, Argentina, 1425 Local Institution Capital Federal, Argentina, 1425 Colombia Local Institution Cali, Colombia Mexico Local Institution Df, Distrito Federal, Mexico, 06720 Local Institution Guadalajara, Jalisco, Mexico, 44280 Local Institution Guadalajara, Jalisco, Mexico, 44520 Local Institution Morelia, Michioacan, Mexico, 58000 Local Institution Monterrey, Nuevo Leon, Mexico, 64460 Local Institution Colima, Mexico, 28019 Local Institution Puebla, Mexico, 72000 Local Institution San Luis Potosi, Mexico, 78240 Panama Local Institution Ciudad De Panama, Panama, 0816-00383 South Africa Local Institution Bloemfontein, Free State, South Africa, 9301 Local Institution Westdene, Gauteng, South Africa, 2092 Local Institution Cape Town, Western Cape, South Africa, 7505 Thailand Local Institution Bangkok, Thailand, 10330 Local Institution Bangkok, Thailand, 10700 Less <<
NCT00603525 - Terminated(Ofatumumab IV trial... More >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) Less << - -
NCT00392925 - Completed - -
NCT00705367 - Completed - -
NCT00452530 Deep Vein Thrombosis ... More >> Pulmonary Embolism Less << Phase 3 Completed - -
NCT00364793 - Completed - -
NCT00256750 Kidney Transplantation ... More >> Chronic Kidney Failure Less << Phase 3 Completed - -
NCT00374322 Neoplasms, Breast Phase 3 Completed - -
NCT00452530 - Completed - -
NCT03324685 Drug Interactions Phase 1 Completed - United States, Florida ... More >> Research Site Daytona Beach, Florida, United States, 32117 Less <<
NCT00705367 Lupus Nephritis Phase 1 Completed - China, Shanghai ... More >> Local Institution Shanghai, Shanghai, China, 200001 Less <<
NCT03574142 Healthy Subjects Phase 1 Completed - China ... More >> Research Site Beijing, China, 100029 Less <<
NCT03058458 Healthy Volunteers ... More >> Asthma Less << Phase 1 Completed - United Kingdom ... More >> Investigator Site Harrow, United Kingdom Less <<
NCT03340935 Malignant Neoplasm ... More >> Cancer Less << Not Applicable Recruiting June 30, 2018 Italy ... More >> Fondazione IRCCS Istituto Nazionale dei Tumori Recruiting Milan, Italy, 20133 Contact: Claudio Vernieri, M.D., Ph.D.    +39 02 23903066    claudio.vernieri@istitutotumori.mi.it Less <<
NCT00256750 - Completed - -
NCT00374322 - Completed - -
NCT01508936 Eosinophilic Asthma Phase 3 Completed - -
NCT01508936 - Completed - -
NCT00371683 Deep Vein Thrombosis ... More >> Pulmonary Embolism Less << Phase 3 Completed - -
NCT00371683 - Completed - -
NCT01270464 Eosinophilic Asthma Phase 3 Completed - -
NCT01270464 - Completed - -
NCT01287039 Eosinophilic Asthma Phase 3 Completed - -
NCT00569803 - Completed - -
NCT01287039 - Completed - -
NCT02311790 Insulin Sensitivity Not Applicable Completed - United States, Massachusetts ... More >> Jean Mayer Human Nutrition Research Center on Aging Boston, Massachusetts, United States, 02111 Less <<
NCT00569803 Transplantation Phase 1 Completed - United States, Texas ... More >> Ppd Development Austin, Texas, United States, 78744 Less <<
NCT00673387 Overweight Ob... More >>esity Less << Phase 2 Completed - -
NCT00534313 Psoriatic Arthritis Phase 2 Terminated(Lack of efficacy wi... More >>th respect to skin-related lesions in the short-term phase) Less << - -
NCT00114777 Renal Transplantation Phase 3 Completed - -
NCT00673387 - Completed - -
NCT01610492 Glomerulonephritis, Membranous Phase 2 Completed - United Kingdom ... More >> GSK Investigational Site Exeter, Devon, United Kingdom, EX2 5DW GSK Investigational Site Stevenage, Hertfordshire, United Kingdom, SG1 4AB GSK Investigational Site Cambridge, United Kingdom, CB2 0QQ GSK Investigational Site Glasgow, United Kingdom, G11 6NT GSK Investigational Site Manchester, United Kingdom, M13 9WL GSK Investigational Site Reading, United Kingdom, RG1 5AN GSK Investigational Site Salford, United Kingdom, M6 8HD GSK Investigational Site Whitechapel, London, United Kingdom, E1 1BB Less <<
NCT00372112 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - Australia, New South Wales ... More >> GSK Investigational Site Camperdown, New South Wales, Australia, 2050 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 Bulgaria GSK Investigational Site Ruse, Bulgaria, 7000 GSK Investigational Site Sofia, Bulgaria, 1431 GSK Investigational Site Sofia, Bulgaria, 1606 Germany GSK Investigational Site Weinheim, Baden-Wuerttemberg, Germany, 69469 GSK Investigational Site Hannover, Niedersachsen, Germany, 30159 GSK Investigational Site Geesthacht, Schleswig-Holstein, Germany, 21502 Netherlands GSK Investigational Site Breda, Netherlands, 4819 EV GSK Investigational Site Hoorn, Netherlands, 1624 NP New Zealand GSK Investigational Site Auckland, New Zealand, 1005 GSK Investigational Site Tauranga, New Zealand Romania GSK Investigational Site Bucharest, Romania, 050159 GSK Investigational Site Iasi, Romania, 700506 Less <<
NCT01610492 - Completed - -
NCT01789970 Low Back Pain Phase 3 Completed - -
NCT00114777 - Completed - -
NCT01525238 - Completed - -
NCT00534313 - Terminated(Lack of efficacy wi... More >>th respect to skin-related lesions in the short-term phase) Less << - -
NCT01525238 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Alabama ... More >> The Children Hospital Of Alabama Birmingham, Alabama, United States, 35233 United States, California Axis Clinical Trials Los Angeles, California, United States, 90036 United States, Florida Nemours Childrens Hospital Orlando, Florida, United States, 32827 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Kentucky Kosair Charities Pediatric Clinical Research Unit Louisville, Kentucky, United States, 40202 United States, Louisiana Lsuhsc-Shreveport Shreveport, Louisiana, United States, 71103 United States, Missouri Childrens Mercy Hospital Kansas City, Missouri, United States, 64108 United States, New York Women And Children'S Hopsital Of Buffalo Buffalo, New York, United States, 14222 United States, Ohio Promedica Toledo Children'S Hospital Toledo, Ohio, United States, 43606 Mercy Children'S Hospital Toledo, Ohio, United States, 43608 United States, Pennsylvania Children'S Hospital Of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children'S Hospital Of Pittsburgh Of Upmc Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee Methodist Le Bonheur Hlthcare Memphis, Tennessee, United States, 38103 United States, Texas Christus Santa Rosa Childrens Hospital San Antonio, Texas, United States, 78207 Mexico Local Institution Guadalajara, Jalisco, Mexico, 44150 Local Institution Monterrey, Nuevo Leon, Mexico, 64460 Local Institution Veracruz, Mexico, 91910 Less <<
NCT01225822 Venous Thromboembolism Phase 2 Completed - -
NCT02722044 Rheumatoid Arthritis Phase 3 Completed - United States, Michigan ... More >> Henry Ford Health System Detroit, Michigan, United States, 48202 United States, North Carolina Medication Management, LLC Greensboro, North Carolina, United States, 27408 United States, Oklahoma Lynn Health Science Institute Oklahoma City, Oklahoma, United States, 73112 United States, Pennsylvania Altoona Center for Clinical Research, PC Duncansville, Pennsylvania, United States, 16635 United States, Texas Austin Regional Clinic, PA Austin, Texas, United States, 78731 Accurate Clinical Management Houston, Texas, United States, 77004 Accurate Clinical Research, Inc. Houston, Texas, United States, 77034 Less <<
NCT00372112 - Completed - -
NCT01225822 - Completed - -
NCT01789970 - Completed - -
NCT02722044 - Completed - -
NCT00420199 Active Rheumatoid Arthritis Phase 3 Completed - Belgium ... More >> Local Institution Bruxelles, Belgium, 1200 Local Institution Yvoir, Belgium, 5530 Germany Local Institution Berlin, Germany, 14059 Local Institution Berlin, Germany, BE-10117 Netherlands Local Institution Amsterdam, Netherlands, 1105 AZ Spain Local Institution Barcelona, Spain, 08036 Local Institution Barcelona, Spain, 08907 Sweden Local Institution Stockholm, Sweden, 171 76 United Kingdom Local Institution London, Greater London, United Kingdom, SE19RT Local Institution Leeds, North Yorkshire, United Kingdom, LS7 4SA Less <<
NCT00819234 Obesity Phase 2 Completed - -
NCT03741218 Obesity Not Applicable Recruiting March 2020 Spain ... More >> Institute of Food Science, Technology and Nutrition, National Research Council (ICTAN-CSIC) Recruiting Madrid, Spain, 28040 Contact: Jara Pérez-Jiménez, PhD    +34915492300 ext 231406    jara.perez@ictan.csic.es Less <<
NCT00420199 - Completed - -
NCT02947568 - Recruiting December 2019 Hungary ... More >> 2nd Department of Medicine and Nephrological Center Recruiting Pécs, Baranya, Hungary, 7624 Contact: Gergo A Molnar, MD, PhD    +3672536050    gergo.molnar@aok.pte.hu    Contact: Eszter Sélley, MD    +3672536050    eszter.selley@aok.pte.hu    Sub-Investigator: Béla Melegh, MD          Sub-Investigator: Lilla Lakner, MD          Sub-Investigator: Kulcsár Imre, MD          Sub-Investigator: Bene Judit, MD          Principal Investigator: István Wittmann, MD Less <<
NCT00927082 Hepatitis B, Chronic Phase 4 Completed - -
NCT00819234 - Completed - -
NCT03460652 ADHD Phase 3 Recruiting March 2019 United States, Arkansas ... More >> Woodland International Research Recruiting Little Rock, Arkansas, United States, 72211 Contact: Lacey Earls    501-221-8681    lacey@woodlandintlresearchgrp.com    Principal Investigator: Jim Aukstuolis, MD          United States, Colorado MCB Clinical Research Centers Recruiting Colorado Springs, Colorado, United States, 80910 Contact: Nichole Gonzalez    719-634-6576    ngonzalez@mcbcrc.com    Principal Investigator: Andrew Sedillo, MD          United States, Florida Meridien Research Recruiting Bradenton, Florida, United States, 34201 Contact: Margaret Bell    941-756-8680    mbell@meridienresearch.net    Principal Investigator: Andrew Cutler, MD          Clinical Neuroscience Solutions, Inc. Recruiting Jacksonville, Florida, United States, 32256 Contact: Sandeep Jandir    904-281-5757    sjandir@cnshealthcare.com    Principal Investigator: Nandita Jones, MD          Innovative Clinical Research, Inc. Recruiting Lauderhill, Florida, United States, 33319 Contact: Kadian Watson    954-990-6326    kwatson@segaltrials.com    Principal Investigator: Rishi Kakar, MD          Meridien Research Recruiting Maitland, Florida, United States, 32751 Contact: Sondra Chapman    407-644-1165    schapman@meridienresearch.net    Principal Investigator: Andrea Marraffino, MD          Clinical Neuroscience Solutions, Inc. Recruiting Orlando, Florida, United States, 32801 Contact: Rebecca Klipper    407-425-5100    rklipper@cnshealthcare.com    Principal Investigator: Robert Molpus, MD          United States, Illinois Capstone Clinical Research Recruiting Libertyville, Illinois, United States, 60048 Contact: Kelly Burns    847-549-7214    kburns@capstoneclinical.com    Principal Investigator: Michael Greenbaum, MD          United States, Kansas Psychiatric Associates Recruiting Overland Park, Kansas, United States, 66211 Contact: Glynis Murphy, PhD    913-438-8221    research@murphyclinic.com    Principal Investigator: William Murphy, MD          United States, Nevada Center for Psychiatry and Behavioral Medicine, Inc. Recruiting Las Vegas, Nevada, United States, 89128 Contact: Jordan Karbins    702-838-0742    jordankabins@gmail.com    Principal Investigator: Ann Childress, MD          United States, New Jersey Hassman Research Institute Recruiting Berlin, New Jersey, United States, 08009 Contact: Vania Dasilva    856-753-7335    vdasilva@hritrials.com    Principal Investigator: Howard Hassman, MD          United States, Ohio Neuro-Behavioral Clinical Research Recruiting Canton, Ohio, United States, 44718 Contact: Natalie Kuemerle    330-493-1118    nkuemerle@nb-cr.com    Principal Investigator: Shishuka Malhotra, MD          Midwest Clinical Research Center, LLC Recruiting Dayton, Ohio, United States, 45417 Contact: Rebecca Vernon    937-424-1050    rvernon@midwestclinical.com    Principal Investigator: Otto Dueno, MD          United States, Oregon Oregon Center for Clinical Investigations, Inc. Recruiting Portland, Oregon, United States, 97214 Contact: Christina Friesen    503-276-6224    christina.friesen@occi.org    Principal Investigator: Beal Essink, MD          Oregon Center for Clinical Investigations, Inc. Recruiting Salem, Oregon, United States, 97301 Contact: Emily Valdez    503-540-0100    emily.valdez@occi.org    Principal Investigator: Drissana Tran, MD          United States, Tennessee Clinical Neuroscience Solutions, Inc. Recruiting Memphis, Tennessee, United States, 38119 Contact: Kelly Iskiwitz, BS    901-843-1045    kiskiwitz@cnshealthcare.com    Principal Investigator: Valerie Arnold, MD          United States, Texas FutureSearch Trials Recruiting Austin, Texas, United States, 78731 Contact: Erin Ashmore    214-369-2600 ext 109    erina@fstrials.com    Principal Investigator: Michael Downing, MD          Bayou City Research, Ltd. Recruiting Houston, Texas, United States, 77007 Contact: Kathy Harpst    832-251-7000 ext 302       Principal Investigator: Matthew Brams, MD          Houston Clinical Trials Recruiting Houston, Texas, United States, 77098 Contact: Janice Roggenkamp    713-527-8448    jroggenkamp@houstonclintrials.com    Principal Investigator: Alain Katic, MD Less <<
NCT00927082 - Completed - -
NCT01240863 Chronic Pain Phase 3 Completed - -
NCT01240863 - Completed - -
NCT01163851 - Completed - -
NCT01021553 - Completed - -
NCT00423319 - Completed - -
NCT00423319 Deep Vein Thrombosis ... More >> Pulmonary Embolism Less << Phase 3 Completed - -
NCT03054194 Healthy Participants Phase 1 Completed - United States, Texas ... More >> Eisai Trial Site San Antonio, Texas, United States, 78217 Less <<
NCT02061098 Overweight Phase 1 Phase 2 Completed - Spain ... More >> UCAM (San Antonio Catholic University from Murcia) Murcia, Spain, 30107 Less <<
NCT01163851 Hypercholesterolemia ... More >> Dyslipidemia Less << Phase 1 Completed - United States, Arizona ... More >> Premier Research Group, Limited Peoria, Arizona, United States, 85381 Dedicated Phase 1, Inc. Phoenix, Arizona, United States, 85013 Premier Research Group Limited Phoenix, Arizona, United States, 85027 United States, Kansas Vince and Associates Clinical Research Overland Park, Kansas, United States, 66211 Vince and Associates Clinical Research Overland Park, Kansas, United States, 66212 Less <<
NCT00111800 - Completed - -
NCT00087568 - Completed - -
NCT00087568 Hepatitis C, Chronic Phase 4 Completed - -
NCT00111800 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT03030053 Mental Processes Not Applicable Active, not recruiting December 2018 United Kingdom ... More >> Hugh Sinclair Unit of Human Nutrition, University of Reading Reading, Berkshire, United Kingdom, RG6 5SG Less <<
NCT03558789 - Recruiting November 1, 2022 France ... More >> CH Valence Recruiting Valence, France, 26953 Contact: Guillaume Buiret, MD    +475757528    gbuiret@ch-valence.fr    Contact: Sandrine Beauchard       sbeauchard@ch-valence.fr    Principal Investigator: guillaume buiret, MD Less <<
NCT00814762 AIDS Phase 1 Completed - Germany ... More >> GSK Investigational Site Erlangen, Bayern, Germany, 91054 GSK Investigational Site Muenchen, Bayern, Germany, 80335 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 50937 GSK Investigational Site Berlin, Germany, 12157 GSK Investigational Site Hamburg, Germany, 20099 GSK Investigational Site Hamburg, Germany, 20246 Less <<
NCT00763867 Heart Failure Phase 3 Completed - United States, Arizona ... More >> Mayo Clinic Arizona Phoenix, Arizona, United States, 85054 United States, Georgia Morehouse School of Medicine Atlanta, Georgia, United States, 30310 United States, Massachusetts Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 United States, Minnesota Minnesota Heart Failure Network Minneapolis, Minnesota, United States, 55415 Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Utah University of Utah Health Sciences Center Murray, Utah, United States, 84107 United States, Vermont University of Vermont - Fletcher Allen Health Care Burlington, Vermont, United States, 05401 Canada, Quebec Montreal Heart Institute Montreal, Quebec, Canada, H1T - 1C8 Less <<
NCT01021553 Premature Ejaculation Phase 2 Completed - United States, California ... More >> GSK Investigational Site San Diego, California, United States, 92120 GSK Investigational Site San Jose, California, United States, 95128 United States, Indiana GSK Investigational Site Fort Wayne, Indiana, United States, 46825 United States, New York GSK Investigational Site New York, New York, United States, 10016 United States, Pennsylvania GSK Investigational Site Bala-Cynwyd, Pennsylvania, United States, 19004 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1081 HV GSK Investigational Site Utrecht, Netherlands, 3584 CJ Less <<
NCT01268566 - Completed - -
NCT01268566 Glioblastoma Multiforme Phase 2 Completed - United States, Arizona ... More >> Research Site Tucson, Arizona, United States United States, California Research Site Los Angeles, California, United States Research Site Stanford, California, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Massachusetts Research Site Boston, Massachusetts, United States United States, Michigan Research Site Detroit, Michigan, United States United States, New York Research Site New York, New York, United States United States, Ohio Research Site Canton, Ohio, United States United States, Pennsylvania Research Site Pittsburgh, Pennsylvania, United States United States, Tennessee Research Site Nashville, Tennessee, United States United States, Texas Research Site San Antonio, Texas, United States United States, Washington Research Site Seattle, Washington, United States Less <<
NCT00867087 Lymphoma, B-Cell Phase 2 Completed - -
NCT00107653 - Completed - -
NCT00107653 Hepatitis C, Chronic Phase 4 Completed - -
NCT00763867 - Completed - -
NCT02532998 Pharmacodynamics ... More >> Healthy Subjects Less << Phase 1 Completed - United Kingdom ... More >> Research Site Harrow, United Kingdom Less <<
NCT01491932 Dyskinesias P... More >>arkinson Disease Movement Disorders Parkinsonian Disorders Anti-Dyskinesia Agents Less << Phase 2 Completed - -
NCT03351751 Healthy Volunteers Phase 1 Completed - United States, Connecticut ... More >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 Less <<
NCT02532998 - Completed - -
NCT02271984 Healthy Phase 1 Completed - Germany ... More >> Please contact the Merck KGaA Communication Center Darmstadt, Germany Less <<
NCT00867087 - Completed - -
NCT02271984 - Completed - -
NCT00817063 Eczema Phase 3 Completed - -
NCT01316939 Crohn's Disease Phase 3 Terminated(This study was term... More >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) Less << - -
NCT03672513 Menopause Nut... More >>ritional Intervention Bone Diseases Less << Not Applicable Completed - Spain ... More >> Universidad de Granada Granada, Spain, 18071 Less <<
NCT01316939 - Terminated(This study was term... More >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) Less << - -
NCT02814656 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 1 Completed - United Kingdom ... More >> Research Site London, United Kingdom Less <<
NCT01318993 Crohn's Disease Phase 3 Terminated(This study was term... More >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) Less << - -
NCT01114620 - Completed - -
NCT01362348 - Terminated(Lack of efficacy id... More >>entified during a preliminary analysis) Less << - -
NCT01362348 Macular Degeneration Phase 2 Terminated(Lack of efficacy id... More >>entified during a preliminary analysis) Less << - United States, Arizona ... More >> GSK Investigational Site Phoenix, Arizona, United States, 85014 United States, Florida GSK Investigational Site Miami, Florida, United States, 33143 GSK Investigational Site Winter Haven, Florida, United States, 33880 United States, Georgia GSK Investigational Site Decatur, Georgia, United States, 30030 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02114 United States, Michigan GSK Investigational Site Grand Rapids, Michigan, United States, 49525 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Texas GSK Investigational Site Austin, Texas, United States, 78705 GSK Investigational Site Houston, Texas, United States, 77030 France GSK Investigational Site Paris cedex 10, France, 75475 GSK Investigational Site Paris cedex 12, France, 75571 Germany GSK Investigational Site Muenchen, Bayern, Germany, 80336 GSK Investigational Site Bonn, Nordrhein-Westfalen, Germany, 53127 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48145 GSK Investigational Site Leipzig, Sachsen, Germany, 04103 Less <<
NCT01090492 Raynaud's Disease ... More >> Peripheral Vascular Disease Less << Phase 2 Completed - -
NCT00817063 - Completed - -
NCT01114620 Influenza Phase 4 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 813-8588 Less <<
NCT01090492 - Completed - -
NCT00793871 Gastrointestinal Neoplasms, Ga... More >>strointestinal Stromal Tumors Less << Phase 4 Completed - China, Jiangsu ... More >> Nanjing Bayi Hospital Nanjing, Jiangsu, China, 210002 China Beijing Cancer Hospital Beijing, China, 100035 307 Hospital of PLA Beijing, China, 100071 Cancer Institute & Hospital Chinese Academy of Medical Sciences and PUMC Bejing, China, 100021 Less <<
NCT00793871 - Completed - -
NCT01318993 - Terminated(This study was term... More >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) Less << - -
NCT02293902 Rheumatoid Arthritis Phase 3 Completed - -
NCT03397641 Atrial Fibrillation Phase 1 Completed - United Kingdom ... More >> Quotient Clinical Nottingham, United Kingdom, NG11 6JS Less <<
NCT02293902 - Completed - -
NCT01727791 Healthy Lactating Women Phase 4 Completed - Belgium ... More >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT01001169 - Completed - -
NCT01001169 Influenza Phase 2 Completed - Japan ... More >> GSK Investigational Site Tokyo, Japan, 157-8535 Less <<
NCT01229436 - Completed - -
NCT01229436 Dupuytren's Contracture Phase 3 Completed - Denmark ... More >> Pfizer Investigational Site Copenhagen, Denmark, 1402 K Pfizer Investigational Site Silkeborg, Denmark, 8600 France Pfizer Investigational Site Montpellier cedex 5, France, 34295 Pfizer Investigational Site Nice, France, 06000 Pfizer Investigational Site Paris, France, 75016 Pfizer Investigational Site Paris, France, Cedex 15 75908 Germany Pfizer Investigational Site Bad Neustadt, Germany, 97616 Pfizer Investigational Site Berlin, Germany, 10627 Pfizer Investigational Site Bonn, Germany, 53123 Pfizer Investigational Site Muenster, Germany, 48149 Pfizer Investigational Site Nurnberg, Germany, 90471 Pfizer Investigational Site Tubingen, Germany, 72076 Hungary Pfizer Investigational Site Miskolc, Hungary, 3526 Italy Pfizer Investigational Site Sesto San Giovanni, Milano, Italy, 20099 Pfizer Investigational Site Modena, Italy, 41124 Pfizer Investigational Site Savona, Italy, 17100 Spain Pfizer Investigational Site Elche, Alicante, Spain, 03203 Pfizer Investigational Site Hospitalet De Llobregat, Barcelona/ Spain, Spain, 08907 Pfizer Investigational Site Barcelona, Spain, 08022 Pfizer Investigational Site Barcelona, Spain, 08036 Pfizer Investigational Site Málaga, Spain, 29010 Sweden Pfizer Investigational Site Malmö, Sweden, SE-205 02 Pfizer Investigational Site Stockholm, Sweden, SE 118 83 Pfizer Investigational Site Uppsala, Sweden, 751 85 United Kingdom Pfizer Investigational Site Derby, United Kingdom, DE22 3NE Pfizer Investigational Site Glasgow, United Kingdom, G4 0SF Pfizer Investigational Site Norwich, United Kingdom, NR4 7UY Pfizer Investigational Site Southampton, United Kingdom, SO16 6YD Less <<
NCT01727791 - Completed - -
NCT02463435 Severe Obesity Not Applicable Completed - Brazil ... More >> Unidade de Pesquisa Clínica do Hospital das Clínicas/UFG Goiânia, Goiás, Brazil, 74605-020 Less <<
NCT01240915 Colitis, Ulcerative Phase 2 Completed - -
NCT03136380 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - Japan ... More >> GSK Investigational Site Tokyo, Japan, 162-0053 Less <<
NCT02204371 Telangiectasia, Hereditary Hem... More >>orrhagic Less << Phase 2 Terminated(The study was termi... More >>nated as the asset was sold to another company who decided not to pursue this indication with this drug.) Less << - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90095 United States, Georgia GSK Investigational Site Augusta, Georgia, United States, 30912-3135 United States, Missouri GSK Investigational Site Saint Louis, Missouri, United States, 63110 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84132 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT03291782 Gout Phase 1 Active, not recruiting October 10, 2018 United States, Florida ... More >> Covance Daytona Beach Clinical Research Unit Daytona Beach, Florida, United States, 32117 Less <<
NCT00555906 Multiple Myeloma Phase 2 Completed - United States, Illinois ... More >> Northwestern Medical Faculty Foundation Chicago, Illinois, United States, 60611 Northwestern Memorial Hospital/Main Labs Chicago, Illinois, United States, 60611 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States, 66205 United States, Maryland University of Maryland Baltimore, Maryland, United States, 21201 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110-1093 Barnes-Jewish Hospital St. Louis, Missouri, United States, 63110 Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 New York Presbyterian, Weill Cornell Medical College New York, New York, United States, 10065 United States, Pennsylvania University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Hollings Cancer Center Charleston, South Carolina, United States, 29425 Medical University of South Carolina Charleston, South Carolina, United States, 29425 Czech Republic Vseobecna fakultni nemocnice v Praze Praha 2, Czech Republic, 12808 Germany Universitaetsklinikum Heidelberg Heidelberg, Germany, 69120 Klinikum Johannes-Gutenberg -Universitaet, III. Medizinische Klinik und Poliklinik Mainz, Germany, 55131 Less <<
NCT02204371 - Terminated(The study was termi... More >>nated as the asset was sold to another company who decided not to pursue this indication with this drug.) Less << - -
NCT01240915 - Completed - -
NCT02179918 Advanced Solid Tumors Phase 1 Completed - United States, California ... More >> Research Administration Office Los Angeles, California, United States, 90095 Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States, 90095 UCLA Hematology-Oncology Clinic Los Angeles, California, United States, 90095 UCLA Oncology Center Los Angeles, California, United States, 90095 United States, Connecticut Smilow Cancer Center at Yale-New Haven Hospital New Haven, Connecticut, United States, 06510 Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States, 06510 United States, Texas South Texas Accelerated Research Therapeutics, LLC San Antonio, Texas, United States, 78229 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 Less <<
NCT01712061 Diabetic Nephropathy Phase 2 Completed - -
NCT01712061 - Completed - -
NCT02179918 - Completed - -
NCT00555906 - Completed - -
NCT02358109 Cardiovascular Diseases ... More >> Diabetes Dyslipidemias Metabolic Syndrome Quality of Life Less << Not Applicable Completed - Spain ... More >> Department of Physiology, Faculty of Farmacy, University of Granada Granada, Andalucía, Spain, 18071 Less <<
NCT02752867 Cognitive Impairment Not Applicable Recruiting April 2018 China, Beijing ... More >> Department of Neurology,Dongfang Hospital,Beijing University of Chinese Medicine Recruiting Beijing, Beijing, China, 100078 Contact: Yunling Zhang, PhD,MD    86 10 67689634 Less <<
NCT03657186 Overweight We... More >>ight Loss Less << Not Applicable Recruiting August 2019 Germany ... More >> Analyze & Realize Recruiting Berlin, Germany, 10369 Contact: Udo Bongartz, Dr. med.          Barbara Grube Recruiting Berlin, Germany, 10709 Contact: Barbara Grube          Jörg Förstermann Recruiting Berlin, Germany, 14059 Contact: Jörg Förstermann Less <<
NCT02164552 - Unknown December 2014 Saudi Arabia ... More >> Center of Excellence for Osteoporosis Research, King Abdulaziz University Recruiting Jeddah, Makkah, Saudi Arabia, 21589 Contact: Veronica B Orbacedo, BSc    0096612640000 ext 25574    vorbacedo@yahoo.com    Contact: Ramia Al-sobhi, BSc    0096612640000 ext 25528    ceor@kau.edu.sa    Sub-Investigator: Ahmed Y Ali, MD          Sub-Investigator: Ghazi Y Refai, MD          Sub-Investigator: Mohammed H Qari, FRCPA          Sub-Investigator: Heba S Kary, MD Less <<
NCT02191462 Pharmacokinetics Phase 1 Completed - Canada, Ontario ... More >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Less <<
NCT00359177 Vomiting Phase 1 Completed - United States, Florida ... More >> GSK Investigational Site Gainesville, Florida, United States, 32608 GSK Investigational Site Orlando, Florida, United States, 32809 Less <<
NCT01677325 NAFLD( Non-alcoholic Fatty Liv... More >>er Disease ) Less << Phase 1 Completed - -
NCT02130557 Leukemia, Myelogenous, Chronic... More >>, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive Less << Phase 3 Active, not recruiting April 4, 2020 -
NCT01935804 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Less << Phase 2 Completed - Saudi Arabia ... More >> Center of Excellence for Osteoporosis Research, King Abdulaziz University Jeddah, Makkah, Saudi Arabia, 21589 Less <<
NCT00778622 Type 2 Diabetes Mellitus Phase 4 Completed - China, Beijing ... More >> Local Institution Beijing, Beijing, China, 100028 Local Institution Beijing, Beijing, China, 100034 Local Institution Beijing, Beijing, China, 100044 Local Institution Beijing, Beijing, China, 100088 Local Institution Beijing, Beijing, China, 100730 Local Institution Beijing, Beijing, China, 101100 Local Institution Beijing, Beijing, China, 200016 China, Guangdong Local Institution Guangdong Province, Guangdong, China, 510180 Local Institution Guangdong Province, Guangdong, China, 528000 Local Institution Guangdong, Guangdong, China, 510180 China, Shanghai Local Institution Shanghai, Shanghai, China, 200003 Local Institution Shanghai, Shanghai, China, 200092 Local Institution Shanghai, Shanghai, China, 201100 Local Institution Shanghai, Shanghai, China, 201200 Less <<
NCT00778622 - Completed - -
NCT01435382 Hypercholesterolemia ... More >> Dyslipidemias Hyperlipidemias Lipid Metabolism Disorders Metabolic Diseases Less << Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Elite Research Institute Miami, Florida, United States, 33169 United States, Kansas Vince and Associates Clinical Research Overland Park, Kansas, United States, 66212 United States, Maryland PAREXEL International - Baltimore Early Phase Clinical Unit Baltimore, Maryland, United States, 21225 United States, Michigan Jasper Clinic, Inc. Kalamazoo, Michigan, United States, 49007 United States, Minnesota Prism Research Saint Paul, Minnesota, United States, 55114 United States, Ohio Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45212 Less <<
NCT03469232 Intense-exuberant Stomach Fire... More >> Syndrom Acute Pericoronitis Recurrent Aphthous Stomatitis Recurrent Herpes Simplex Labialis Less << Phase 1 Phase 2 Recruiting November 1, 2018 China, Beijing ... More >> Third affiliated hospital of Beijing University of traditional Chinese medicine Recruiting Beijing, Beijing, China, 100029 Contact: Lu Qiang, Professor    8610-52075325       Principal Investigator: Lu Qiang, Professor          Dongfang Hospital Affiliated to Beijing University of traditional Chinese medicine Recruiting Beijing, Beijing, China, 100078 Contact: Hong Mu, Professor    010-67618333       Principal Investigator: Hong Mu, Professor          China, Sichuan Affiliated Hospital to Chengdu University of traditional Chinese medicine Recruiting Chengdu, Sichuan, China, 610075 Contact: Yuling Zuo, Professor    028-87769902       Principal Investigator: Yuling Zuo, Professor Less <<
NCT01712074 Alzheimer's Disease Phase 2 Terminated(The study was termi... More >>nated October 23, 2015 as pre-specified, interim analysis futility criteria were met. The termination was not due to safety concerns.) Less << - -
NCT02130557 - Active, not recruiting - -
NCT01473407 Chronic Kidney Disease ... More >> Chronic Renal Failure Less << Phase 3 Completed - -
NCT01435382 - Completed - -
NCT01473420 Chronic Renal Failure ... More >> Chronic Kidney Disease Less << Phase 3 Completed - -
NCT01473407 - Completed - -
NCT03021291 Overweight and Obesity Not Applicable Completed - United States, California ... More >> Arternis Institute for Clinical Research San Diego, California, United States, 92103 Clinical Trial Investigators Tustin, California, United States, 92780 United States, Colorado University of Colorado Aurora, Colorado, United States, 80045 United States, Florida Westside Center for Clinical Research Jacksonville, Florida, United States, 32205 United States, Louisiana Pennington Biomedical Research Baton Rouge, Louisiana, United States, 70808 United States, Massachusetts Boston University Medical Center Boston, Massachusetts, United States, 02118 United States, New York Cornell Weill Medical College New York, New York, United States, 10065 United States, Ohio Radiant Research Cincinnati, Ohio, United States, 45249 Aventiv Research Columbus, Ohio, United States, 43213 United States, Pennsylvania Geisinger Health System Danville, Pennsylvania, United States, 17822 United States, Texas Texas Diabetes and Endocrinology Round Rock, Texas, United States, 78681 Czechia Health & Care SRO Prague, Czechia, 182 00 Denmark University of Cophenhagen Copenhagen, Denmark, DK-1958 Italy IRCCS Policlinico San Donato Milan, Italy, 20097 University of Rome Rome, Italy, 00186 Spain University of Navarra Pamplona, Spain, 31008 Less <<
NCT00570063 Schizophrenia Phase 2 Terminated - United States, California ... More >> California Clinical Trials Medical Group, Inc. Glendale, California, United States, 91206 Glendale Adventist Medical Center Glendale, California, United States, 91206 Telecare-Cresta Loma Lemon Grove, California, United States, 91945 California Clinical Trials Medical Group Paramount, California, United States, 90723 LaPaz Geropsychiatric Center Paramount, California, United States, 90723 California Clinical Trials Medical Group San Diego, California, United States, 92123 United States, Connecticut Connecticut Mental Health Center-Yale University, Clinical Neuroscience Research Unit New Haven, Connecticut, United States, 06519 United States, New Jersey CRI Worldwide, LLC Willingboro, New Jersey, United States, 08046 United States, Oklahoma St. Anthony Hospital Oklahoma City, Oklahoma, United States, 73101 IPS Research Company Oklahoma City, Oklahoma, United States, 73103 Less <<
NCT01712074 - Terminated(The study was termi... More >>nated October 23, 2015 as pre-specified, interim analysis futility criteria were met. The termination was not due to safety concerns.) Less << - -
NCT00886821 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> Cetero Research Miami Gardens, Florida, United States, 33169 United States, Texas Cetero Research - San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT01473420 - Completed - -
NCT00886821 - Completed - -
NCT01994291 - Terminated - -
NCT01312909 Smoking Cessation Phase 4 Completed - -
NCT00531752 - Completed - -
NCT00570063 - Terminated - -
NCT00531752 Attention Deficit Hyperactivit... More >>y Disorder Less << Phase 2 Completed - United States, California ... More >> Bay Area Research Institute Lafayette, California, United States, 94549 Pharmacology Research Institute Los Alamitos, California, United States, 90720 Pharmacology Research Institute Newport Beach, California, United States, 92660 United States, Illinois The University of Illinois at Chicago, Institute for Juvenile Research Chicago, Illinois, United States, 60608 United States, Massachusetts Massachusetts General Hospital, ADHD Program Cambridge, Massachusetts, United States, 02138 United States, New York New York University School of Medicine New York, New York, United States, 10010 United States, Virginia NeuroScience, Inc Herndon, Virginia, United States, 20170 Less <<
NCT01312909 - Completed - -
NCT02408562 Parkinson's Disease Phase 1 Phase 2 Terminated(Issues with develop... More >>ment and supply of infusion system for delivery of IMP. Prolonged approval process for the clinical study sNN0031-004.) Less << - Germany ... More >> Klinikum-Bremerhaven Bremerhaven, Germany, DE-27574 Sweden Lund University Hospital Lund, Sweden, 22185 Karolinska University Hospital Huddinge Stockholm, Sweden, 141 86 United Kingdom King's College Hospital London, United Kingdom, SE5 9RS John Radcliffe Hospital Oxford, United Kingdom, OX3 9DU Less <<
NCT01994291 Macular Edema, Diabetic Phase 2 Terminated - -
NCT02007512 Breast Cancer Phase 2 Active, not recruiting March 29, 2019 -
NCT03008954 Overweight Ob... More >>esity Less << Not Applicable Completed - Czechia ... More >> Hradec Králové Hradec, Czechia, 500 00 Charles University Prague, Czechia, 121 08 Denmark University of Cophenhagen Copenhagen, Denmark, DK-1958 Italy Federico University Hospital Naples, Italy, 80131 Policlinico Umberto I Rome, Italy, 00161 Less <<
NCT02650193 Non-metastatic Breast Cancer Phase 2 Completed - Hungary ... More >> CRU Hungary Kft.,CRU Early Phase Unit, Miskolci Semmelweis Kórház és Egyetemi Oktató Kórház Miskolc, BAZ Megye, Hungary, 3529 Debreceni Egyetem Klinikai Központ, ÁOK, Onkológiai Klinika Debrecen, Hajdú-bihar Megye, Hungary, 4032 Országos Onkológiai Intézet Budapest, Hungary, 1122 Spain Hospital Universitario Arnau de Vilanova Lleida, Cataluna, Spain, 25198 Hospital Universitario de Fuenlabrada, Servicio de oncologia Fuenlanbrada, Madrid, Spain, 28942 START Madrid - CIOCC, Unidad de fases 1 planta 3, Hospital Universitario HM Sanchinarro Madrid, Spain, 28050 Hospital Arnau de Vilanova. planta 6, unidad de Oncología Valencia, Spain, 46015 Less <<
NCT02007512 - Active, not recruiting - -
NCT01860196 Adult Cerebral Palsy Phase 4 Completed - -
NCT02034266 Type 1 Diabetes Phase 2 Completed - Canada, Ontario ... More >> University Health Network, Division of Neurology, Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT02650193 - Completed - -
NCT02800967 Hypertension ... More >>Overweight Less << Not Applicable Unknown June 2017 Serbia ... More >> Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, University of Belgrade Belgrade, Serbia, 11000 Less <<
NCT03620760 Unstable Angina Pectoris ... More >> Coronary Stent Implantation Less << Phase 4 Recruiting December 31, 2020 China, Beijing ... More >> Xiaofan Wu Recruiting Beijing, Beijing, China, 100029 Contact: Xiaofan Wu, Master Less <<
NCT02757625 - Completed - -
NCT01628107 - Completed - -
NCT01628107 Chronic Renal Failure Requirin... More >>g Hemodialysis Less << Phase 3 Completed - -
NCT01006122 Excessive Daytime Sleepiness ... More >> Narcolepsy Less << Phase 2 Completed - United States, Arizona ... More >> Pfizer Investigational Site Phoenix, Arizona, United States, 85006 Pfizer Investigational Site Phoenix, Arizona, United States, 85051 Pfizer Investigational Site Tucson, Arizona, United States, 85712 United States, California Pfizer Investigational Site Los Angeles, California, United States, 90048 Pfizer Investigational Site Orange, California, United States, 92868 United States, Florida Pfizer Investigational Site Brandon, Florida, United States, 33511 Pfizer Investigational Site St. Petersburg, Florida, United States, 33707 United States, Georgia Pfizer Investigational Site Atlanta, Georgia, United States, 30342 Pfizer Investigational Site Macon, Georgia, United States, 31201 United States, Illinois Pfizer Investigational Site Vernon Hills, Illinois, United States, 60061 United States, Kentucky Pfizer Investigational Site Crestview Hills, Kentucky, United States, 41017 Pfizer Investigational Site Louisville, Kentucky, United States, 40217 United States, Mississippi Pfizer Investigational Site Hattiesburg, Mississippi, United States, 39401 Pfizer Investigational Site Hattiesburg, Mississippi, United States, 39402 United States, North Carolina Pfizer Investigational Site Durham, North Carolina, United States, 27710 United States, Ohio Pfizer Investigational Site Dublin, Ohio, United States, 43017 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19114 Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19139 United States, South Carolina Pfizer Investigational Site Columbia, South Carolina, United States, 29201 United States, Texas Pfizer Investigational Site Austin, Texas, United States, 78731 Pfizer Investigational Site Houston, Texas, United States, 77063 Less <<
NCT02757625 ICU Sedation Phase 3 Completed - Japan ... More >> Asahikawa Medical University Hospital Asahikawa, Hokkaido, Japan, 078-8510 Hyogo Prefectural Kobe Children's Hospital Kobe, Hyogo, Japan, 650-0047 Shikoku Medical Center for Children and Adults Zentsuji, Kagawa, Japan, 765-8507 Osaka Women's and Children's Hospital Izumi, Osaka, Japan, 594-1101 Osaka Medical College Hospital Takatsuki, Osaka, Japan, 569-8686 Jichi Medical University Hospital Shimotsuke, Tochigi, Japan, 329-0498 Juntendo University Hospital Bunkyo-ku, Tokyo, Japan, 113-8431 Tokyo Metropolitan Children's Medical Center Fuchu, Tokyo, Japan, 183-8561 University Hospital, Kyoto Prefectural University of Medicine Kyoto, Japan, 602-8566 Okayama University Hospital Okayama, Japan, 700-8558 Osaka City General Hospital Osaka, Japan, 534-0021 Shizuoka Children's Hospital Shizuoka, Japan, 420-8660 Less <<
NCT01628120 - Completed - -
NCT02334943 Immune Deficiency ... More >> HIV-related Gut Disease - Cause Unknown Activation of Latent Virus Other Diagnoses, Comorbidities, and Complications Less << Not Applicable Completed - France ... More >> University hospital Montpellier Montpellier, France, 34295 Less <<
NCT00565812 Osteoarthritis Phase 2 Completed - -
NCT02366637 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Terminated(Study terminated on... More >> 7 April 2015 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study) Less << - United Kingdom ... More >> Medicines Evaluation Unit Ltd Wythenshawe, Manchester, United Kingdom, M23 9QZ Nottingham University Hospital NHS Trust Nottingham, Nottinghamshire, United Kingdom, NG5 1PB University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom, B15 2WB Heart of England NHS Foundation Trust Birmingham, United Kingdom, B9 5SS Respiratory Medicine, Bradford Institute of Health Research Bradford, United Kingdom, BD9 6RJ Less <<
NCT01628120 Chronic Renal Failure Requirin... More >>g Hemodialysis Less << Phase 3 Completed - -
NCT00755807 Multiple Sclerosis Phase 3 Completed - -
NCT00755807 - Completed - -
NCT01006122 - Completed - -
NCT00425061 Asthma Phase 2 Completed - -
NCT03446209 Familial Mediterranean Fever Phase 2 Recruiting May 30, 2020 Germany ... More >> Universitätsklinikum Köln, Klinik I für Innere Medizin Recruiting Cologne, NRW, Germany, 50937 Contact: David Kofler, PD Dr. med.    49 221 478-87925    david.kofler@uk-koeln.de    Contact: Stefan Krämer, Dr. med    +49 221 478-4004    stefan.kraemer@uk-koeln.de    Charité Universitätsmedizin Berlin, Klinik für Rheumatologie und Klinische Immunologie, Abteilung -Neue Therapien & Studien Recruiting Berlin, Germany, 10117 Contact: Eugen Feist, Prof. Dr. med.    49 - 30/ 450 513 025    Eugen.Feist@charite.de    Contact: Claudia Kedor, MD    49 - 30/ 450 513 025    Claudia.Kedor@charite.de    University Hospital Tuebingen; Department of oncology, hematology, rheumatology, immunology and pulmology Recruiting Tuebingen, Germany, 72076 Contact: Joerg C Henes, MD    +4970712982711    joerg.henes@med.uni-tuebingen.de    Sub-Investigator: Theodoros Xenitidis, MD Less <<
NCT02351908 HIV Phase 4 Completed - United Kingdom ... More >> SSAT Clinical Research Facility London, United Kingdom, SW10 9NH Less <<
NCT03127852 Heart Failure ... More >> Chronic Obstructive Pulmonary Disease Chronic Kidney Disease Uncontrolled Hypertension Diabetes Less << Not Applicable Recruiting August 23, 2018 Canada, Ontario ... More >> University Health Network Recruiting Toronto, Ontario, Canada Contact: Emily Seto, PhD    416-669-9295    emily.seto@utoronto.ca Less <<
NCT02366637 - Terminated(Study terminated on... More >> 7 April 2015 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study) Less << - -
NCT02760238 - Recruiting October 2025 Canada, Ontario ... More >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 1Z5 Contact: Vikas Gupta, MD    416-946-2885    vikas.gupta@uhn.ca Less <<
NCT01285323 Eosinophilic Asthma Phase 3 Completed - -
NCT02027987 Traumatic Brain Injury Phase 1 Unknown December 2016 China, Shaanxi ... More >> Institute of Neurosurgery, Xijing Hospital, Fourth Military Medical University Recruiting Xi'an City, Shaanxi, China, 710032 Contact: Hu S Jie, M.D., Ph.D.    086 029 84773307    hushijie@fmmu.edu.cn    Contact: Fei Zhou, M.D., Ph.D.    086 029 13992888996    feizhou@fmmu.edu.cn    Principal Investigator: Hu S Jie, M.D., Ph.D. Less <<
NCT00425061 - Completed - -
NCT03528005 Fragility Mul... More >>timorbidity Less << Not Applicable Recruiting December 31, 2019 Taiwan ... More >> Hualien Tzu Chi Hospital,Buddhist Tzu Chi Medical Foundation Recruiting Hualien City, Taiwan, 970 Contact: Sheng-lun Kao, MD    88638561825 ext 9    stevenkao7434@gmail.com    Shulin Primary Care center Recruiting New Taipei City, Taiwan, 238 Contact: Chia-Yun Chang, MD    886226812134       Yingge Primary Health Care center Recruiting New Taipei City, Taiwan, 239 Contact: Tzu-Hsing Hung, MD    886226702304    tpc252@ntpc.gov.tw    Cheng's primary care clinic Not yet recruiting New Taipei City, Taiwan, 241 Contact: Ting-Ching Tang, MD       drmichelletang@gmail.com    National Yang-Ming University Hospital Recruiting Yilan, Taiwan, 264 Contact: Chun-feng Huang, MDPhD    88639325192    16083@ymuh.ym.edu.tw    Taipei Veterans General Hospital Yuanshan Branch Recruiting Yilan, Taiwan, 264 Contact: Wei-Ju Lee, MDPhD    8869222141 ext 5210    leewju@gmail.com Less <<
NCT01285323 - Completed - -
NCT03233568 - Completed - Italy ... More >> San Donato Hospital San Donato Milanese, MI, Italy, 20097 Less <<
NCT01104701 Type 2 Diabetes Phase 2 Completed - United States, Arizona ... More >> Research Site Phoenix, Arizona, United States United States, Nebraska Research Site Lincoln, Nebraska, United States Less <<
NCT00107718 Melanoma Phase 2 Completed - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90089 GSK Investigational Site San Francisco, California, United States, 94115 GSK Investigational Site Santa Monica, California, United States, 90404-2104 United States, Connecticut GSK Investigational Site New Haven, Connecticut, United States, 06520 United States, Florida GSK Investigational Site Jacksonville, Florida, United States, 32209 GSK Investigational Site Miami Beach, Florida, United States, 33140 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60637 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46202 United States, Maryland GSK Investigational Site Lutherville-Timonium, Maryland, United States, 21093 United States, New York GSK Investigational Site New York, New York, United States, 10016 United States, Ohio GSK Investigational Site Toledo, Ohio, United States, 43614-5809 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213-2584 Australia, New South Wales GSK Investigational Site Waratah, New South Wales, Australia, 2298 GSK Investigational Site Westmead, New South Wales, Australia, 2145 Australia, Queensland GSK Investigational Site Douglas, Queensland, Australia, 4814 GSK Investigational Site South Brisbane, Queensland, Australia, 4101 GSK Investigational Site Woolloongabba, Queensland, Australia, 4102 Australia, Tasmania GSK Investigational Site Hobart, Tasmania, Australia, 7000 Australia, Victoria GSK Investigational Site East Melbourne, Victoria, Australia, 3002 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 Less <<
NCT01104701 - Completed - -
NCT03588000 Diabetes Mellitus, Type 2 Not Applicable Active, not recruiting October 2020 China ... More >> Community Health Service Center of Malu Town, Jiading District Shanghai, China, 201801 Community Health Service Center of Nanxiang Town, Jiading District Shanghai, China, 201802 Community Health Service Center of Zhenxin, Jiading District Shanghai, China, 201824 Community Health Service Center of Juyuan New District, Jiading District Shanghai, China, 201899 Less <<
NCT00549744 Asthma Phase 2 Completed - New Zealand ... More >> GSK Investigational Site Wellington, New Zealand, 6035 South Africa GSK Investigational Site George, Eastern Cape, South Africa, 6529 GSK Investigational Site Bloemfontein, South Africa, 9301 Less <<
NCT00565812 - Completed - -
NCT02461992 Hemophilia A Phase 1 Completed - China ... More >> Phase I Unit, Clinical Pharmacology Research Center, Peking Union Medical College Hospital Beijing, China, 100032 Hematology Department,Beijing Children's Hospital, Capital Medical University Beijing, China, 100045 Less <<
NCT02461992 - Completed - -
NCT01641393 Exocrine Pancreatic Insufficie... More >>ncy: Cystic Fibrosis Less << Phase 3 Completed - -
NCT03558503 Bladder Cancer ... More >> Urothelial Carcinoma Urothelial Carcinoma Bladder Less << Phase 2 Recruiting September 2020 United States, Arizona ... More >> Mayo Clinic Not yet recruiting Phoenix, Arizona, United States, 85054 Contact: Mark Tyson, MD       Tyson.Mark@mayo.edu    Contact: Christina Mihok       Mihok.Christina@mayo.edu    United States, Arkansas Arkansas Urology Recruiting Little Rock, Arkansas, United States, 72211 Contact: Richard Emanuel D'Anna, MD    501-219-8900    alturodoc@hotmail.com    Contact: Katie O'Brien    501.219.8900 ext 2002    katie@arkansasurology.com    United States, California Tower Urology Not yet recruiting Los Angeles, California, United States, 90048 Contact: Arnold Cinman, MD    310-854-9898    cinman5676@towerurology.com    Contact: Shiblee Nomanee    310854-9898 ext 168    nomanees@towerurology.com    UCLA - University of California, Los Angeles Not yet recruiting Los Angeles, California, United States, 90095 Contact: Chamie Karim, MD    310-206-8183    kchamie@mednet.ucla.edu    Contact    (310)794-5929       Providence Medical Institute Recruiting Santa Monica, California, United States, 90404 Contact: Jennifer Linehan, MD    520-440-5142    Jennifer.Linehan@providence.org    Contact: Kelly Garver    310-582-7456    Garverk@JWCI.ORG    United States, Iowa University of Iowa Not yet recruiting Iowa City, Iowa, United States, 52242 Contact: Michael O'Donnell, MD    319-356-2421    michael-odonnell@uiowa.edu    Contact    (319)384-5458       United States, Maryland John Hopkins University Not yet recruiting Baltimore, Maryland, United States, 21218 Contact: Max Kates, MD    410-550-3506    Mkates@jhmi.edu    Contact    410-955-6850       United States, Michigan University of Michigan Comprehensive Cancer Center Not yet recruiting Ann Arbor, Michigan, United States, 48109 Contact: Alon Weizer, MD    734-647-8903    aweizer@med.umich.edu    United States, Nebraska Adult & Pediatric Urology, PC Recruiting Omaha, Nebraska, United States, 68114 Contact: Trainer Andrew, MD    402-399-7894    atrainer@adultpediatricuro.com    Contact: Kim Ganzel    402-397-7894    research@adultpediatricuro.com    United States, New York Manhattan Medical Research Recruiting New York, New York, United States, 10016 Contact: Huang William, MD          Contact: Carmela Graci-Pipitone    917-409-3919    cgpipitone@manhattanmedicalresearch.com    Weill Cornell Medical College Not yet recruiting New York, New York, United States, 10065 Contact: Douglas Scherr, MD    212-746-5788    dss2001@med.cornell.edu    Contact: Thomas Flynn    212.746.4739    thf3001@med.cornell.edu    Montefiore Medical Center (Albert Einstein) Not yet recruiting New York, New York, United States, 10461 Contact: Alexander Sankin, MD    718-920-4531    asankin@montefiore.org    Contact    347-842-1715       Western New York Urology Associates Recruiting New York, New York, United States, 14225 Contact: Kent Chevli, MD       kchevli@wnyurology.com    Contact: Stephanie Malczewski    716-844-5553    smalczewski@wnyurology.com    United States, North Carolina The University of North Carolina Not yet recruiting Chapel Hill, North Carolina, United States, 27572 Contact: Angela Smith, MD    919-966-8217    angela_smith@med.unc.edu    Contact    919-537-3505       United States, Oregon Oregon Urology Not yet recruiting Springfield, Oregon, United States, 97477 Contact: Bryan Mehlhaff, MD    541-284-5509    investigator@oregonurology.com    Contact: Stephanie Kerns    541-284-5508    stephanie@oregonurology.com    United States, Pennsylvania Penn State Hershey State College Not yet recruiting Hershey, Pennsylvania, United States, 17033 Contact: Jay Raman, MD    717-531-8887    jraman@hmc.psu.edu    Contact: Kathleen Lehman    (717) 531-5930    klehman3@hmc.psu.edu    United States, South Carolina Carolina Urologic Research Center Recruiting Myrtle Beach, South Carolina, United States, 29572 Contact: Neil Shore, MD    843-839-1679    Nshore@gsuro.com    Contact: Lindsey Rabon    843-839-1679    LRabon@atlanticurologyclinics.com    United States, Texas Urology San Antonio Not yet recruiting Fredericksburg, Texas, United States, 78233 Contact: Daniel Saltzstein, MD    210-617-4116    saltzstein@urologysa.com    Contact: Kethsaly Salinas    210-617-4116    kethsaly.Salinas@urologysa.com    Baylor College of Medicine Not yet recruiting Houston, Texas, United States, 77030 Contact: Seth Lerner, MD    713-798-4001    slerner@bcm.edu; godoy@bcm.edu    Contact    713-798-8514       Israel Carmel Medical Center Not yet recruiting Haifa, Israel, 3436212 Contact: Boris Fridman, MD    972-537176389    BORISFR@clalit.org.il    Contact: Hilla Cohen    972-544753731    HillaCo@clalit.org.il    Rabin Medical Center Not yet recruiting Petah tikva, Israel, 49372 Contact: Yaron Erlich, CM       yarone@clalit.org.il    Contact: Natali Oginets    972-542003783    nataliog@clalit.org.il    Sheba Medical Center Not yet recruiting Ramat Gan, Israel, 52621 Contact: Menahem Laufer, MD          Contact: Efrat Ezra    972-545446438    Efrat.Ezra@sheba.health.gov.il Less <<
NCT02799264 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT03515291 Myocardial Fibrosis Phase 2 Not yet recruiting August 2020 -
NCT02639975 Glaucoma Phase 1 Completed - -
NCT03610334 Healthy Volunteers Phase 1 Recruiting July 2019 France ... More >> Centre d'Investigation Clinique - Centre de Pharmacologie Clinique et d'Evaluations Thérapeutiques (CIC-CPCET) Recruiting Marseille, France, 13385 Contact: Christine Audebert, MD    491384641 ext +33    christine.audebert@ap-hm.fr    Contact: Laurence Attolini, PhD    491388003 ext +33    laurence.attolini@ap-hm.fr    Principal Investigator: Christine Audebert, MD          Sub-Investigator: Marie-Noelle Lefebvre, MD          Sub-Investigator: Frank Rouby, MD Less <<
NCT02683746 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01233869 Polycystic Kidney, Autosomal D... More >>ominant Less << Phase 2 Completed - -
NCT03189225 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Diabetes Centre, Heartlands Hospital Birmingham, United Kingdom, B9 5SS NHS Lothian Edinburgh, United Kingdom, EH16 4SA Highland Diabetes Institute Inverness, United Kingdom, IV2 3JH Less <<
NCT02683746 - Completed - -
NCT01703624 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - United Kingdom ... More >> Medicines Evaluation Unit Manchester, United Kingdom, M23 9QZ Less <<
NCT02287779 Non-Alcoholic Steatohepatitis Phase 1 Completed - United States, Tennessee ... More >> New Orleans Center for Clinical Research Knoxsville, Tennessee, United States, 37920 Less <<
NCT01803776 Overweight Gl... More >>ucose Metabolism Disorders Lipid Metabolism Disorders Blood Pressure Less << Not Applicable Active, not recruiting November 2022 Finland ... More >> University of Eastern Finland Kuopio, Finland, 70211 Less <<
NCT00397722 Social Phobia Phase 2 Completed - -
NCT02287779 - Completed - -
NCT01233869 - Completed - -
NCT02969044 - Completed - -
NCT02613910 Pemphigus Phase 3 Terminated(Novartis has acquir... More >>ed the rights to ofatumumab and terminated the OPV116910 and OPV117059 studies. This decision is not linked to any safety consideration.) Less << - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90045 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48103 Less <<
NCT03121911 Expiratory Flow Limitation ... More >> Recent Myocardial Infarction Less << Not Applicable Not yet recruiting October 31, 2020 -
NCT02969044 Rheumatoid Arthritis Phase 2 Completed - -
NCT00269087 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - Japan ... More >> GSK Investigational Site Kodaira, Japan, 187-0002 GSK Investigational Site Kyoto, Japan, 612-0026 GSK Investigational Site Osaka, Japan, 596-8501 GSK Investigational Site Tokyo, Japan, 164-0012 Less <<
NCT02876952 Myocardial Infarction Not Applicable Recruiting June 2018 Spain ... More >> Department of Physical Education and Sport. Faculty of Education and Sport-Physical Activity and Sport Section. University of the Basque Country Recruiting Vitoria-gasteiz, Araba/álava, Spain, 01007 Contact: SARA MALDONADO-MARTIN, PhD       sara.maldonado@ehu.eus    Sub-Investigator: Juan Jose GOIRIENA, PhD Less <<
NCT02613910 - Terminated(Novartis has acquir... More >>ed the rights to ofatumumab and terminated the OPV116910 and OPV117059 studies. This decision is not linked to any safety consideration.) Less << - -
NCT02197910 Pre-hypertension Not Applicable Unknown March 2016 Italy ... More >> S. Orsola-Malpighi University Hospital Recruiting Bologna, BO, Italy, 40138 Contact: Arrigo FG Cicero, MD, PhD    ++39516362224    arrigo.cicero@unibo.it    Sub-Investigator: Arrigo FG Cicero, MD, PhD          Principal Investigator: Claudio Borghi, MD, PhD          Sub-Investigator: Maddalena Veronesi, MD          Sub-Investigator: Sergio D'Addato, MD, PhD Less <<
NCT01809587 Constipation ... More >>Irregular Bowel Movement Frequency Less << Phase 3 Completed - Germany ... More >> Analyze & Realize Ag Berlin, Germany, 10369 Less <<
NCT01213394 Kidney Transplantation ... More >> Cardiovascular Diseases Less << Phase 3 Terminated(Poor recruitment.) - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT02533648 Type 2 Diabetes Mellitus Phase 3 Unknown May 2016 France ... More >> CRNH Rhône Alpes Recruiting Lyon, France, 69310 Contact: Martine LAVILLE, Professor    +33. 4 78 86 29 81    martine.laville@chu-lyon.fr    Contact: Nathalie FEUGIER    +33. 4 78 86 19 72    nathalie.feugier@chu-lyon.fr    Principal Investigator: Martine LAVILLE, professor Less <<
NCT01644396 Moderate to Severe Plaque Psor... More >>iasis Less << Phase 4 Completed - Russian Federation ... More >> Site Reference ID/Investigator# 67547 Ekaterinburg, Russian Federation, 620076 Site Reference ID/Investigator# 78433 Kazan, Russian Federation, 420012 Site Reference ID/Investigator# 67542 Moscow, Russian Federation, 107076 Site Reference ID/Investigator# 67546 Saratov, Russian Federation, 410028 Site Reference ID/Investigator# 78417 Smolensk, Russian Federation, 214018 Site Reference ID/Investigator# 78413 St. Petersburg, Russian Federation, 190013 Site Reference ID/Investigator# 67545 St. Petersburg, Russian Federation, 194044 Less <<
NCT01644396 - Completed - -
NCT03525678 Multiple Myeloma Phase 2 Recruiting June 30, 2020 -
NCT02548767 Chronic Disease of Cardiovascu... More >>lar System Type 2 Diabetes Obesity Less << Not Applicable Recruiting June 2020 United States, California ... More >> University of California, Davis Recruiting Davis, California, United States, 95616 Clinical Research Center Recruiting Sacramento, California, United States, 95655 Contact    916-843-9441       Touro University California Translational Research Clinic and Student Health Clinic Active, not recruiting Vallejo, California, United States, 94592 Less <<
NCT02729051 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT02660736 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT03008785 Bloodpressure Not Applicable Completed - Brazil ... More >> Guilherme Morais Puga Uberlandia, Minas Gerais, Brazil, 38400-678 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.95mL

1.19mL

0.59mL

29.74mL

5.95mL

2.97mL

59.48mL

11.90mL

5.95mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories